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ABBREVIATIONS 
 
3  oculomotor motor nucleus 
4  trochlear motor nucleus 
5  trigeminal motor nucleus 
5n  trigeminal nerve 
6  abducens motor nucleus 
6n abducens nerve 
7  facial motor nucleus 
7asc ascending facial nerve fibers 
7g facial nerve genus  
7n  descending facial nerve fibers 
9n  glossopharyngeal nerve 
10  dorsal vagal motor nucleus 
10n  dorsal vagal nerve fibers 
12  hypoglossal motor nucleus 
12n  hypoglossal motor fibers 
A  vestibular cell group A 
a  nucleus angularis 
aa aminoacid 
Amb  ambiguous motor nucleus 
AP  anteroposterior 
ap  area postrema 
aVI  accesory abducens motor nucleus 
B  vestibular cell group B 
b1  first branchial arch 
b2  second branchial arch 
b3  third branchial arch 
bv  blood vessels 
cb  cerebellum 
CCDD  congenital cranial dysinnervation disorders 
ce  external cuneate nucleus 
CFEOM  Congenital fibrosis syndrome  
CG  central gray of the pons 
CID  congenital innervation dysgenesis syndrome 
cn  cerebellar nuclei 
CNS  central nervous system 
coc  cochlear nuclei 
con  cochlear nuclei 
cp  cortical plate 
cp  choroidal plexus 
CSP  caudal secondary prosencephalon 
D  diencephalon 
d  descending vestibular nucleus 
DC dorsal cochlear nucleus 
dcn  dorsal column nuclei 
Dd  nucleus Deiters dorsalis 
dh  dorsal horn 
DNA  deoxyribonucleic acid 
Dv  nucleus Deiters ventralis 
dV  dorsal trigeminal motor nucleus 
dVr  rostral part of dorsal trigeminal motor nucleus 
dpc  days post coitum 
DRS  Duane’s retraction syndrome 
DRSS  Duane radial ray syndrome 
DV  dorsoventral 
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ECn external cuneate nucleus 
EVS exome variant server 
EW  nucleus of Edinger–Westphal 
F  forebrain 
FBM  facial branchiomotor nucleus 
g7  facial genu 
ge  ganglionic eminences 
GFP  green fluorescen protein 
Gi gigantocellular reticular nucleus 
gIX  glossopharyngeal sensory ganglia 
gV  trigeminal sensory ganglia 
gVII  facial sensory ganglia 
gVIII  statoacoustic sensory ganglia 
gX  vagal sensory ganglia 
gXI  accessory sensory ganglia 
H  hindbrain 
HCFP hereditary congenital facial paresis 
HGPPS   horizontal gaze palsy with progressive scoliosis 
Hyp  hypothalamus 
I  isthmus 
ic  inferior colliculi  
III  oculomotor nucleus 
IIIth  oculomotor nerve 
is  isthmic nucleus 
Ist  isthmus  
IV  trochlear nucleus 
IVth  trochlear nerve 
IX(m)  glossopharyngeal motor nucleus 
IXth  glossopharyngeal nerve 
IO inferior olive 
ISH  in situ hybridization 
IRt intermediate reticular nucleus 
IsO  isthmic organizer 
la  nucleus laminaris 
LL  nuclei of the lateral lemniscus 
lld  lemnisci lateralis, pars dorsalis nucleus 
lli  lemnisci lateralis, pars intermedian ucleus  
llv  lemnisci lateralis, pars ventralis nucleus 
LPGi  lateral paragiganto- cellular nucleus 
LRt  lateral reticular nucleus 
M  midbrain 
m  medial vestibular nucleus 
m1-2  mesomeres 
mc  cochlear nucleus magnocellularis 
MBS  Möbius syndrome 
MdD dorsal medullary reticular nucleus 
MdV ventral medullary reticular nucleus 
mes  mes- encephalic neuromere 
MH  medullary hindbrain 
mlf medial longitudinal fascicle 
MPS  massive parallel sequencing 
mRNA  messenger ribonucleic acid 
MVe  medial vestibular nucleus 
NGS  next generation sequencing 
NMD nonsense mediated decay 
NP  neural primordium 
nucb   cerebellar nucleus  
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nuce  cuneatus externus nucleus 
nufl  funiculi lateralis nucleus 
nufs  fasciculi solitarii nucleus 
null  lemnisci lat- eralis nucleus 
nurdV  radix descendens of V nucleus 
oid  inferior olivary nucleus pars dorsalis 
oiv  inferior olivary nucleus pars ventralis 
olsl  oliva superior, lateral nucleus 
olsm  oliva superior, medial nucleus 
os  superior olivary nucleus 
osr  rostral part of superior olivary nucleus 
ot  otic vesicles 
p1-3  prosomere 
p  principal sensory nucleus of the trigeminal column 
pbn   parabrachial nuclei 
PCRt parvicellular reticular nucleus 
pd pyramidal decussation 
PedHy   peduncular hypothalamus 
PH  pontine hindbrain 
pl  lateral pontine nucleus 
PIs  preishtmic 
pm  medial pontine nucleus 
PMH  pontomedullary hindbrain 
Pn basilar pontine nuclei 
PnC caudal pontine reticular nucleus 
PnR pontine raphe nucleus 
PNS  peripheral nervous system 
Po  paraolivary region 
pon  pontine nuclei 
POTel     preoptic telencephalon  
PPH  prepontine hindbrain 
PPnR prepontine raphe nucleus 
Pr prepositus nucleus 
Pt  pretectum 
Pth  prethalamus 
r0-11  rhombomeres 
RA  retinoic acid 
RAmb retroambiguus nucleus 
rc  central reticular nucleus 
rgc  gigantocellular reticular nucleus 
rhl  rhombic lip 
rl  lateral reticular nucleus 
rIX  retrofacial glossopharyngeal motor nucleus 
RMgD raphe magnus nucleus, dorsal part 
RMgV raphe magnus nucleus, ventral part 
RNA  ribonucleic acid 
ro  raphe obscurus nucleus 
Rob raphe obscurus nucleus 
rp  raphe pallidus nucleus 
RPa raphe pallidus nucleus 
rpc  parvicellular reticular nucleus 
RSP  rostral secondary prosencephalon 
RT-PCR  reverse transcriptase polymerase chain reaction 
RtTg reticular tegmental nucleus 
rubm  ruber nucleus 
RVL rostroventrolateral reticular nucleus 
s  tractus solitarius nucleus 
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sc  superior colliculus 
SIFT Sorting intolerant from tolerant 
SNP Single nucleotide polymorphism 
SO  superior olive 
Sol nucleus of the solitary tract 
sP  secondary prosencephalon 
Sp5C  caudal portion of the spinal trigeminal nucleus 
Sp5I interpolar trigeminal nucleus 
SpC  spinal cord 
spd  dorsal supraspinal motor nucleus 
spv  ventral supraspinal motor nucleus 
SpVe spinal vestibular nucleus 
sVII  superficial facial motor nucleus 
svz  subventricular zone 
t  descending trigeminal nucleus 
Tg  nucleus tangentialis 
Th  thalamus 
Thy  terminal hypothalamus 
tz trapezoid body 
V  trigeminal motor nucleus 
vh ventral horn 
vesn  vestibular nuclei 
vh  ventral horn of spinal cord 
VI  abducens motor nucleus 
Vth  trigeminal nerve 
VIth  abducens nerve 
VII(m)  medial facial motor nucleus 
VIIth  facial nerve 
VIIIth  statoacoustic nerve 
Vm  visceromotor column 
Vpr   sensorius principal nerve trigeminal nucleus 
Vs  superior vestibular nucleus 
vz  ventricular zone 
WES  whole exome sequencing 
WGS  whole genome sequencing 
Wt Wildtype 
X(m)  vagal motor nucleus 
Xth  vagal nerve 
XI  spinal accessory nerve nucleus 
XIth  accessory nerve 
XIIL  hypoglossal motor nucleus, pars lingualis 
XIIth  hypoglossal nerve 
XIIts  hypoglossal motor nucleus, pars tracheosyringealis 
zi  zona intermedia 
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1. MORPHOGENESIS OF THE VERTEBRATE BRAIN 
The morphogenesis of the vertebrate brain consists of a series of complex three-
dimensional transformations. The nervous system, which is divided into Central 
Nervous System (CNS) and the Peripheral Nervous System (PNS), originates from the 
ectoderm, one of the three germ layers of the gastrula stage1. The CNS is derived from 
the neural plate and encompasses by the brain and the spinal cord. The Peripheral 
Nervous System (PNS), on the other hand, is compounded by the cranial nerves, spinal 
nerves, and the ganglia arising from the ectodermal placodes and neural crest cells. 
The development of the CNS starts at the second week of human gestation with an 
increase of the thickness of the central ectoderm resulting in the formation of the 
neural plate2 (Fig. 1). Around 20-28 days of gestation the neural plate starts to roll up 
along its antero-posterior axis as a consequence of the release of molecules from 
adjacent cells (endoderm, mesoderm, Hensen’s node). These molecules can be divided 
into planar (follistatin, noggin and FGF8) and vertical (chordin, cerberus and retinoic 
acid) inductor signals3,4. Then the neural plate is transformed in a neural tube in a 
process called neurulation that finalizes with the closure of both extremes of the 
neural tube. In human the next step starts at 24-36 days of gestation with a 
heterogeneous proliferation of cells that result in a differential growing and expansion 
of the neural tube, ending with the formation of the primary prosencephalon, the 
mesencephalon and the rhombencephalon. Further growing and specification events 
will create additional subdivisions within each of these vesicles1.  
 
All these morphogenetic processes occur under the influence of different cues and 
regulatory mechanisms. Besides lineage-specific transcription factors, there are other 
molecules that mediate cellular processes, such as cell-cell and cell-substratum 
adhesion6, axon guidance7,8,9, attraction and repulsion10 and molecules regulating 
neuronal migration11. Consequently, the correct integration of these active and 
repressing signals is crucial for normal brain morphogenesis, and defects therefore can 
result in a neurodevelopmental disorder. 
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Figure 1. Scheme showing the early stages of CNS development from the neural plate 
to neural tube. a. Representation of the cellular movements within the embryonic 
disc. The direction of the movements is indicated by arrows. b. Trilaminar embryonic 
disc showing the two types of induction (planar, blue arrows; vertical, green arrows). c. 
Scheme of the embryo showing the different parts of the mesoderm. d. Formation of a 
neural groove in the neural plate. e. Terminal phase of the primary neurulation: dorsal 
fusion of the neural tube and route of migration of the neural crest indicated by 
arrows. (Figure adapted and published with the permission of L. Puelles)5. 
 
The spatial and temporal analysis of gene expression patterns in the brain can bring to 
light the molecular mechanisms that occur during brain development. This approach 
has been termed genoarchitecture, making reference to the specific gene expression 
patterns of the different neuronal population or their precursors at different stages of 
development12. According to the domains of gene expression, we can study the natural 
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boundaries of the brain regions at several developmental stages. The gene expression 
patterns studies are typically done by the detection of the messenger ribonucleic acid 
(mRNA) of the gene in the neuronal cytoplasm, by in situ hybridization (ISH). 
Alternatively, the gene expression can be observed at the protein level by 
immunohistochemistry or immunofluorescence; or by reporter genes like beta-
galactosidase or GFP (green fluorescent protein) under the control of promoter regions 
of genes of interest in transgenic mice13,14.  
 
1.1. Neuromeric model 
The neuromeric model is a structural plan for the brain of all vertebrates that has been 
discussed over the last twenty-five years according to the conjunct analysis of 
morphological and molecular data15-24. This model defines a rostrocaudal (or 
anteroposterior; AP)25 and dorsoventral (DV) division of the brain, which corresponds 
to a set of transverse subunits of the neural tube called neuromeres and four basic DV 
or longitudinal zones, respectively (Fig. 2). According to this model, the neuromeres 
are homologous, because they can be divided into DV subunits (roof, alar, basal and 
floor plates) sharing the same DV pattern along the longitudinal axis. These 
neuromeres are histogenetic fields that display a specific molecular identity and that 
have an autonomous proliferation regulation and morphogenetic development. As a 
consequence, their respective cells have similar genetic, molecular and functional 
characteristics. In comparison to the classical anatomic studies, this model establishes 
the causal boundaries based on the study of gene expression patterns during brain 
development as a novelty, instead of strictly morphological comparative 
developmental data.  
 
At early stages of development it is difficult to identify the brain subdivisions, since the 
neural tube is a flat epithelium with barely any anatomical mark that allows the 
delimitation of the boundaries. From rostral to caudal positions, the first neuromere is 
a large subunit called the primary prosencephalon, followed by the mesencephalon, 
the rhombencephalon and the spinal cord. At later stages these subunits are 
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secondarily regionalized into several subdivisions8,26,27. Therefore, the primary 
prosencephalon is the precursor of the secondary prosencephalon and the 
diencephalon. In turn, the secondary prosencephalon is subdivided into telencephalon 
and hypothalamus. The diencephalon is regionalized into three prosomeres (p1-3), 
which from rostral to caudal are the prethalamus, thalamus and pretectum. Recently 
new molecular data have confirmed the classical morphological descriptions about the 
subdivisions of the mesencephalon into two mesomeres (m1-2)28,29. The 
rhombencephalon is divided in seven rhombomeres30 and five cryptorhombomeres31. 
Finally the spinal cord is regionalized into myelomeres32.  
 
 
Figure 2. Series of diagrams of lateral views of the different stages of mouse brain 
development. Regionalization of the neural tube according to the neuromeric model. 
a. Neural primordium (NP) at early stages without divisions. b. Neural tube is divided 
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into Forebrain (F), Midbrain (M), Hindbrain (H) and Spinal Cord (SpC). c. At this stage 
the forebrain is already regionalized in two regions, the secondary prosencephalon 
(SP) and the Diencephalon (D) and the hindbrain in four subdivisions, the Prepontine 
(PPH), the Pontine (PH), the Pontomedullary (PMH) and the Medullary (MH). d. Later 
stage in which more subdivisions appear. The secondary prosencephalon is divided 
into caudal secondary prosencephalon (CSP) and rostral secondary prosencephalon 
(RSP). The diencephalon into prosomeres (p1-3), the midbrain into mesomeres (m1, 
m2), and the hindbrain into Isthmus (Is) and rhombomeres (r). e. Schematic 
dorsoventral and rostrocaudal organization of the neural tube. The presumptive 
alar/basal limit is marked with a dark line. The roof plate appears in grey color and the 
floor plate in red. The rostral secondary prosencephalon has formed the preoptic 
telencephalon (POTel), the terminal hypothalamus (Thy) and the peduncular 
hypothalamus (PedHy). P1 has formed the Pretectum (Pt), P2 the thalamus (Th) and p3 
the prethalamus (PTh). The Midbrain is divided into the main midbrain (M) and the 
smaller preishtmic divisions (PIs). (Figure adapted and published with permission of 
Prof. Dr. L. Puelles)23. 
 
Remarkably, the neuromeric model is considered a conservative model because the 
number and characteristics of the brain neuromeres are preserved through the 
species, from lamprey to human brain21,33,34. In summary, this model provides a 
morphological tool that can be used for making predictions of brain development, as 
well as for the study of its evolution across the species. Furthermore, this model is also 
potentially useful from a clinical point of view, because it allows to explain the 
developmental origin of given brain structures involved in neurodevelopmental 
disorders. 
 
2. HINDBRAIN 
In the adult brain the hindbrain is organized into three regions, the prepontine region 
which contains the cerebellum, the pons and the medulla oblongata. It contains 
several nuclei, cell populations that form inter-meshed neural networks (reticular 
formation), in addition to the origin and termination of the majority of the cranial 
nerves. Only the oculomotor nerve (IIIth) originates in the mesencephalon, while the 
rest of the cranial nerves originate in the hindbrain. The hindbrain nuclei are involved 
in crucial functions for the maintenance of the body homeostasis, and sensory and 
motor actions1. 
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2.1. Regionalization of the hindbrain  
In all vertebrates the developing hindbrain is subdivided into transverse units, called 
rhombomeres, separated by interrhombomeric boundaries. As commented above, 
these neuromeric units are distinct molecular entities and they express specific 
combinations of genes25,35. Interestingly, the cells of the interrhombomeric boundaries 
present a number of characteristics, such as clonal restriction36, aggregation of early 
axons37, reduced gap-junctional permeability38, and expression of distinct molecular 
markers39,40. The absence of cell intermixing between rhombomeres at early stages has 
been shown by ablation of the boundaries in chick embryos41 and labeling of cell clonal 
populations37. In zebrafish these boundaries act as signaling centers, regulating cell 
differentiation of adjacent rhombomeres42,43.  
 
Figure 3. Dorsal scheme of 
the chick hindbrain without 
the roof plate. On the right 
side are shown the motor 
nuclei and the exit points of 
their efferent nerves. The 
trigeminal (mV), facial 
(mVII) and glossopharyngeal 
cranial (mIX) nerves 
innervate the first (b1), 
second (b2) and third (b3) 
branchial arches, 
respectively, and the vagus 
nerve (mX) a large part of 
the body. The direction of 
the neural crest cells from 
the different rhombomeres 
are indicated by green 
arrows. Shown on the left 
side are the rhombomeres 
and the positions of the 
cranial sensory ganglia (gV 
and gVII–gXI) and the otic 
vesicles (ov) (Figure adapted 
from C. Kiecker)44.  
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The vertebrate hindbrain was classically subdivided into seven or eight 
rhombomeres15,45, however more recent studies have proposed its subdivision into 
twelve rhombomeres, from rostral r0 or isthmus until r11, according to studies in 
chick25,31,46  and in mouse5,47,48. During early developmental stages, the region 
composed of r0 and r1 develops as a morphogenetic field under the influence of 
gradient signals from the so-called isthmic organizer49. Subsequently, rhombomeres 
r2-r6 appear like bulges overtly segmented, separated by constrictions of the neural 
tube wall15,36,38. In contrast, the most caudal region of the hindbrain, 
cryptorhombomeres r7-r11 lack visible morphological boundaries, therefore their 
limits have been just identified by fate maps and gene expression patterns 
studies25,31,50. Therefore, the hindbrain can be subdivided into r0-r1 as a single 
morphogenetic field; r2-r6 as the overtly segmented region; and the 
cryptorhombomeres, from r7-r11. It is important to note that these three subregions 
correlate with the gross anatomical units of the prepontine region (including the 
cerebellum), the pons and the medulla oblongata47. 
 
Finally, from a clinical point of view, hindbrain segmentation governs the neural crest 
migration processes and therefore influences the fate of the mesenchymal neural crest 
derivatives such as craniofacial bones and other connective tissues of head and neck51. 
It is also involved in preservation of neural structures at post-segmental and adult 
stages52,53. Furthermore, the segmentation of the hindbrain and its derived neural crest 
control the formation of the cranial nerves, nuclei and ganglia. Phenotypic studies in 
mice, with targeted disruptions in one of the genes involved in segmentation, are 
providing more insights about the importance of these genes in the adult morphology 
and physiology54-57.  
 
2.1.1. Molecular basis in hindbrain segmentation  
The AP patterning of the hindbrain is governed by three secondary organizers or 
signaling centers, which produce a gradient of different molecules along the 
rostrocaudal axis. These molecules or morphogens58 regulate the development and 
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fate of the diverse cell populations according to their respective AP positions. Two of 
these secondary molecular organizers are placed within the own hindbrain, the Isthmic 
Organizer (IsO) localized in the isthmic region59 and a second organizer located at 
middle positions in the hindbrain, around r460 (Fig. 4). The third organizer is shaped by 
retinoic acid (RA) secreted by the paraxial mesoderm (somites) that are adjacent to the 
caudal hindbrain and spinal cord61.  
 
The IsO participles in both midbrain and hindbrain organization62,63. The IsO secretes 
diffusible molecules as WNT (mainly Wnt1) and FGF (FGF8, FGF17, FGF18) that 
regulate the expression of two engrailed genes, En-1 and En-2, which are involved in 
the development of adjacent areas64. In the first phase, the IsO specific genes are 
under the influence of planar and vertical interactions from the node and axial and 
paraxial mesoderm59. During the second phase, the IsO genes establish a complex 
network to maintain the organizer65. The anterior domains to the IsO are defined by 
Otx2 expression and the caudal ones by Gbx265,66. After that, the expression of En and 
Pax, Wnt1 and Fgf8 are activated in the caudal midbrain and anterior hindbrain, 
respectively, triggering the molecular network responsible of the development of the 
cerebellum, tectum and other neural structures characteristics of this region64. The 
signaling center located around r4 is a source of FGFs that regulate the specific 
expression of Krox20 and mafB/kr, respectively expressed in r3 plus r5, and r5-r660,67. 
Finally the caudal signaling center in hindbrain patterning is placed at caudal positions 
of this region and at the spinal cord, including both the neuroepithelium and the 
adjacent somites68-70. The main posteriorizing signal from this organizer consists of All-
trans Retinoic Acid (RA), which is synthesized by RALDH enzymes71 and acts through 
the nuclear receptors RARs and RXRs. These receptors are ligand-inducible 
transcription factors that bind to a short DNA motif (RA responsive elements RARE and 
RXREs) to modulate transcription72. Hence, most of the Hox-family segmentation genes 
of the hindbrain contain a RARE DNA motif in their regulatory region73. Consequently, 
Hox gene expression along the AP axis is controlled by RA produced from the hindbrain 
caudal source. In turn, the rostral hindbrain secretes cytochrome oxidase p45074 which 
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degrades RA, leading to the formation of a caudo-rostral decreasing gradient of this 
morphogen along the axis61.  
 
 
Figure 4. Scheme showing the three signaling sources acting over hindbrain 
patterning. The three signaling sources are localized within the isthmus (midbrain/r1 
boundary) as source of FGFs and other molecules, r4 as source of FGF3 and FGF8 and 
caudal tissues as sources of RA. Rostral is to the left and caudal positions to the right. 
(Adapted from Maves et al.)60. Retinoic acid (RA), otic vesicle (ot), r (rhombomere). 
 
Besides the aforementioned signaling centers acting along the AP axis of the hindbrain, 
other signaling pathways involving Eph/ephrins regulate cell sorting between 
rhombomeres. The interaction between cells expressing Eph receptors and cells 
expressing a ligand (ephrin) creates signals that establish differences between cell 
adhesion inside each segment and repulsion of cells from neighboring segments, 
leading to the formation of the respective interrhombomeric boundaries75. 
 
At the same time of interrhombomeric boundary formation, the hindbrain 
neuroepithelium becomes organized into successive rhombomeres. The genes that 
participate in this segmentation process can be classified into ‘segmentation genes’ 
and genes involved in regional identity. Segmentation genes include those genes 
whose inactivation leads to abolition of hindbrain territories or modification of their 
size76,77. This group of genes is expressed in specific segmented patterns during early 
development. It includes the homeodomain-containing genes Gbx2, Iro7 and vHnf1, 
the leucine-zipper gene MafB, and the Zinc-finger gene Krox20. The second group of 
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genes regulates the histogenetic fate of each of the rhombomeres in which they are 
expressed, according to their AP position. This group is mainly represented by the Hox 
family transcription factors. The mutation of these genes leads to changes in positional 
identity between segments, as described below78.  
 
Hox genes 
Hox genes encode a highly conserved family of homeodomain transcription factors with 
important roles in the metazoan body plan79,80. Hox genes were first described in 
Drosophila, but they are present in most animal phyla from hydra to chordates (Fig. 5). 
They regulate segmentation and developmental patterning in all bilaterians81. This 
protein family is characterized by the presence of a homeobox motif, a helix-turn-helix 
motif responsible for sequence-specific DNA binding. In vertebrates there are 39 Hox 
genes organized within four chromosomal clusters (A-D)82. Within each cluster all genes 
have the same orientation with respect to transcription, thus the genomic organization 
and temporal and spatial expression is conserved through species.  
 
 
Figure 5. Hox genes in Drosophila, mouse and human presented in their respective 
clusters and chromosomes (Adapted from Graham et al)86. 
 
There are 13 paralogous groups based on the orientation and similarities in their 
sequences, although not all of the paralogous Hox genes are present in all the clusters. 
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Their main singular characteristic is termed ‘colinearity’, meaning that they present a 
spatial and temporal expression gradient from 3’ to 5’ position along AP axis during 
successive stages in development83. There are two possible mechanisms proposed for 
the Hox colinearity, although none of them can fully explain all the gain and loss of 
function phenotypes. The first one is based on the 3’ to 5’ opening of Hox cluster 
chromatin according to transcriptional regulation84. The second mechanism is based on 
the interactions between Hox genes and it is known as posterior prevalence85. This 
concept proposes that more caudal Hox genes have the ability to repress the expression 
of more anterior Hox genes. 
 
Hox gene expression and function 
As a consequence of the colinearity, the Hox genes located at 3’ positions within the 
cluster are expressed in anterior positions and at earlier stages in development than Hox 
genes at 5’ positions, following the so-called Hox code. In general genes within the same 
cluster are expressed with a two segment periodicity with respect to the adjacent genes 
(Fig. 7). Interestingly, this code also plays a role within individual cells to define their 
specific fates87,88. In the vertebrate hindbrain Hox expression code is associated with 
rhombomere patterning/organization (Figure 7). The Hox gene expression patterns 
extend from the spinal cord into the hindbrain displaying an anterior boundary that 
corresponds with interrhombomeric limits89,90. As a consequence, genes from groups 1-3 
present an anterior limit between r2/r691,92 than genes from groups 4-7 within 
r6/r1125,93, while genes from groups 8 to 10 present an anterior limit of expression that 
the spinal cord level94,95.  
 
Misexpression or inactivation of Hox genes results in homeotic changes in 
rhombomere gene expression, rhombomere identity and development of their 
respective segmentary structures97,98. The inactivation of Hox genes leads to the 
rostralization of the caudal rhombomeres, while the Hox gene overexpression 
produces the opposite effect. The role of Hox genes in developmental processes of 
several organs and systems is reflected by the notion that their mutation cause 
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widespread alterations in hindbrain derivatives: neurons, neural crest, endodermal 
and mesodermal tissues95,99-101. Until now there are 10 HOX genes known to contribute 
to human disorders (HOXA1, HOXA2, HOXA11, HOXA13, HOXB1, HOXB13, HOXC13, 
HOXD4, HOXD10, and HOXD13)102. They present different patterns of inheritance, 
penetrance and pathogenesis but interestingly, the phenotypes in humans and mice 
resemble the colinearity property of Hox genes. Therefore, mutations in genes at more 
3’ position cause pathological lesions in more anterior body positions, i.e. mutations in 
HOXB1 are related with facial paralysis55. On the contrary, mutations in genes at 5’ 
positions are preferentially related with alteration in distal parts of the body, like those 
resulting from mutations in HOXD13 in limb malformation103. Concerning the 
hindbrain, mice carrying knockout alleles of 3’ Hox genes have defects in the 
development of the rhombomeres. For example, the inactivation of Hoxa1 leads to a 
partial loss of r4 and r5, defects in facial an abducens motoneurons and malformations 
in other cranial nerves104.  
 
 
Figure 6. Hox gene expression patterns correlated with rhombomeres and 
cryptorhombomeres boundaries in the mouse hindbrain. Higher domains of expression 
are indicated by darker colors, and members within a paralogous group are represented 
in the same color. (Adapted from Alexander et al., Marín et al., 2008, and Tomás-Roca et 
al., 2014)25,48,95. 
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Hox gene regulation in the hindbrain 
Retinoic acid (RA) and Fgf are the most important signals regulating Hox gene 
expression within the hindbrain62,102. Hox genes from the 3’ region have been shown 
to have RARE sequences. Hence, RA plays a role initiating early Hox gene expression 
and patterning the hindbrain104. RA directly activates Hoxa1, Hoxb1, Hoxa4, Hoxb4, 
and Hoxd4 genes69,73,106-108. It is important to note that concentration of retinoic acid 
varies along the rostrocaudal axis, as commented above. The highest concentration of 
RA in the hindbrain is at the caudal levels decreasing progressively in rostral directions. 
At early stages, RA is produced in neighboring somites of the neural tube but at later 
stages the sources change to the caudal hindbrain109. At the beginning of the hindbrain 
segmentation, 3’ Hox genes are activated by RA and rhombomere-specific 
transcription factors (Krox20 and Kreisler/MafB)110. During the next step there is a 
maintenance of Hox expression by autoregulation, pararegulation (between 
paralogues) and cross-regulation111.  
 
FGFs regulate Hox expression at different locations and developmental stages. 
Rostrally, FGFs secreted from the Isthmic region are involved in regulating the anterior 
limit of Hox expression112. In the other hand, Fgf3 and Fgf8 are expressed in hindbrain 
before segmentation around the prospective r4, regulating the expression of Hoxa2 
and other hindbrain segmentation genes60. Additionally, at early neural plate stages 
FGF8 secreted from the node influences Hox expression during axis elongation via Cdx 
genes.  
 
There are other pathways involved in Hox gene regulation; vhnf plays an indirect role 
to specify r5/r6 identity by repressing Hoxb1 and activating krox20 and Kreisler.113. 
Krox20 activates the transcription of Hoxa2, Hoxb2 and EphA4 in r3 and r5114. It also 
activates, together with Kreisler, the expression of Hoxb3 in r5115. Kreisler activates the 
expression of Hoxa3 and Hoxb3 in r5 and r6 by binding to cis-modules upstream of 
those genes116. Moreover, cross- and auto-regulation of Hox genes plays an important 
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role in hindbrain segmentation84. In summary, there is evidence of presence of many 
feed-forward and feedback loops regulating rhombomere Hox genes expression.  
 
Finally the specificity and sensitivity of HOX-binding to the DNA is modulated by 
several cofactors117. The two main cofactors are PBX (proto-oncogenes Pre-B cell 
leukemia transcription factors) and MEIS (murine ectopic integration site), both 
belonging to the TALE (three-amino acid-loop-extension) family. The first subfamily 
includes Pbx1-4ref118, which directly interact with HOX proteins to enhance their 
specificity. The MEIS subfamily includes Meis and Prep in vertebrates, which both 
regulate HOX activity as a component of the DNA-bound HOX complex by stabilizing 
and promoting nuclear localization of the PBX protein119,120.  
 
2.2. Histogenic organization of the hindbrain. 
Similar to other regions of the brain, the wall of the hindbrain is regionalized into four 
longitudinal zones, the roof, alar, basal and floor plates. His121 was the first to affirm 
that the lateral wall of the central nervous system could be divided in a dorsal plate, 
which contains the sensory centers, and a basal plate, containing the motor centers 
that are separated by the sulcus limitants48,122. In general the longitudinal areas 
correspond to functional somatosensitive, viscerosensitive, visceromotor and 
somatomotor regions. The alar or sensory plate contains all the primary afferent 
centres, while within the basal or motor plate there are the efferent centres50. The 
basal plate is subdivided into a medial or somatomotor zone and an intermedioventral 
or visceromotor zone. In turn, the somatomotor zone includes the superior, medius, 
and inferior reticular nuclei, and the superior and inferior raphe nuclei, the 
somatomotor nuclei of IV, VI and XII nerves, and the rostral end of the spinal motor 
column. In this column there are also non-somatomotor nuclei, such as the 
forementioned reticular and raphe nuclei, or the interpeduncular nucleus and the 
inferior olive, which have migrated from dorsal regions. The intermedioventral or 
visceromotor zone presents the origin of the visceromotor and parasympathetic-
preganglionic nuclei of V, VII, IX, X and XI nerves (Fig. 8). The functional exceptions 
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within this column are the Mauthner neuron (restricted to amniotes), the efferent 
nucleus of the VIII the nerve, the precerebellar nucleus of the funiculus lateralis, the 
superior olive (in anurans), the nucleus of the lateral lemniscus, and two auditory relay 
nuclei. The alar plate can be also subdivided in an intermediodorsal column that 
contains viscerosensory and somatosensory nuclei and a dorsal column integrated by 
somatosensory nuclei1,50,122.  
 
The intersections between the longitudinal columns with the rhombomeres results in 
histogenetic fields of the hindbrain organized into a cartesian-like grid24,122. At the first 
stages of neurogenesis, different types of neurons appear with a segmental pattern of 
neurogenesis in the overtly segmented hindbrain (r2-r6). In contrast, in the rostral and 
caudal hindbrain the respective patterns of differentiating neurons appear more 
homogeneous along these territories38,123. Therefore, at early stages of development 
the longitudinal columns appear subdivided into discrete units along the AP axis 
according to their incipient neuronal differentiation pattern.  
 
At later stages, when the definitive neuronal populations have already formed, they 
can be assigned to their respective rhombomere of origin using fate mapping 
experiments. Some of the brainstem nuclei follow the segmental pattern of the 
hindbrain, remaining within one rhombomere as seen for the superior olive located in 
r5. However, other nuclei present a plurisegmental origin within several 
rhombomeres, like the nucleus of the fasciculus solitarious (across r8-r11) or abducens 
nucleus (across r5-r6 in the chick)25. These plurisegmental nuclei could share similar 
characteristics through the adjacent rhombomeres besides their specific molecular 
identity derived from the different rhombomeres.  
 
Not all hindbrain neurons stay in their original location. There are some neurons that 
originate in proliferation zones and afterwards they migrate towards their final 
destination in other hindbrain regions. For instance, the rhombic lip is a proliferative 
zone placed dorsally adjacent to the choroidal roof integrated by different 
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rhombomeric units. The neurons originated in this zone carry out a tangentional 
migration until their final areas of the hindbrain where they give rise to structures such 
as the cochlear nuclei, the pontine nuclei and the inferior olive51,124. 
 
 
Figure 7. Topological maps of the hindbrain. a. Fate map of the avian rhombomeric 
hindbrain. (Figure adapted and published with the permission of F.Cambronero and 
Puelles, F.Marin)29,30.  
 
3. CONGENITAL CRANIAL DYSINNERVATION DISORDERS 
The Congenital Cranial Dysinnervation Disorders (CCDDs) comprise a heterogeneous 
group of diseases characterized by congenital, non-progressive developmental 
abnormalities of one or more cranial nerves125 (Table 1). As a consequence, there is a 
primary or secondary inappropriate innervation of the targeted muscles, resulting in a 
secondary pathology of these muscles. In addition to the motor nerves that are 
affected in CCDDs, the sensory branches of the cranial nerves can also be involved126. 
The term CCDDs has been replaced by some authors by Congenital Innervation 
Dysgenesis (CID) syndromes127,128. Both terms are essentially equal, although CID is a 
more general definition including the alteration of nerves of others parts of the body. 
CCDDs include syndromes such as, Duane’s Retraction Syndrome (DRS), Duane Radial 
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Ray Syndrome, Horizontal Gaze Palsy with Progressive Scoliosis, Congenital fibrosis of 
the extraocular muscles, HOXA1 spectrum and Hereditary Congenital Ptosis, 
Hereditary Congenital Facial Paresis and Möbius syndrome. 
 
DRS or Stilling–Turk Syndrome is the most common CCDD. It is characterized by 
limitation or absence of abduction and/or adduction of the eyes, retraction of the 
ocular globe and narrowing of the palpebral fissure129. Up to 10% of the cases are 
familial, and two loci are known, the DURS1 locus (MIM 126800) at chromosome 8q13 
and DURS2 (MIM 604356) at 2q31ref130. For the DURS1 locus, a DRS-associated 
translocation breakpoint disrupted the CPA6 gene, which is involved in peptide 
processing in the brain130. The DURS2 locus is associated with dominant mutations in 
CHN1131-133, which encodes the Ras GTPase-activating protein N-chimerin134. Mutations 
in CHN1 result in alteration of the abducens (VIth) and oculomotor (IIIth) nerves 
development. Recently, de novo microdeletions have been identified in one patient, 
each encompassing only one gene, RNF34 at 12q24.31 and PPARA at 22q13.31135. 
Finally, it has been shown that mutations in COL25A1 cause autosomal recessive CCDD, 
in one family with DRS and congenital ptosis phenotype136. 
 
Duane Radial Ray Syndrome (MIM 607323) is characterized by the same features as 
DRS plus upper extremity anomalies and variable cardiac, renal, hearing and vertebral 
abnormalities. It maps to 20q13 and is associated with nonsense mutations in SALL4 
gene137. Finally, recessive HOXA1 mutations have been associated with two related 
syndromes (MIM 601536) that present bilateral Duane Radial Ray Syndrome, deafness, 
and internal carotid and cerebrovascular malformations: the Athabaskan brainstem 
dysgenesis syndrome (observed in two native American tribes) and the Bosley-Salih-
Alorainy syndrome (BSAS, observed in Saudi Arabian and Turkish families)ref138. 
 
Horizontal Gaze Palsy with progressive scoliosis presents bilateral absence of 
horizontal eye movement, with full vertical gaze, variable convergence, and variable 
congenital nystagmus in combination with scoliosis developing during childhood. It is 
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an autosomal recessive disorder caused by mutations in ROBO3ref139 mapping to 
11q23-25140 (MIM 607313). ROBO3 is specifically expressed by commissural axons and 
participate in the midline crossing axons of the hindbrain and spinal cord during 
development141,142.  
 
 
Figure 8. Cranial nerves origin and innervation. By courtesy of Encyclopaedia 
Britannica, Inc., copyright 2007; used with permission.  
 
Three types of Congenital Fibrosis of the ExtraOcular Muscles (CFEOM) have been 
described. CFEOM1 (MIM 135700) is the most common of these, whose main features 
are bilateral ptosis and severe restriction of upgaze so that neither eye is able to reach 
the midline143,144. Heterozygous missense mutations in KIF21A have been identified as 
the genetic cause. KIF21A encodes a kinesin microtubule-associated protein associated 
with anterograde organelle transport in neuronal cells144. CFEOM2 (MIM 602078) is an 
autosomal recessive disorder characterized by bilateral ptosis and absent adduction of 
the eyes, up- and downgaze. CFEOM2 is associated to homozygous loss of function 
mutations in the PHOX2A gene145. This gene encodes a transcription factor essential 
for oculomotor and trochlear motoneurons survival. Finally, CFEOM3 is similar to 
CFEOM1 with more variability and occasional ability to elevate the eyes above the 
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midline146. CFEOM3 has been associated with heterozygous mutations in two genes, 
TUBB3ref147 and KIF21A148, and three different loci146-149. Interestingly both TUBB3 and 
KIF21A are essential for axon growing towards their targeted extraocular muscles. The 
characteristic feature of Hereditary Congenital Ptosis is the isolated drooping of the 
upper eyelid. Two loci have been associated with this disease, the PTOS1 locus maps to 
chromosome 1 (MIM 178300)150 and PTOS2 on chromosome X151. To date all the 
identified genes associated with CCDD are involved in neuronal development, 
supporting the hypothesis of the primary neural origin of the CCDD rather than a 
primarily abnormality of the muscles. Due to the overlapping features amongst the 
various CCDDs and because of the considerable variability of the clinical presentation 
of each individual disorder, even within families, it is sometimes a challenge to make 
the correct clinical diagnosis.  
 
In the present thesis I will focus in two disorders from CCDD group, the Hereditary 
Congenital Facial Paresis and Möbius syndrome for which genetic defects were not 
known at the start of my research.  
 
3.1 Hereditary Congenital Facial Paresis 
Hereditary Congenital Facial Paresis (HCFP) is a rare autosomal dominant disease 
characterized by uni- or bilateral weakness or paralysis of the facial muscles152. 
Postmortem studies in HCFP hindbrain tissues have identified a maldevelopment of 
the facial (VIIth) cranial nerve or its nucleus as the cause of the facial paralysis. The 
neuropathological analysis described a marked decrease in the number of neurons 
within the facial motor nucleus (FBM) in three members of a family with HCFP linked 
to chromosome 3ref153. In contrast to Möbius syndrome, HCFP patients present normal 
ocular motility. 
 
Two HCFP loci have been reported, HCFP1 and HCFP2. The first locus HCFP1 locus 
(MIM 601471) maps to a 3 cM region at chromosome 3q21–q22 and was identified by 
linkage analysis performed in two large familiesref153,154. The phenotype associated 
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with HCFP1 is an asymmetrical, bilateral, facial weakness, with involvement of the 
three branches of the facial nerve. Non-manifestating obligate carriers of the disease 
allele are known and the estimated penetrance is around 95%. The second locus, 
HCFP2 (MIM 604185) was identified by linkage analysis in a Dutch family and is located 
on chromosome 10q21.3–q22.1ref155. In this family the penetrance is approximately 
60%. The phenotype is characterized by asymmetrical, uni- or bilateral, facial 
weakness, with involvement of the three branches of the facial nerve. In this case, 
hearing loss and congenital deafness were also described in some affected individuals. 
In order to identify the genetic defect underlying HCFP many genes from both loci have 
been sequenced. Those genes have been selected according to their localization within 
the two HCFP loci, function in facial nerve or hindbrain development, functions on 
gene knockout and their specific mRNA expression in hindbrain or facial motor 
nucleus153-157. Several genes located within or nearby these loci have been proposed as 
candidate genes. For HCFP1: PODXL2, KLF15, FLJ40083, TMCC1, PLEXIN-A1, EEFSEC, 
RAB7A, PGT, GATA2, PLXND1ref153,154,156-158 and MGLL (data not published), and for 
HCFP2: EGR2 (also known as KROX20), CTNNA3, LRRTM3ref155,158 and REEP3 (data not 
published). However to the date no gene underlying HFCP cause has been identified. 
 
1.1. Möbius Syndrome 
Möbius syndrome (MBS) is a rare congenital disorder characterized by an impairment 
of ocular abduction and congenital non-progressive facial weakness159,160. This 
paralysis can be uni- or bilateral and as a consequence MBS patients are unable to 
show their facial expression. In Möbius patients there are two cranial nerves involved 
the facial nerve (VIIth) which is also affected in HCFP and the abducens nerve (VIth). 
Additional features are commonly seen, making the clinical manifestation of MBS 
extremely variable. Examples of associated features are the dysfunction of other 
cranial nerves, such as the hypoglossal (XIIth), oculomotor (IIIth), trochlear (IVth), 
trigeminal (Vth), vestibulocochlear (VIIIth), and glossopharyngeal (IXth), limb 
malformations, such as syndactyly, brachydactyly, ectrodactyly of the hands, and 
talipes equinovarus, craniofacial dysmorphism, muscoloskeletal system defects, 
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absence of the pectoralis major (Poland syndrome), hearing and vision problems and a 
wide variety of occasional features. 
 
 
Figure 9. Facial and abducens nerves origins. a. Transverse section of the hindbrain at 
facial nerve and facial motor nucleus level and facial nerve branches b. Transverse 
section of the hindbrain at abducens nerve origin and abducens nerve branches. 
(Figure adapted and published with the permission of L. Puelles)5. 
 
The neuropathologic findings in MBS patients are very heterogeneous. The syndrome 
has been described as a rhombencephalic syndrome159,160 rather than an isolated 
cranial nerve developmental disorder like HCFP. According to these findings, four MBS 
categories have been proposed161: group I is characterized by hypoplasia or absence of 
cranial nerve nuclei; group II, by fewer number of neurons and neuronal degeneration 
secondary to a facial nerve defect; group III, is characterized by loss of neurons, 
neuronal degeneration, focal necrosis, gliosis, and hindbrain lesions with calcifications; 
and group IV, is characterized by myopathic changes without cranial nerve affectation. 
Results from electrophysiological analyses have suggested defects at nuclear, 
supranuclear or peripheral levels in different patients162,163, supporting the hypothesis 
of widespread brainstem involvement.  
 
The etiology and the pathogenesis of MBS are still unclear, although two major 
hypotheses have been proposed. First a vascular theory suggesting that an 
interruption of blood supply to the hindbrain, resulting in ischemia, could lead to a 
hypoxic state in specific brainstem areas during development164,165. The use of some 
teratogenic factors during pregnancy, such as misoprostol165, thalidomide167, 
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ergotamine168, and cocaine169 can give rise to an ischemic insult. Accordingly, there is 
an higher MBS prevalence in some populations due to increased exposure to these 
drugs (e.g. >50% in Brazil)168. The second hypothesis, for a primary defect in hindbrain 
development, is a genetic cause supported by a few reports of familial occurrence with 
autosomal dominant169, autosomal recessive170, and X-linked recessive inheritance172. 
Most of these cases manifest an atypical MBS phenotype. Examples include, a 
reciprocal translocation between chromosomes 1p34 and 13q13 co-segregating in 
seven family members173, a deletion of chromosome 13q12.2 in a 2.5-year-old girl with 
MBS174, a reciprocal translocation involving chromosome 1p22.3 and 2q21.1 in a male 
with MBS174 and a reciprocal translocation between chromosome 1p22 and 11p13 in a 
MBS-like patient176. Additionally, a founder mutation in HOXB1 has been described in 
an autosomal recessive phenotype overlapping MBS features55. However, the majority 
of the MBS cases are sporadic and sibling recurrence is rare. To the date of starting this 
thesis, all the efforts to elucidate a gene underlying the typical MBS occurring in 
isolated cases had failed. 
 
  
 
Table 1. Genes associated to congenital cranial dysinnervartion disorders.  
 
Disorder Pattern of inheritance Main clinical features 
Locus 
(OMIM number) Gene Potential function Ref 
Duane’s Retraction 
Syndrome 
Up to 10% of 
cases AD 
limitation of abduction and/or 
adduction of the eyes, retraction 
of the ocular globe, narrowing of 
the palpebral fissure 
DURS1 
8q13 
MIM 126800 
CPA6 Biosynthesis of neuroendocrine peptides 129 
DURS2 
2q31.1 
MIM 604356 
CHN1 Ras GTPase activating protein involved in neuronal signal-transduction 130-132 
 COL25A1 A brain-specific membrane-bound collagen 136 
Duane Radial Ray 
Syndrome AD 
Duane´s Retraction syndrome, 
upper extremity anomalies, 
variable cardiac, renal, hearing 
and vertebral abnormalities 
20q13.2  
MIM 607323 SALL4 Zinc finger transcription factor 134,137 
Athabaskan disgenesis 
syndrome AR 
lateral gaze palsy, deafness, 
central hypoventilation, cardiac 
outflow tract anomalies, mental 
retardation, cerebrovascular 
abnormalities 
7p15.2 
MIM601536 HOXA1 
Placement of hindbrain segments in 
the proper location 138 
Bosley-Salih-Alorainy 
syndrome 
Horizontal Gaze Palsy with 
progressive scoliosis AR horizontal gaze palsy, scoliosis 
11q23-q25 
MIM 607313 ROBO3 
Regulates axonal navigation at the 
ventral midline of the neural tube 139,140 
Congenital Fibrosis of the 
ExtraOcular Muscles 
CFEOM1 
AD 
bilateral blepharoptosis, 
ophthalmoplegia with the eyes 
below the middle line 
12q12  
MIM 135700 KIF21A Microtubule dependent transport 144 
Congenital Fibrosis of the 
ExtraOcular Muscles 
CFEOM2 
AR 
 bilateral ptosis, absent 
adduction of the eyes,  up- and 
downgaze 
 
11q13.4  
MIM 602078 PHOX2A 
Development of the autonomic 
nervous system regulating the 
expression of tyrosine hydroxylase and 
dopamine beta-hydroxylase, 
145 
Congenital Fibrosis of the 
ExtraOcular Muscles 
CFEOM3 
AD 
Ptosis, restrictive external 
ophthalmoplegia, -additional 
neurologic symptoms 
16q24.3  
MIM 600638 TUBB3  147 
AD variable involvement and 12q12 KIF21A  Microtubule dependent transport 148 
 
 
severity of ophthalmoplegia and 
ptosis 
MIM135700  
AD 
congenital bilateral ptosis, 
limitation of the superior rectus, 
bilateral excyclotropia 
13q12.11  
MIM 609384  
Neurogenesis and axon guidance and 
maintenance. 149 
Hereditary Congenital 
Ptosis 
AD Simple, with external 
ophthalmoplegia, and with 
blepharophimosis. 
PTOS1 
1p34.1-p32 
MIM 178300    
150 
X-linked 
PTOS2 
Xq24-q27.1  
MIM 300245 
151 
Hereditary Congenital 
Facial Paresis AD 
congenital unilateral or bilateral 
hereditary facial palsy 
HCFP1 
3q21-q220147 
MIM 
  153,154 
HCFP2 
10q21.3-q22.1 
MIM604185 
  155 
Möbius Syndrome Sporadic, AD, AR, X-linked 
nonprogressive facial palsy, 
abducens palsy    169-172 
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2. AIM AND OUTLINE OF THIS THESIS 
The aims of the research reported in this thesis are to obtain more insight into the 
molecular organization of the developing hindbrain and to identify the genetic causes 
of MBS and HCFP. To achieve these goals, I have used a morphological and a genetic 
approach.  
 
For the morphological strategy I have conducted two studies: the first of them focused 
in the analysis of hindbrain segmentation; and the second study consisted of the 
selection of genes according to their specific expression in the facial motor nucleus at 
embryonic stages. The latter study provided candidate genes for HCFP that were 
subsequently sequenced in a cohort of patients. Using a genetic strategy in a second 
phase of this project, I have applied Next Generation Sequencing techniques to unravel 
the genetic defects underlying MBS and HCFP. Afterwards, the causativeness of the 
candidate genes was proved by the study of the mutant mouse brains during 
development.  
 
In Chapter 2 I have analyzed the corroborated the predicted hidden segmentation 
within the mouse medulla oblongata by correlating different morphological landmarks 
with the gene expression pattern of Hox paralogue groups three to eight. In Chapter 3 
I have described the expression pattern of genes located within HCFP1 and HCFP2 loci, 
in the mouse embryonic brainstem, in order to propose candidate genes for HCFP 
according to their possible expression in the developing facial motor nucleus or related 
hindbrain structures.  
 
Chapter 4 includes the identification of frameshift mutations in MEPE in one HCFP 
family, one family with otosclerosis and one patient with sensorineural hearing loss. In 
Chapter 5 the results of the application of NGS techniques to MBS patients are 
presented. Two de novo mutations were found in two different genes, PLXND1 and 
REV3L. Subsequent Sanger sequencing of these genes in our cohort of 103 patients 
revealed two additional de novo mutations in each gene. The pathogenic role of both 
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genes was established by a morphonoanatomical study of Plxnd1 and Rev3l mutant 
mice. Chapter 6 provides a summary and discussion of the overall results of this study 
and future research perspectives. 
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ABSTRACT 
The medulla oblongata is the caudal portion of the vertebrate hindbrain. It contains 
major ascending and descending fiber tracts as well as several motor and interneuron 
populations, including neural centers that regulate the visceral functions and the 
maintenance of bodily homeostasis. In the avian embryo, it has been proposed that 
the primordium of this region is subdivided into five segments or crypto-rhombomeres 
(r7 to r11), which were defined according to either their parameric position relative to 
intersomitic boundaries or a stepped expression of Hox genes. In the present work we 
examine the implied similar segmental organization of the mouse medulla oblongata. 
To this end, we analyze the expression pattern of Hox genes from groups 3 to 8, 
comparing them to the expression of given cytoarchitectonic and molecular markers, 
from mid-gestational to perinatal stages. As a result of this approach, we conclude that 
the mouse medulla oblongata is segmentally organized, similarly as in avian embryos. 
Longitudinal structures such as the nucleus of the solitary tract, the dorsal vagal motor 
nucleus, the hypoglossal motor nucleus, the descending trigeminal and vestibular 
columns, or the reticular formation appear subdivided into discrete segmental units. 
Additionally, our analysis identified an internal molecular organization of the migrated 
pontine nuclei that reflects a differential segmental origin of their neurons as assessed 
by Hox gene expression.  
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INTRODUCTION 
The developing brain of vertebrates is subdivided into transverse segments or 
neuromeres disposed serially along the longitudinal axis. Though they show regional 
diversity, all neuromeric units share the same primary dorsoventral zones (roof, alar, 
basal and floor plates), as a consequence of a common mechanism of dorsoventral 
patterning. This shared fundamental morphological organization represents what is 
metamerically repeated. These segments express specific combinations of 
developmental genes that control more detailed differential specification of their 
primary dorsoventral zones, and behave during development as relatively self-
contained proliferative and histogenetic units. Interactions between neighboring 
neuromeres may include interchange of specific cell populations by tangential 
migration. Neuromeres have been putatively identified within the forebrain, midbrain 
and hindbrain1-7. 
 
In the hindbrain, some of these neuromeric segments –known as rhombomeres- 
appear at early stages as observable bulges of the neural tube wall, separated by 
external transverse constrictions and ventricular interrhombomeric ridges; they are 
each correlated with different hindbrain motor nuclei and nerve roots1,8 (and display 
an heterochronic pattern of neurogenesis, with the even-numbered rhombomeres 
ahead of the odd-numbered ones. The interrhombomeric boundaries display specific 
cellular and molecular characteristics, such as particular (longer) cell cycle kinetics, 
reduced gap-junctional permeability, differential cell-cell adhesive properties and 
restriction of clonal neuroepithelial cell dispersion9. Various transcription factors 
belonging to the Hox family (among other genes) were demonstrated with respect to 
these boundaries in a characteristic sequence10-12. 
 
All these characteristics appear only in rhombomeres r2 to r6. Rostrally, the isthmus 
(r0) and r1 units develop under the influence of gradiental signals from the isthmic 
organizer, forming a morphogenetic field together with the caudal midbrain13. 
Caudally to r6 (facial motor nucleus level), the hindbrain includes a large medullary 
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territory lacking observable outer transverse constrictions. The neurogenetic pattern 
of this caudal region is rather homogeneous along the rostrocaudal axis, without 
apparent discontinuity with the spinal cord14,15. This caudal territory has been 
classically identified as an enlarged r7 segment1, or subdivided into r7 plus an enlarged 
r8 that contains the hypoglossal nerve roots. However, the hypothetical boundary 
between r7 and r8 does not share the forementioned molecular and cellular 
characteristics of typical interrhombomeric boundaries, and the hypothetical r8 is 
about 4 times larger than the rest of rhombomeres1,8.  
 
A possible hidden segmentation of the forementioned r7 plus r8 medullary region was 
first contemplated by Cambronero and Puelles16. These authors took into account that 
this neural region lies adjacent to the first 4-5 pairs of (postotic) somites, while in the 
nearby presumptive spinal cord the apparent segmental units (myelomeres) are 
separated by clonal boundaries aligned with the middle of adjacent somites1,17,18. 
Consequently, Cambronero and Puelles16 performed quail-to-chick grafts of medullary 
neuroepithelial portions delimited by planes crossing through the middle of adjacent 
somites, aiming to fate-map potential hidden rhombomeres beyond r6 in the adjacent 
neuroepithelium. Each graft down to the middle of the 5th somite indeed gave rise to a 
segment-like portion of the mature hindbrain, with surprising coincidence of the 
arbitrary limits with cytoarchitectonic internuclear boundaries. This led to the proposal 
of a segmental map of 5 pseudo- or crypto-rhombomeres (r7 to r11) in the medulla 
oblongata16. Ulteriorly, an analysis of late embryonic Hox gene expression patterns 
within the medullary region in the chick hindbrain demonstrated that the rostral 
expression limits of the paralogue Hox groups 4 to 7 sequentially coincide with the 
proposed limits of r7-r11, similarly as the paralogue Hox groups 1-3 identify the r1-r6 
limits19. These findings were clearly consistent with the concept of pseudo- or 
cryptorhombomeres postulated by Cambronero and Puelles16, emphasizing the higher 
relevance of molecular differentiation of rhombomeres over their delimitation via 
characteristics of the interrhombomeric limits. 
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The region mapped in this way corresponds to the portion of the adult brain classically 
called medulla oblongata, that contains structures such as the motor hypoglossal 
nucleus, the nucleus of the solitary tract and the dorsal motor vagal nucleus, as well as 
portions of the trigeminal descending column, the reticular formation, and the 
vestibular column. All these structures display 5 segmental subdivisions lying caudal to 
the overt r6 neuromere7,16. The resulting segmental hindbrain map including 11 
rhombomeres (or 12 of them, if we consider the isthmus as r0) can be extrapolated 
into the topological map of the anamniote brainstem, as proposed from studies in 
diverse fish and amphibian species20. Concerning mammals, a corresponding 
segmental organization of the medulla oblongata has been postulated in the mouse 
brain according to the regionalized expression of some molecular markers within 
serotonergic and glutamatergic neuronal populations21-23. 
 
In the present study we aimed to corroborate the predicted hidden segmentation 
within the mouse medulla oblongata by correlating morphological landmarks such as 
the motor nuclei and the pyramidal decussation at the hindbrain/spinal cord 
boundary, as well as the disposition of blood vessels, nerve roots and fiber tracts, with 
the forementioned stepped Hox-gene expression pattern. The resulting segmental 
map of the medulla oblongata was used to interpret the expression pattern of Calb2, 
Th, Trh, Gal and Cart genes within this brain region. Additionally, our study provided 
information in relation to the cryptorhombomeric ascription of the pontine progenitor 
domains, deducible from a molecular regionalization of the basilar pons. 
 
MATERIAL AND METHODS 
In situ hybridization (ISH) and immunohistochemistry  
All animals were treated according to the stipulations and laws of the European Union 
(2010/63/UE) and the Spanish Government (Royal Decree 53/2013) and the ethical 
guidelines on animal experiments of the University of Murcia. Swiss albino mice bred 
in the Service of Laboratory Animals of the University of Murcia were used.  
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Embryos at 14.5 and 16.5 days post coitum (dpc) -staged according to Theiler24-, as 
well as postnatal day 0 (P0) pups, were decapitated and their brains dissected out. 
These specimens were fixed by immersion in paraformaldehyde 4% in PBS pH 7.5 at 
4ºC for 24-48 hours. After fixation, the brains were embedded in agarose and cut in a 
vibratome at 80-100 um thickness in the sagittal plane. The sections were first 
processed for in situ hybridization (ISH) with digoxigenin riboprobes for the different 
Hox genes, and subsequently counterstained with 3A10 immunohistochemistry, as 
commented below. 
 
EST cDNA clones of respective Hox genes were obtained either from RZPD, ImaGenes 
GmbH or Geneservice Ltd (services currently integrated in Source BioScience, 
Nottingham, UK). These clones consisted of IMAGp998L154446Q (Hoxa3), 
IMAGp998O0113791Q (Hoxb3), IMAGE: 30145107 (Hoxd3), RZPDp981c0713D (Hoxb4), 
IRAPp965E0881D (Hoxc4), RZPDp981C03284D5 (Hoxa5) IRAMp995L079Q (Hoxb5,), 
IMAGp998N1912668Q (Hoxc5), RZPDp981E04288D (Hoxa6), IRAVp968D1230D 
(Hoxb6), IRAKp961O1666Q (Hoxc6), IMAGE: 4986801 (Hoxa7), IMAGp998B153740Q 
(Hoxb7), IMAGp998F23989Q (Hoxb8) and IMAGp998I121402Q (Hoxd8). The Hoxd4 
cDNA was cloned from genomic DNA in the lab by PCR, using primers that flanked a 
region including the second exon and the 3'UTR of this gene.  
  
Respective digoxigenin-labeled riboprobes were synthesized from all the cited cDNAs, 
and used for ISH on vibratome-floating sections according to Nieto et al.25, with minor 
modifications. To detect the hybridized product, the sections were incubated with 
alkaline phosphatase-conjugated antidigoxigenin Fab fragments, and nitroblue 
tetrazolium/bromochloroindolyl phosphate (NBT/BCIP) were used as chromogenic 
substrates for the final phosphatase reaction. After the ISH, the sections were 
processed for immunohistochemistry with the 3A10 antibody (Hybridoma Bank, Iowa 
Univ., Iowa), following standard peroxidase-diaminobenzidine methods. 
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Finally, the sections were mounted with Eukitt and photographed with an Axiophot 
camera with a Zeiss Axiocam camera (Carl Zeiss, Oberkochen, Germany) or with a 
ScanScope digital slide scanner (Aperio, Vista, CA, USA). 
 
 14.5 dpc 15.5 dpc 16.5 dpc 18.5 dpc P0 P4 
Hoxa3 H80  H45  H81  
Hoxb3 H57, Gp#EN1287 AB#100056326 H62  H79 
AB#10009
2319 
Hoxd3 H51, Gp#EN1290 AB#100093060 
H64, 
H108  H83  
Hoxa4 H9 Gp#EB664  H1  H4  
,Hoxb4 H21, Gp#MH3073  H18  H14, H29  
Hoxc4 H22  H19 AB#100077728 H15 AB#100081843 
Hoxd4  AB#100085315 H85  H86 AB#100101317 
Hoxa5 H10, H127, Gp#EN692  H2  
H5, H93, 
H133  
Hoxb5 H12  AB#100056327 
H20, 
H89 AB#100072330 H7 
AB#10007
5759 
Hoxc5 H35  H25, H28  H31  
Hoxa6 H11, Gp#EH1322  H36  H6  
Hoxb6 H13, Gp#EH1240 AB#100072762 H23 AB#100077738 H8 
AB#10008
1822 
Hoxc6 H26, Gp#MH3074 AB#100073054 H27    
Hoxa7 H30, H90, Gp#EN165 
AB#100057606 
 H24 
AB# 
100085496   
Hoxb7 H38 AB#113390109 H76 AB# 100094304  
AB#10009
4296 
Hoxb8 H75, Gp#EN2488 AB#100094038 H43, H77 
AB# 
100098210 H39 
AB#10009
4295 
Hoxc8 Gp#MH3051 AB#100072481     
Hoxd8 Gp#MH3002 AB#100059027     
Table 1. Embryonic brains analyzed for Hox expression. “H”-labeled cases correspond 
to brains processed for Hox ISH and 3A10 immunohistochemistry as commented in 
Methods, and the other items refer to image series retrieved from the indicated 
databases (Gp = Genepaint; AB = Allen Developing Mouse Brain Atlas). 
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Collection of ISH images from web sources 
We retrieved from online high-throughput ISH databases image series corresponding 
to serial sections of mid-gestational mouse embryos or perinatal brains processed for 
detection of Hox, Calb2, Th, Cart, Gal, Adam19 and Trh gene expression (Tables 1 and 
2). 
 
The Genepaint (http://genepaint.org/) online database provided ISH series from 
C57BL/6 14.5 dpc mouse embryos. The Allen Developing Mouse Brain Atlas (ADMBA) 
(http://developingmouse.brain-map.org) provided ISH series from 15.5 dpc to P4 
C57BL/6 mouse embryos and postnatal brains. In the latter database the embryonic 
ISH sections were counterstained with Feulgen-HP yellow.  
 
Additionally, the GENSAT database (www.gensat.org) provided image sections from 
transgenic E15.5, P7 or adult brains with GFP-reporter constructions for Chat, Layn and 
Fev genes, in which the detection of expression was done by immunohistochemistry 
for GFP (Fig. 1). 
 
 14.5 dpc 15.5 dpc 18.5 dpc P4 
Adam19   AB#100076349 AB#100081475 
Calb2    AB#100051842 
Cart Gp#EB1557 AB#100042591 AB#100054822 AB#100092234 
Gal Gp#EG539  AB#100055854 AB#100056067 
Th Gp #MH130 AB#100053204 AB#100071454 AB#100073400 
Trh Gp#MH3188 AB#100083525 AB#100051790 AB#100054752 AB#100054942 
Table 2. Embryonic brains analyzed for Adam19, Calb2, Cart, Gal, Th or Trh expression, 
as retrieved from the indicated databases. 
 
Results 
In the present work we used morphological and molecular criteria to delimit predicted 
interrhombomeric boundaries in the mouse hindbrain. We obtained in this way a 
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segmental map of the medulla oblongata, which was used to locate more precisely the 
position of several neurochemically specific neuron populations. 
  
Delimitation of segmental boundaries by cytoarchitectonic landmarks 
We first traced the intersegmental boundaries according to morphological landmarks 
such as the motor nuclei and some fiber formations, including nerve roots, known to 
have a specific topographic correlation with them. Transversally coursing (radial) blood 
vessels visible in medial sagittal sections often help to determine the deformed spatial 
framework of neuromeres. The relationship between these landmarks and given 
rhombomeres is already known according to previous studies performed at early 
stages of neural tube development, as commented below. In general, the coincidence 
of the rostral and caudal boundaries of diverse nuclei at a particular transversal plane 
bespeaks of a potential interrhombomeric boundary16. 
 
The motor nuclei have a clearcut correlation with specific rhombomeres because they 
can be identified when the interrhombomeric boundaries are still visible, as reported 
in different vertebrate species1,26,27. Therefore, in the 9.5 to 10.5 dpc mouse embryo, 
the trochlear nucleus appears in the isthmus (r0), the trigeminal motor nucleus 
develops within r2 and r3; the facial branchiomotor and visceromotor nuclei form 
respectively in r4 and r5; the abducens motor nucleus lies in r6, and the ambiguus, 
dorsal vagal and hypoglossal motor nuclei are found within the caudal territory 
classically considered as r7 plus r828. However, the facial branchiomotor nucleus 
follows a characteristic caudalwards migration leading it to be positioned finally within 
r6ref29-31. 
 
We identified the forementioned motor nuclei by means of the Chat gene, which 
labels all cholinergic cells, including motoneurons32. To this end, we mapped the motor 
nuclei in transgenic mice expressing EGFP under control of the Chat promoter region 
(Figs. 1a-d). Since this material offered by Gensat does not include a complete image 
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series, we additionally consulted the Chat ISH series from the Allen Developing Mouse 
Brain Atlas (data not shown). 
 
Regarding the mature facial branchiomotor nucleus, expected to be located within r6 
as its final postmigratory position29,30, we found that it bulges out considerably, 
deforming locally the hypothetical boundaries of r6 (Figs. 1a-c). The apparent 
overgrowth of this nucleus is apparent also in relation to interrhombomeric 
boundaries traced according to Hox gene expression (see below). Other Chat-positive 
landmark features related to the facial nerve are its ascending fibers within r6 (7asc), 
the genu facialis passing through r5 around the abducens nucleus (7g) and the efferent 
root fibers within r4 (7n) (Figs. 1a-d). 
 
The ambiguus, dorsal vagal and hypoglossal nuclei supposedly extend through several 
crypto-rhombomeres inside the medulla oblongata. The ambiguus nucleus (Amb) is 
formed by several cell aggregates with decreasing size and extends from r7, just caudal 
to the facial branchiomotor nucleus, to approximately r10 (Figs. 1a, b and data not 
shown; see Watson et al.23; their Fig.11.10). The ambiguus nucleus is continuous 
caudally with the retroambiguus nucleus33 which would probably fit into r11 (data not 
shown). In their turn, the vagal (10) and hypoglossal (12) nuclei putatively extend over 
r9, r10 and r11. That is, their anterior ends lie within a distance of 2-rhombomeres-
wide from the facial branchiomotor nucleus and its ascending fibers in r6, while their 
posterior ends about the pyramidal decussation (see below). 
 
The proposed location in r9-r11 of the hypoglossal and vagal nuclei, as deduced from 
the Chat expression images, coincides with the results obtained in the Hox-related 
segmental map of the medulla oblongata in the chick19 and in the mouse (present 
work). Nevertheless, the rostralmost hypoglossal nerve fibers show a rostrally concave 
curve into r8, which suggests that there may exist a minor origin  within r8, whose 
motoneurons are undetectable, or have secondarily migrated into r9 (arrows in Figs. 
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1d, g). Therefore, we can observe Chat-positive rootlets from r8 to r11 (Figs. 1d, g), 
while the nucleus itself occupies only r9, r10 and r11 (Figs. 1d, f, g). 
 
Another interesting landmark in relation to the caudal hindbrain is the pyramidal 
decussation, classically considered as the boundary between the mammalian hindbrain 
and spinal cord. Therefore, in the mouse brain it might be used to define the limit 
between the last hindbrain segment (r11) and the first myelomere or spinal cord 
segment (my1). However, in sagittal sections this structure does not correspond to a 
single limiting plane, but appears as a thick fiber bundle occupying roughly the space of 
a rhombomere. We identified the pyramidal decussation by the expression of 
transgenic GFP under the control of the Layn promoter region, in the corresponding 
GENSAT series. The Layn gene is expressed in cortical pyramidal neurons from 
perinatal stages onwards (Allen Mouse Brain Atlas; data not shown). Since the GFP 
protein is present in the axons, the pyramidal decussation appears strongly 
immunopositive for GFP (pd in Figs. 1e, f). Alonso et al.21 considered its posterior end 
as the r11/my1 boundary, including therefore the crossing fibers within r11. However, 
we found that the pyramidal decussation lies behind the topologically transverse plane 
limiting the caudal end of the hypoglossal and vagal nuclei, and we interpret this plane 
as the r11/my1 limit, according to both Cambronero and Puelles16 and our own Hox 
mapping results (see below). Therefore, we traced the r11/my1 limit at the upper end 
of the pyramidal decussation (Figs. 1e, f), so that in our interpretation the crossing 
fibers lie within my1 (see Discussion). 
 
In order to trace the segmental map of the hindbrain, we considered that the 
interrhombomeric boundaries are planes topologically transverse to the longitudinal 
(anteroposterior) axis, irrespective that these may become deformed by brainstem 
curvatures. In the pontine region (r2-r6), the rhombomeres appear skewed and 
wedge-shaped, narrowing from ventral to dorsal (the corresponding choroidal roof 
areas are found caudal to the cerebellum), adapting to the convex pontine 
curvature34,35. This deformation disappears in the medullary region, while at the 
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brain/spinal angle r10 and r11 become skewed in the opposite sense, widening from 
ventral to dorsal, due to the cervical flexure16. 
 
There are additional structures that define topologically transverse (dorsoventral) 
limiting planes at given anteroposterior positions, so that any neighboring 
interrhombomeric boundaries must be traced parallel to them. Several axonal tracts 
follow this transverse direction, namely the ascending and efferent facial nerve fibers 
(7asc, 7n; occupying respectively r6 and r4) -Figs. 1a-c, h-, the abducens nerve fibers in 
r5 (6n in Fig. 1c) and the hypoglossal and vagal nerve fibers from r8 to r11 (12n and 
10n in Figs. 1b, g). Median sagittal sections also show the decussation of the trapezoid 
body, which is restricted to r5 -tz in Fig. 1e- (similarly as the corresponding interstitial 
nuclei and the superior olivary nuclei, more laterally -Di Bonito et al36, L. Puelles, 
personal observations-). The decussation of the olivocerebellar superficial arcuate 
fibers occurs between r8 and r11, in agreement with the extent of the migrated 
inferior olive cells (data not shown). In the process of angiogenesis, the major median 
and paramedian blood vessels of the hindbrain have a tendency to distribute 
segmentally and follow a radial course from the meningeal entry points towards the 
ventricular surface, keeping this original orientation till adult stages37-39 (Fig. 1h). The 
radial glia cells within each rhombomere also follow the transverse axis (radiality), 
since they extend perpendicularly from the ventricular to the meningeal surfaces; 
these fibers sometimes show higher density at intersegmental boundaries40. However, 
due to the curvature of the neural wall both vessels and radial glia processes can be 
detected clearly only in midsagittal sections (Fig. 1h and data not shown). 
 
On the other hand, there are axonal tracts that follow the curved anteroposterior axis, 
such as the medial longitudinal fasciculus (Fig. 1g), whose fibers are perpendicular to 
the forementioned transverse structures; they also are of help as spatial guides for the 
segmental map. All these landmarks were used as a framework for the putative 
delimitation of rhombomeres, which was correlated with the following results of Hox 
gene expression.  
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Delimitation of segmental boundaries by Hox expression 
We analyzed Hox gene expression domains aiming to assess whether intersegmental 
boundaries can be delimited in the mature differentiated mouse hindbrain, as at early 
neural tube stages. At these early stages, the domains of these genes extend stepwise 
from the spinal cord up to different hindbrain domains following a rule of 3’ to 5’ 
spatial Hox colinearity11. The conservation of this pattern across ontogeny into late 
embryonic stages was already reported in chick embryos19. Concerning the mouse 
prepontine-pontine-retropontine region, which forms part of the overtly segmented 
hindbrain region (r2-r6; note the basilar pons lies in r3 and r4), most of the boundaries 
within this region have been corroborated in the adult thanks to transgenic Cre/Flp 
mice labeling either r2-, r4-, or r3-plus-r5-derived territories36,41,42 .  
 
In the present work we focused on the medullary region formed by 
cryptorhombomeres r7-r11 as described in the chick, examining as well their rostral r5-
r6 and caudal my1 neighbors. Within this study we identified the rostral limit of the 
Hoxb8 expression domain as an apparent molecular marker for the hindbrain/spinal 
cord boundary, delimited morphologically by the pyramidal decussation, as 
commented above. Additionally, we found that specific members of the Hox gene 
groups are differentially expressed within the basilar pontine nuclei, implying a 
specific, origin-derived molecular regionalization of this structure. We next report the 
expression patterns observed for the 3rd to 8th Hox gene paralogue groups, described 
within the framework of segmental landmarks mentioned above.  
 
Hoxa3, -b3 and -d3 delimit respectively the r4/r5, r6/r7 and r5/r6 boundaries 
At 10.5 – 11 dpc Hoxa3 is expressed in the neuroepithelium extending from the spinal 
cord up to the r4/r5 boundary43,44. We analyzed serial sections at 14.5 dpc and P0, 
corroborating Hoxa3 expression in the hindbrain caudal to the r4/r5 boundary. That is, 
at P0 the positive zone abuts rostrally r4 as identified by the efferent facial nerve fibers 
(7n in Figs. 2a, c)29 and the caudal part of the basilar pons. The domain of this gene 
includes r5, a rhombomere characterized by the presence of the facial nerve genus 
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(7g), the abducens motor nucleus together with its fibers (6n) -Figs. 2b, d28-, and the 
superior olivary complex (plus the periolivary region -Po in Fig. 2c-) and the trapezoid 
nuclei (plus the trapezoid decussation -tz in Fig. 2d-).  
 
 
Figure 1. Delimitation of rhombomeres according to motor nuclei and fiber tracts. a-
d. Sagittal sections of a P7 transgenic brain with GFP under the Chat promoter, 
processed for immunohistochemistry for the former protein. Ambiguus (Amb), 
trigeminal (5), abducens (6), facial branchiomotor (7), vagal (10) and hypoglossal (12) 
motor nuclei and their nerve fibers are labeled. The intersegmentary boundaries are 
represented by dotted lines. The arrow in D points to hypoglossal nerve fibers in r8 
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while this nucleus remains in r9-r11. e-f Sagittal sections of a P7 transgenic brain with 
GFP under the Layn promoter, processed for immunohistochemistry for the former 
protein. Segment-related fibers are visible like the fibers of the pyramidal decussation -
pd- behind r11, and the trapezoid body -tz- (unlabeled) in r5. g. Sagital section of an 
16.5 dpc brain processed for 3A10 immunohistochemistry, showing the medial 
longitudinal fascicle (mlf), the facial ascending nerve fibers (7asc) and the vagal (10) 
and hypoglossal (12) nuclei and nerve fibers of the latter (12n). The hypoglossal 
nucleus covers from r9 to r11 but its anteriormost fibers extend into r8 (arrow). h 
Sagittal section at the midline of a P7 transgenic brain with GFP under the Fev 
promoter, processed for immunohistochemistry for the former molecule. The labelling 
corresponds to the raphe serotonergic groups, including the prepontine raphe (PPnR), 
pontine raphe (PnR), dorsal and ventral raphe magnus (RMgD, RMgV), raphe obscurus 
and raphe pallidus (ROb, RPa) nuclei, located respectively in r2, r3-r4, r5-r6 and r7-
r11ref20. It can be observed also the location of the (unlabeled) basilar pontine nuclei 
(Pn) in r3-r4, the trapezoid body (tz) in r5, and the inferior olive (IO) in r8-r11. Since 
this is a midline section, the major blood vessels are visible following the dorsoventral 
axis. Images a-f and h are retrieved from the Gensat database. These and all the 
following images in this paper correspond to brain sagittal sections with the rostral end 
to the left.  
 
Concerning sensory columns, the Hoxa3 domain includes the whole viscerosensory 
column, i.e. the nucleus of the solitary tract (Sol), and portions of the vestibular nuclei 
(medial -MVe- and spinal -SpVe- vestibular nuclei) up to the r4/r5 boundary (Figs. 2a-
d). Laterally, the caudal portion of the dorsal cochlear nucleus appears derived from 
r5, in agreement with Farago et al.41, being labeled as a rostral part of the Hoxa3 
expression domain (data not shown; see DCin Fig. 2E for Hoxb3). In lateral sections, the 
interpolar portion of the spinal trigeminal nucleus appears labeled (data not shown; 
see Sp5I for Hoxb3 in Fig. 2e).  
 
The Hoxa3 expression domain includes also the corresponding portions of the 
hindbrain reticular formation, i.e. the caudal portion of the caudal pontine reticular 
nucleus (PnC), the parvicellular reticular nucleus (PCRt), the medullary dorsal reticular 
nucleus (MdD), the intermediate reticular nucleus (IRt), and, laterally, the lateral 
reticular nucleus (LRt) (Figs. 2a, c); medially, there is lower expression of the marker in 
the gigantocellular reticular nucleus (Gi) and medullary ventral reticular nucleus (MdV) 
(Figs. 2b,d). The ambiguus, vagal and hypoglossal motor nuclei are included within this 
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domain, in agreement with their reported rhombomeric positions, as commented 
above (Fig. 1). 
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Figure 2. Hoxa3, -b3 and -d3. Sections of embryonic and postnatal brains processed for 
3A10 immunohistochemistry (reddish precipitate) and ISH (blue precipitate). a-d for 
Hoxa3, e-f for Hoxb3, and g-h for Hoxd3. Hoxa3 expression domain reaches from the 
spinal cord up to the r4/r5 limit (arrows in a, b). Hoxb3 expression shows a domain 
with high expression reaching from the spinal cord up to the r6/r7 limit, plus a small 
region with weaker expression in the dorsal portion of r6 (asterisks in e, f). g, h Hoxd3 
expression abutts the r5/r6 limit. In these and ulterior figures, the sections in each 
vertical column are ordered from lateral to medial levels; interrhombomeric 
boundaries are indicated by dotted lines, while boundaries of cytoarchitectural regions 
(e.g. Sol -nucleus of the solitary tract-, MVe -medial vestibular nucleus, SpVe -spinal 
vestibular nucleus-) are indicated by dashed lines. 
 
There appeared as well Hoxa3 expression throughout the basilar pontine nuclei (Pn) 
and the suprajacent reticular tegmental nucleus (RtTg) (Figs. 2a, c, d). These structures 
reportedly form by tangential migration from r6-r7 rhombic lip41,45, so that their 
progenitors are fully included within the Hoxa3 domain. These neurons clearly keep 
the expression of this marker gene throughout their migration, as observed previously 
in the chick19. 
 
In contrast, Hoxb3 has an early domain of expression of high intensity up to the r6/r7 
boundary, while there is additional weaker expression covering r4, r5 and r6, as 
described in 11 dpc embryos44. We found that this pattern is largely maintained at 14.5 
dpc and P0, so that the principal expression domain reaches up to the r6/r7 boundary, 
including the corresponding portions of the sensory, motor and reticular entities (Figs. 
2e, f). There is additional weak expression of Hoxb3 in the dorsal part of r6 (asterisks in 
Figs. 2e, f), including portions of the spinal trigeminal (Sp5I) and vestibular (SpVe) 
columns, as well as the dorsal cochlear nucleus (DC in Fig. 2e), whose caudalmost part 
derives from r5 according to Farago et al41. The expression observed in these 
structures would thus be a remnant from earlier stages44. Hoxb3 is also expressed 
throughout the basilar pontine nuclei and the reticular tegmental nucleus (Fig. 2f). 
 
At early neural tube stages, Hoxd3 is expressed from the spinal cord up to r6, with 
additional weak expression in r5ref44. We found that this gene is consistently expressed 
up to the r5/r6 boundary at 14.5 dpc and P0, including r6 as its rostralmost 
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rhombomeric domain, in both alar and basal plates (Figs. 2g, h, and data not shown). 
The facial branchiomotor nucleus is not labeled, though lying within r6, due to its 
origin within r4 (Fig. 2g); the labelling around the facial motor nucleus suggests that 
the r5/r6 and r6/r7 boundaries are topologically deformed by the ectopic development 
of this large nucleus (Figs. 1a-c, 2e, g). Additionally to its expression domain reaching 
up to r6, Hoxd3 is also strongly expressed in the periolivary region (Po) in r5, 
suggesting a possible tangential translocation of these cells from r6 (Fig. 2g); Hoxd3 is 
also expressed in the migrated basilar pontine nuclei, whose expression shows strong 
signal intensity in 14.5 and 15.5 dpc brains, but decreases in perinatal brains (Fig. 2h 
and data not shown). 
 
In conclusion, Hoxa3 and -d3 genes distinctly delimit the caudal or retropontine 
interhombomeric boundaries within the overtly segmented hindbrain (respectively 
r4/r5 and r5/r6), while the domain showing high expression for Hoxb3 marks the r6/r7 
boundary, that is, the rostral limit of the crypto-rhombomeric medulla oblongata. As 
commented above, if we compare these patterns with those observed at early stages, 
there are some downregulation phenomena43,43, but the respective late expression 
patterns of these genes conserve without significant variations the topography 
observed at mid-gestational to perinatal stages.  
 
Hoxa4, -b4, -c4 and -d4 delimit the r7/r8 boundary 
Hoxa4 is expressed in the neural tube at 9.5-10.5 dpc with an anterior boundary within 
the medullary region11,47,48 proposed that this gene had a principal expression domain 
up to the r7/r8 boundary, plus a domain of weak expression in r7, thus reaching the 
r6/r7 boundary. In our material, the domain of this gene abuts rostrally a transverse 
plane that leaves approximately the space of a rhombomere behind r6, as defined by 
the position of the facial motor nucleus (Figs. 3a, d). Therefore we have interpreted 
this anterior boundary of expression as the r7/r8 boundary. As happened with the 
studied Hox3 genes, this pattern is maintained from 14.5 dpc at least up to P0 (Figs. 3a-
f). However, the perinatal staining shows low intensity in sagittal sections close to the 
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midline, pointing to a downregulation of this gene in the medullary basal plate 
(Figs.3c,f).  
 
The other Hox4 paralogues (Hoxb4, -c4 and d-4) were described to display at early 
stages (9.5 to 11 dpc) anterior boundaries within the medulla oblongata with rostral 
limits roughly coinciding with the r6/r7 boundary11,46 (We found that this shared limit 
fits instead r7/r8, with minor variations. We describe next the common pattern for 
these four Hox4 genes. 
 
Figure 3. Hoxa4. Sections of embryonic and postnatal brains processed for 3A10 
immunohistochemistry and Hoxa4 ISH. The expression domain of Hoxa4 lies just 
behind r7 (which is defined by comparison to r6) delimiting thus the r7/r8 boundary. In 
b, the white square in the right upper corner is an artifact derived from the merging of 
photographic fields of this brain section. 
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Besides the Hox4 domain extending longitudinally from r8 down to the spinal cord, 
there appears additional expression of these genes more rostrally in the basilar 
pontine nuclei (Pn) and the reticular tegmental nucleus (RtTg), mainly in their 
respective caudal halves (Figs. 3e; 4b, d, e, f, h, j). This result suggests that the caudal 
portions of these tangentially migrated nuclei originate from the rhombic lip caudal to 
r7/r8. 
 
In the alar plate, the labeled r7/r8 boundary crosses through the vestibular column, 
specifically the medial and spinal vestibular nuclei (MVe, SpVe), the somatosensory 
trigeminal descending column, namely its interpolar nucleus (Sp5I), and the 
viscerosensory column, represented by the nucleus of the solitary tract (Sol) (Figs. 3a-
d; 4a-i, j). Therefore, the Hoxa4 domain includes a restricted caudal portion of these 
nuclei, while lacking evident correlation with any overt cyto- or chemoarchitectural 
boundaries within them33,49. 
 
Concerning motor nuclei, the Hoxa4 domain includes the full extent of the dorsal vagal 
(10) and hypoglossal (12) nuclei, although the labelling of their cell populations 
appears heterogeneous (Figs. 3c, f; 4e, f, h, j). The caudal portions of the ambiguus 
motor nucleus (Amb) are also labeled, leaving its rostralmost r7 portion unlabeled 
(Figs. 3a, d; 4a, d). Structures lying just rostral to the hypoglossal nucleus, such as the 
nucleus prepositus hypoglossi (Pr), or ventral to it such as the nucleus of Roller (Ro) are 
weakly Hoxa4-positive and are thus included in this domain (Figs. 3c, f; 4e,f, h, j). As 
mentioned above, Hox4 genes show downregulation in the basal derivatives (Figs. 3c, 
f; 4e, f, h, j). After extrapolating the classical reticular subdivisions33 into our schema, 
the r7/r8 boundary defined by Hox4 genes apparently divides the parvicellular reticular 
(PCRt), intermediate reticular (IRt) and gigantocellular (Gi) nuclei into rostral and 
caudal parts (Figs. 3a-d; 4a-f). Ventrally, the inferior olive showed labelling in some of 
its cell populations, suggesting a Hox-related internal regionalization of this structure 
(IO in Figs 3b-f; 4b, d, e, f, h, j); this is a structure derived by dorsoventral tangential 
migration from the medullary rhombic lip, which extends from r8 to r11ref16,50 (Fig. 1h).  
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Figure 4. Hoxb4, -c4 and -d4. Sections of embryonic and postnatal brains processed for 
3A10 immunohistochemistry and ISH a-d for Hoxb4, e-f for Hoxc4 and g-j for Hoxd4 
genes. The expression domain reachs up to the r7/r8 limit principally in lateral sections 
corresponding to the hindbrain alar plate a-d, g-i, while in medial/basal sections the 
expression appears partially downregulated e,f,h,i. 
 
Hoxa5, -b5 and -c5 delimit the r8/r9 boundary 
In 12.5 dpc embryos, Hoxa5, -b5 and -c5 share a domain of expression extending from 
the spinal cord up to a sharp transverse plane within the caudal portion of the medulla 
oblongata46, although this limit was not correlated so far with any interrhombomeric 
boundary (due to the assumption that none were present in this area, as commented 
in the Introduction). 
 
We found that the rostral expression limit of these genes lies caudal to r6 as defined by 
the facial motor nucleus, approximately at a range twice as large as the width of a 
rhombomere when compared with the r7/r8 boundary, thus apparently corresponding 
to the r8/r9 limit (Figs. 5a, c, e, g). The expression appears downregulated in 
paramedian sections through the r9-r11 domain (Figs. 5b, d, f, h). A salient 
morphological feature associated with this limit is its coincidence with the rostral end 
of the dorsal vagal and hypoglossal nuclei (Figs. 5b, d, f, h). The dorsal medullary 
reticular nucleus (MdD) was also largely included within this basal domain, although in 
our material we could not identify its possible rostral limit with the gigantocellular 
reticular nucleus (Gi) across the r8/r9 border33. 
 
The Hox5-positive alar domain of the hindbrain includes from r9 to r11 the 
corresponding caudal segmental portions of the nucleus of the solitary tract (Sol), the 
spinal and medial vestibular nuclei (SpVe, MVe), and the interpolar and caudal 
trigeminal nuclei (Sp5I, Sp5C) (Figs. 5a-h). Moreover, other hindbrain alar structures 
such as the area postrema (AP), and the dorsal column nuclei (dcn) are completely 
included within this domain (Figs. 5a-h). The external cuneate nucleus (ECn) apparently 
falls entirely within r9, lying dorsal to the caudalmost (r9) portion of the interpolar 
nucleus (Figs. 5a, c, e, g; 6f-h). In some sections at lateral levels the expression of these  
76 
 
Figure 5. Hoxa5, -b5 and -c5. Sections of embryonic and postnatal brains processed for 
3A10 immunohistochemistry and ISH a, b for Hoxa5, c-f for Hoxb5 and g, h for Hoxc5 
genes. The expression domain of these genes reachs from the spinal cord up to the 
r8/r9 boundary. The arrow in H points to the caudal portion of the basilar pontine 
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nuclei (Pn) expressing Hoxc5. In Fig. g, the white square beneath r6-r8 is an artifact 
derived from the merging of photographic fields of this brain section. 
 
genes shows a caudorostral gradient of decreasing expression towards the r8/r9 
boundary, with weaker expression within r9 (e.g. r9 in Figs. 5e, h). In the lateralmost 
sections there is an apparent rostralward dispersion of Hoxb5 positive cells within the 
trigeminal column, a feature observed in all the analyzed stages (Sp5I in Fig. 6f, and 
data not shown).  
 
The basilar pontine (Pn) and reticular tegmental (RtTg) nuclei display Hoxa5, -b5 and -
c5 labeling, but only in some neurons at their caudal ends, thus suggesting a sparse 
contribution of the r9-r11 rhombic lip to the formation of these nuclei, perhaps limited 
to r9 (arrow in Fig. 5H and data not shown). The corresponding segmental portion of 
the inferior olive lying in these rhombomeres expressed weakly these genes (Figs. 5d, 
f, h and data not shown).  
 
Hoxa6 and -b6 delimit the r9/r10 boundary 
In 10.5-12.5 dpc mouse embryos, the expression domains of Hoxa6 and -b6 have a 
similarly unspecified rostral boundary within the caudal medulla oblongata51,52, while 
Hoxc6 is expressed only up to a rostral boundary within the cervical spinal cord, being 
thus absent from the hindbrain53. We corroborated these results for mid-gestational 
and perinatal mice. At 14.5 dpc and P0, Hoxa6 (Figs. 6a, b) and -b6 (Figs. 6c, d) are 
expressed up to a rostral boundary that intersects the caudal portions of the nucleus 
of the solitary tract (Sol), the spinal trigeminal nucleus (Sp5), the dorsal column nuclei 
(dcn), the dorsal vagal (10) and hypoglossal (12) motor nuclei, and the intermediate 
reticular nucleus (IRt); this limit passes behind the external cuneate nucleus (ECn) in r9 
-Figs. 6f, g-. This transverse boundary can be extrapolated into other components of 
the reticular formation and the inferior olive, although these structures do not display 
significant expression. Similarly to the former Hox paralogues, the expression appears 
principally in alar structures, while there is a downregulation of the signal in the 
hindbrain basal plate, as noted in medial sagittal sections (Figs. 6b, d). The rostral limit 
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of these genes coincides with the cytoarchitectonically distinct boundary between the 
interpolar and caudal nuclei of the descending trigeminal column, which are 
identifiable principally in lateral sections according to their differential pattern of Calb2 
expression -Ashwell et al.54, - (Sp5I and Sp5C in Figs. 6g, h). Coherently with the 
segmental pattern of the preceding Hox paralogues, the anterior limit of the domain of 
these Hox6 genes would correspond to the r9/r10 limit, so that they would be 
expressed in the r10 and r11 crypto-rhombomeres plus the spinal cord. 
 
 
Figure 6. Hoxa6, -b6 and -c6. (A-E) Sections of embryonic and postnatal brains 
processed for 3A10 immunohistochemistry and ISH a, b for Hoxa6, c, d for Hoxb6, and 
e for Hoxc6 genes. The expression domain of these genes reaches from the spinal cord 
up to the r9/r10 boundary, but they are mostly restricted to structures of the alar plate 
such as the dorsal column nuclei (dcn) and the caudal trigeminal nucleus (Sp5C). f-h 
Lateral sections showing expression respectively of Hoxb5 f, Hoxb6 g and Calb2 h 
genes in the descending trigeminal column. The caudalis portion of this column can be 
recognized by a laminar organization, with its outer layer positive for Calb2, while the 
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interpolaris portion show a more homogeneous and dispersed labeling for this gene 
(Sp5C and Sp5I in h). The identification of interrhombomeric boundaries according to 
Hoxb5 and Hoxb6 expression (f, g) shows that the boundary between Sp5I and Sp5C 
coincides with the r9/r10 limit, that is, the anterior limit of the Hox6 domain.  
 
In its turn, Hoxc6 appears expressed more caudally, in the alar and basal plates of the 
cervical spinal cord; its signal decreases gradually from caudal to rostral, so that there 
is no sharp rostrocaudal boundary (Fig. 6e). 
 
Hoxb7 delimits the r10/r11 boundary 
Among the Hox7 paralogue genes, Hoxa7 is expressed in 12.5 dpc embryos in the 
spinal cord, up to a rostral boundary within the cervical region55. We also found the 
expression of Hoxa7 restricted to the spinal cord, with topography similar to Hoxc6 
(data not shown). 
 
On the other hand, Hoxb7 expression reaches further up into the caudal end of the 
medullary region, ending slightly rostral to the obex56. In our material from 14.5 dpc 
and P0, Hoxb7 expression extends into the caudal end of the hindbrain, involving parts 
of the dorsal column nuclei (dcn) and the caudal nucleus of the descending trigeminal 
column (Sp5C), plus the local reticular formation (Figs. 7a, b). According to the 
stepwise Hox expression pattern, we interpreted that this boundary corresponds to 
the postulated r10/r11 limit, so that Hoxb7 would be expressed in r11 and the spinal 
cord.  
 
Hoxb8 delimits the r11/spinal cord boundary 
Hoxb8 is apparently expressed up to the boundary between hindbrain and spinal cord 
in 12.5 dpc embryos57. In our material at 14.5 dpc and P0 the expression of this gene 
appeared in the alar plate of the cervical spinal cord (Figs. 7c-f), ending at a transverse 
limit disposed behind the hypoglossal motor nucleus (Figs. 7D, F) and just rostral to the 
pyramidal decussation (Figs. 1E, F). We argue that this transverse plane marks the limit 
between r11 and my1 (first myelomere), that is, the limit between the hindbrain and 
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the spinal cord. Remarkably, the domain of expression of this gene includes a sizeable 
part of the conventional caudal trigeminal nucleus (Sp5C), with strong expression up to 
the r11/my1 boundary (Figs. 7c, e). However there appeared additionally weaker 
gradiental expression within the dorsal part of r11 (Figs. 7c, e, f; 10d). Additionally, 
Hoxb8 was also expressed in part of the intermediate reticular nucleus, which may 
include the retroambiguus nucleus (RAmb) -Figs. 7c, d-f. 
 
On the other hand, the Hoxc8 and -d8 expression domains are restricted to the spinal 
cord, lacking expression in the medulla oblongata58,59. The image series available in the 
Allen Brain web confirmed this pattern (data not shown).  
 
Figure 7. Hoxb7 and Hoxb8. Sections of embryonic and postnatal brains processed for 
3A10 immunohistochemistry and ISH a, b for Hoxb7; and c-f for Hoxb8. Hoxb7 
expression reaches up to the r10/r11 limit, while Hoxb8 has a domain of strong 
expression reaching up to the r11/spinal cord boundary, plus additional weaker 
staining in the r11 portion of the caudal trigeminal nucleus (asterisks in c, e) and in the 
retroambiguus nucleus (RAmb).  
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Segmental map of some medullary neurochemically-identified populations 
We analyzed the topological location of some neurochemically-identified populations 
of the medulla oblongata, following the segmental (pseudorhombomeric) map derived 
here from cytoarchitectural landmarks and Hox expression patterns. We focused on 
marker molecules with regionalized expression in the nucleus of the tractus solitarius 
(Th, Cart and Gal) and the hypoglossal motor nucleus (Trh). These two nuclei extend 
across several of the crypto-rhombomeres, so that any rostrocaudal molecular 
subdivisions may correlate with differential segmental origins. Our approach does not 
allow co-labeling at single cell level of Hox genes and these molecular markers, but 
offers the possibility to place particular neuronal populations within the coordinates of 
the segmental map. 
 
 
Figure 8. Th and Hoxa6. Sections of embryonic brains processed for ISH a, b for Th and 
c, d for Hoxa6. The images inside each horizontal row a-c and b-d correspond to 
approximately the same mediolateral level. The Th-positivie portion of the nucleus of 
the solitary tract (A2), is located acrosss the r9/r10 boundary. These images have been 
retrieved from the Genepaint database (see Tables 1 and 2). 
82 
 
Th 
In the hindbrain, the neuronal populations expressing tyrosine hydroxylase develop a 
noradrenergic or adrenergic phenotype. The noradrenergic/adrenergic A2/C2 cell 
group occupies the commissural nucleus and the medial nucleus of the tractus 
solitarius60. This cell group is visible immunohistochemically in mid-gestational brains  
 
Cart 
Cocaine- and amphetamine regulated transcript (CART) peptide is expressed in 
hindbrain areas involved in homeostatic regulation, including the nucleus of the 
solitary tract, the dorsal vagal complex and the area postrema, as detected by 
immunohistochemistry in the postnatal and adult rat brain63,64. In the embryonic 
mouse medulla oblongata, Cart mRNA expression appears in scattered cells of the 
reticular formation as well as in a discrete population within the nucleus of the solitary 
tract (Sol), as we have observed in mid- and late gestational brains pertaining to the 
Genepaint and Allen Brain databases (Figs. 9a, e). The comparison with Hoxa5 and -b5 
gene expression (Figs. 9b, g, h) shows that it is located at the anterior end of the Hox5 
domain, that is, within r9, at both 14.5 dpc and P4. 
 
Gal 
In the medulla oblongata of the rat at perinatal stages, Galanine (Gal) protein is 
expressed in neurons of the nucleus of the solitary tract, dorsal vagal nucleus and 
reticular populations65 while in the adult there appear additionally other medullary 
positive regions66. 
 
We analyzed the material from the forementioned databases (Table 2) showing Gal 
mRNA expression, finding that at 14.5 dpc and P4 stages the expression of this gene 
appears particularly strong in a discrete neuronal population located within the 
commissural/medial portions of the nucleus of the solitary tract (Sol in Figs. 9c, j). This 
Gal-positive subdivision lies posterior and medial to the Cart population commented 
above. After comparison with the domain of Hox6 paralogues, that reach up to the 
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r9/r10 boundary (Figs. 9d, k, l), we concluded that this Gal-positive population would 
be located within r10 (Figs. 9c, j). 
 
 
Figure 9. Cart, Gal, Hox5 and Hox6. Sections of embryonic brains processed for ISH a, 
e for Cart , b for Hoxa5, g, h for Hoxb5, i, j for Gal, d for Hoxa6, and k, l for Hoxb6, 
respectively from stages 14.5 dpc (a-d; retrieved from the Genepaint database) and 
18.5 dpc (e-i; retrieved from the Allen Brain database). The Cart-positive region of the 
nucleus of the solitary tract (Sol) is located within r9 (a, e) while the Gal-positive region 
of that nucleus is located within r10 (c, j) as deduced from the comparison with similar 
sections processed for ISH detection of Hoxb5 and -b6 genes. 
 
Trh 
Trh (thyrotropin-releasing hormone) is expressed principally in the hypothalamus, as 
described either by immunohistochemistry or ISH in the perinatal and adult rodent 
brain67,68. Additionally, in the medulla oblongata, Trh expression appears in the raphe 
nuclei, external cuneate nucleus, dorsal vagal complex and area postrema, according 
to the forementioned works. Analyzing the material of the Allen Brain Institute, we 
observed that at perinatal stages the medullary expression of Trh mRNA appears 
principally in the raphe nuclei and the hypoglossal motor nucleus. The positive raphe 
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nuclei are the ventral raphe magnus (RMgV) in r5-r6 and the raphe pallidus (RPa) 
extending from r7 to r11ref21. The expression in the hypoglossal nucleus is transient, 
since it disappears at later stages (data not shown). The hypoglossal Trh expression 
appears principally in two discrete neuronal subpopulations (arrows in Fig. 10b, and 
data not shown). We compared the position of these patches with the full extent of 
the hypoglossal nucleus, identified by the expression of Adam19ref69, detected by ISH in 
sections from the Allen Brain (Figs. 10a).  
 
We used this marker for motor nuclei instead of Chat because good quality images 
were not available for the latter in the Allen Brain public database. According to our 
segmental map, the two hypoglossal Trh populations would be respectively placed 
within r9 (or near the r9/r10 limit), and in r11, as observed at 18.5 dpc and P4 (arrows 
in Fig. 10d, and data not shown). These rhombomeres were identified by comparison 
with similar sections processed for Hoxb7 and Hoxb8 ISH (Figs. 10c, d). This molecular 
regionalization of the hypoglossal motor nucleus may be related to a temporal 
differentiation pattern (if this is regulated heterochronically according to a segmental 
pattern) or to differential specification of the motoneuron pools that innervate 
different tongue muscles70.  
 
 
Figure 10. Trh, Hoxb7 and Hoxb8. Sections of postnatal (P4) brains, close to the 
midline, processed for ISH a for Adam19, b for Trh, c for Hoxb7 and d for Hoxb8, 
retrieved from the Allen Brain database. The hypoglossal motor nucleus (12) is 
surrounded by dashed lines. Trh expression appears in two discrete cell populations 
within this nucleus, located respectively in r9 near the r9/r10 limit, and in r11 (arrows). 
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DISCUSSION 
We have found that in the embryonic and perinatal mouse medulla oblongata Hox 
genes from the paralogue groups 3 to 8 display correlative differential anterior limits 
of expression which follow the principle of 3'-5' colinearity; these limits are disposed 
transversally and subdivide this hindbrain region into successive segment-like units. 
These units can be easily correlated with equivalent territories of the avian medulla 
oblongata, described according to their antimeric delimitation relative to intersomitic 
boundaries16, as well as by a comparable Hox paralogue expression pattern18. 
Therefore, the mouse medulla oblongata can also be subdivided into rhombomere-like 
hidden segments -cryptorhombomeres- which share with typical rhombomeres at 
least their stepped Hox expression pattern, apart of a standard dorsoventral structural 
organization (summarized in Fig. 11). The cryptic molecular boundaries correlate 
topographically with some nuclear or intranuclear transverse boundaries visible 
cytoarchitectonically or chemoarchitectonically, and also mark some unexpected 
intranuclear subdivisions. 
 
The concept of medulla oblongata 
Classical neuroembryology subdivided the embryonic hindbrain into two territories 
called metencephalon and myelencephalon71, conceived as rostral and caudal 
hindbrain vesicles of the neural tube. These territories were assumed to give 
respectively rise to the pons and medulla oblongata regions in the adult brain, 
conventionally identified according to their external gross morphology. Major 
morphological features attributed to the pons included the cerebellum in its dorsal 
part and the prominent basilar pontine nuclei together with the fibers of the middle 
cerebellar peduncle ventrally, while in its turn the medulla oblongata includes the 
pyramids and the bilateral bulge of the inferior olive ventrally and the restiform body 
(inferior cerebellar peduncle) and the dorsal column nuclei dorsally; the pyramidal 
decussation appears at its caudal end20. 
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In contrast, modern developmental biology focused on the analysis of early hindbrain 
regionalization into rhombomeres (started by Orr72), that is, into smaller segmental 
units identified and characterized by cellular and molecular criteria1,8,11,73. Eventually, 
fate-mapping experimental analyses showed that the seemingly fading early segmental 
boundaries were merely hidden, persisting throughout ontogeny and correlating with 
distinct boundaries between cytoarchitectonic subdivisions of the adult hindbrain34,35.  
 
The forementioned fate maps, however, included only the region of the pons, which 
appears overtly segmented at early stages of development, while the medulla 
oblongata essentially derives from a large, apparently unsegmented territory found 
caudal to rhombomere r6. This caveat was solved by Cambronero and Puelles16 who 
tested the assumption that, similarly as in the spinal cord, hidden caudal hindbrain 
segments might have boundaries antimeric to the intersomitic limits. The cryptic 
segmental map of the chicken medulla that they obtained experimentally (formed by 
segments of regular size, from r7 to r11) was ulteriorly corroborated by the discovery 
of a corresponding co-linear Hox expression pattern19, leading to the present-say 
concept of cryptorhombomeres2. The set of five overt rhombomeres (r2-r6) plus the 
cryptic isthmus and r1 units (r0-r1) and the cryptorhombomeres r7-r11 build up a 
division of the embryonic and adult hindbrain into 12 transverse units, which cannot 
be conciliated causally with the classic simpler schema of metencephalon and 
myelencephalon (the latter are now regarded as obsolete concepts, due to the 
experimental falsation derived from the fate mapping and molecular studies; they 
should no longer be used in neuroanatomy, to avoid confusion); Puelles6 proposed 
that the classic metencephalon can be conveniently reclassified into isthmus (r0), 
prepontine (r1-r2), pontine (r3-r4) and retropontine (r5-r6) regions, whereas the r7-r11 
cryptorhombomeres build the medulla oblongata proper (see also the reference 
atlases of the Allen Developing Mouse Brain Atlas; developingmouse.brain-atlas.org). 
The experimentally corroborated developmental organization of the medulla 
oblongata into 5 transversal units derived from respective cryptorhombomeres, which 
was reported first for chicken embryos16,19 can be extrapolated to the mammalian 
hindbrain according to the highly conserved Hox gene expression pattern, as we 
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demonstrated in this work. Similar studies would be predicted to validate the same 
pattern in other vertebrate phyla, as is suggested already by a number of comparative 
anatomic results1,74-77. 
 
The role of Hox genes in the regionalization of the pons and medulla oblongata 
Hox genes are involved in multiple developmental processes requiring different 
positional identities along a given spatial axis, considering in vertebrates either the 
body plan of the whole organism, or particular structures such as the neural tube, the 
embryonic gut or the digits78,79. 
 
In the case of the neural tube, in particular the portion of the hindbrain with typical 
overt rhombomeres r2 to r6 (vaguely referred to as the ’pons’), the graded expression 
of Hox paralogues according to their genomic co-linearity is known to participate in the 
acquisition of differential identity by each of these rhombomeres, due to the activation 
of unique combinations of transcription factors within each unit80. However, this is not 
the only mechanism responsible for rostrocaudal regionalization, since, additionally, 
the neuroepithelium of neighboring rhombomeres may become isolated by 
boundaries that restrict the intermingling of proliferating neuroepithelial cell clones, 
and apparently also the transmission of morphogenetic signals via neuroepithelial gap-
junctions, between adjacent rhombomeres9,13,81. These secondary phenomena 
contribute to the morphologic definition and differential structural differentiation of 
the overt rhombomeric territories as a result of the relative autonomy of their 
respective histogenetic processes, which affects as well differential axonal 
navigation15,82. These distinct features of overt interrhombomeric boundaries 
apparently are not shared by the cryptorhombomeric limits, leading to the tendency to 
produce more homogeneous (apparently continuous) plurineuromeric columns of 
derivatives in the case of both motor and sensory nuclei. Nevertheless, fundamental 
molecular segmentation characterizes the whole hindbrain and largely resides in the 
observed co-linear pattern of Hox gene expression (r2-r11), amplified by the rostral 
distinction between isthmus and r1. This molecular pattern is able to establish iterated 
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causally relevant transverse molecular boundaries and corresponding differential 
segmental molecular identity codes throughout this brain territory. There is evidence 
for patterns corroborating the whole hindbrain as an unitary primary developmental 
field or brain tagma, as indicated, e.g., by the development of serotonergic neurons21. 
The delimiting patterns that appear restricted to overt rhombomeres can be assumed 
to obey particular secondary patterning or interactive effects occurring within a specific 
subset of rhombomeres (r2-r6). 
 
In conclusion, the medulla oblongata, formed by the cryptorhombomeres r7-r11, 
develops under the influence of a graded Hox pattern that strictly continues the 
pattern observed across the overt rhombomeres19 (present work), but apparently lacks 
intersegmental boundaries identifiable according to the criteria valid for overt 
segments. That is, the cellular and molecular characteristics of interrhombomeric 
boundaries, such as clonal lineage restriction9,81, reduced gap junction permeability13, 
specific cell cycle kinetics83 and expression of some specific molecular markers84 
appear only at the boundaries r1/r2 to r6/r7. Therefore we postulate that in the 
medullary hindbrain the Hox code works as a source of periodically distributed 
positional information for the migration, aggregation and differentiation of neuronal 
derivatives of the cryptorhombomeres, whose development does not require the level 
of segregation found at the overt rhombomeres. Note that, irrespective of these 
differences, some quite sharp cytoarchitectonic boundaries develop within the 
medullary region, as exemplified by the limit between the interpolar and caudal 
divisions of the spinal trigeminal column. 
 
Recently, gain- and loss-of-function experiments in mouse and chick embryos have 
shown that Hox proteins from the paralogue groups 1 to 4 drive the neuroepithelial 
cellular segregation at interrhombomeric boundaries, inducing as well the typical 
morphology of the cells at these limits85. Unfortunately, these authors did not examine 
the medullary hindbrain; it would be of interest to study with this approach the cryptic 
medullary segmental units defined by a comparable Hox expression pattern19 (present 
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results) but lacking as far as we presently know lineage-restricted and cytochemically 
defined boundaries, as commented above.  
 
 
Figure 11. Schemes showing respectively a view of the hindbrain with some of the 
morphological features described in this work (up), and the Hox expression pattern in 
relation to intersegmentary boundaries (down).  
 
Possible significance of the expression of Hox genes in the hindbrain at late 
developmental stages 
Historically, the hindbrain was assumed to lose its original segmental structure by late 
developmental stages. The rhombomeres were thus held to be transient structures of 
the early neural tube, since they could not be recognized morphologically in the more 
differentiated brain1,8. The correlation of distinct neuronal populations with particular 
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rhombomeric territories was accepted only for the motor nuclei, since these coexist 
temporarily with the visible rhombomeres1,8,27. This view changed when it was shown 
by quail-chick fate mapping experiments that the rhombomeres keep 
theirmorphological limits as hidden segmental units at least until late gestational 
stages34,35. Cambronero and Puelles16 found the same result for the avian medullary 
cryptorhombomeres, which are never visible morphologically. Additionally, labeling of 
the rhombomeres by transgenesis in the mouse also has shown the persistence of the 
delimited neuromere-derived fields until adult stages36,41,42. 
 
According to these fate maps a segmental map of the adult hindbrain can be 
elaborated (reviewed in Puelles6, Puelles et al.7, Nieuwenhuys20) including the position 
of all the neuronal populations in relation to the segmental scaffold. However, many 
classic hindbrain anatomic entities (cell populations or nuclei) do not display a one-to-
one relationship with particular rhombomeres, revealing a multi- or plurisegmental 
origin (note such columns may be structurally homogeneous or not). This raises the 
possibility that the original multiple Hox gene code of each complex columnar entity 
conditions the ulterior development of specific identities of subpopulations or 
subnuclei inside those structures6,7. 
 
In this regard, we have shown that both overt and cryptic rhombomeres develop their 
differential segmental structure maintaining their endogenous primary Hox expression 
pattern (with minor variations), at least until late gestational stages in the chick18 and 
perinatal stages in the mouse (present work). This suggests that the Hox genes have a 
role in the differential development of these segments beyond their early role in the 
molecular segmentation of the neuroepithelium. These transcription factors, acting 
interactively with dorsoventral fate determinants, may govern the production of 
specific neuronal phenotypes, e.g., cells using specific neurotransmitters and 
transmitter-related molecules, as well as the establishment of detailed patterns of 
connections which display a segmental pattern (e.g. Díaz et al.86).  
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The segmental-like maintenance of the Hox pattern is particularly striking in the case 
of the basilar pontine nuclei, which develop within r3 and r4ref41,42,45 (see Fig. 1h) after 
a complex route of tangential migration; they supposedly come as a whole from the 
r6-r9 rhombic lip progenitor area45,87 (present data). Our ISH results, and those of Di 
Meglio et al. about the expression of Hox2 to -5 genes, suggest that these cell 
populations keep memory of their original Hox expression profile within the co-linear 
rostrocaudal segmental sequence. Notably, the anterior portion of these nuclei located 
within r3 possibly derives from r6-r7, according to its expression of Hox3 paralogue 
genes (Figs. 2c, d, f), while the posterior portion formed within r4 would derive from 
r8, according to its expression of Hox4 genes (Figs. 3e, 4b-f). An additional caudal sliver 
derived from r9 (at the back of r4) may be distinguished according to its Hox5 
expression (Fig. 5h and data not shown).  
 
Concerning the typical motor and sensory columnar anatomic structures of the 
medulla oblongata (the ambiguus, hypoglossal and vagal nuclei, the nucleus of the 
solitary tract, the trigeminal and vestibular columns, and the dorsal column nuclei) as 
well as the inferior olive and the reticular formation, we also showed that they display 
an AP molecular regionalization according to the co-linear expression of Hox genes. 
The Hox pattern thus apparently provides a scaffold that potentially organizes the 
detailed heterogeneity of neuronal populations along the AP axis up to intracolumnar 
levels of subdivision that were not considered by the classic neuroanatomists. 
Medullary systems such as the inferior olive with an internal AP pattern of 
olivocerebellar projections88, the trigeminal descending column subdivided into 
architectonic and hodologic subregions along its AP axis89, or the respiratory rhythm 
generator in the rostral ventrolateral90,91 medulla9, would likely be organized according 
to this segmental pattern. Further developmental, anatomic and physiological 
experiments examining these implicit (cryptically delimited) neuronal subpopulations 
keeping in mind the Hox positional scaffold and/or mouse lines characterized by 
conditional Hox loss-of-function  are needed to examine this possibility.  
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ABSTRACT 
Hereditary Congenital Facial Paresis (HCFP) consists of the paralysis or weakness of 
facial muscles caused by a maldevelopment of the facial branchiomotor (FBM) nucleus 
and its nerve. Linkage analyses have related this disorder to two loci, HCFP1 and 
HCFP2, placed respectively in human chromosomal regions 3q21.2–q22.1 and 
10q21.3–q22.1, but the causative genes are still unknown. In this work we aimed to 
identify which genes from these loci are expressed in the developing hindbrain and 
particularly in the facial branchiomotor nucleus. To this end, we retrieved from the 
ENSEMBL genomic database the list of these genes as well as their respective mouse 
orthologs. Subsequently we mined the GenePaint and Allen Brain Atlas databases of in 
situ hybridization analysis, as well as previous literature, searching for their respective 
expression patterns in the embryonic mouse brain. Besides previously known genes 
(Gata2 and Tmcc1), we found a new gene (Mgll) from the HCFP1 locus with strong and 
specific expression in the developing facial branchiomotor nucleus. In turn, the HCFP2 
locus appeared as a large gene-desert region, flanked by two new genes (Reep3 and 
Lrrtm3) expressed in the aforementioned nucleus. The concurrence of genomic 
position and neural expression pattern makes these genes new suitable candidates for 
HCFP. 
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INTRODUCTION 
Hereditary congenital facial paresis (HCFP) is an autosomal dominant disease 
characterized by the selective paralysis or weakness of facial muscles. It is caused by 
uni- or bilateral maldevelopment of the facial branchiomotor nucleus (FBM) in the 
hindbrain, as has been deduced from neuroimaging and postmortem 
neuropathological observations1-3.  
 
HCFP is a member of the Congenital Cranial Dysinnervation Disorders (CCDD), a disease 
family including syndromes with abnormal motility of the eye, the eyelid, and/or facial 
movement, such as Duane and Möbius syndromes and other congenital palsies of 
different cranial nerves4. Early reports considered HCFP as a variant of the Möbius 
syndrome, which is characterised, besides the facial palsy, by an impairment of ocular 
abduction, affecting consequently both facial (VII) and abducens (VI) nerve and nuclei. 
The later syndrome can involve additionally other hindbrain cranial nerves and 
orofacial, limb and musculoskeletal malformations. Postmortem and neuroimaging 
analysis of Möbius cases have shown a general hypoplasia or dysgenesis of the 
brainstem5, in contrast to the HCFP where the only compromised neural structure is 
the facial branchiomotor nucleus and its nerve. These observations led thus to propose 
Möbius syndrome and HCFP as two different disorders1-4. 
 
Linkage analysis have led to the identification of two genetic subtypes of this disease, 
HFCP1 (MIM601471) and HFCP2 (MIM604185), associated to respective loci placed in 
chromosomal regions 3q21-q22 and 10q21.3-q22.1. Initially they were named 
respectively as MBS2 and MBS3 due to their first assignment as Möbius syndrome 
subtypes. Kremer et al.6 first identified the HFCP1 locus by linkage analysis in a Dutch 
family. The HFCP2 locus was characterized by Verzijl et al.7 through linkage analysis in a 
second affected Dutch family. 
 
Several studies have aimed to identify the precise genes from these loci that could be 
involved in this disease. To this end, van der Zwaag et al.8 considered three genes as 
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possible candidates: PGT and GATA2 from the HCFP1 locus, and EGR2 from the HCFP2 
locus. PGT codes for the prostaglandin transporter, and was chosen because it had 
been described a correlation of prenatal exposure to a synthetic prostaglandin with an 
increasing of Möbius incidence in newborns9. In turn, GATA2 and EGR2 code for 
respective transcription factors that are involved in the formation and/or specification 
of the hindbrain neuromeric untis or rhombomeres (r). At early neural tube stages, 
Gata2 is specifically expressed in ventral r410, which is the rhombomere where the 
facial motor nucleus is born11, while Egr2 is expressed in neighbouring r3 and r5, being 
necessary for their development as shown by loss-of-function studies in the mouse12. 
The study of van der Zwaag et al.8 identified several mutations of these genes either in 
the HCFP1 or HCFP2 Dutch families, but these variations did not cosegregated with the 
HCFP disorder. Therefore, these genes were discarded as causative elements of this 
disease. Incidentally, updated genomic maps show that two of these genes are not 
contained within the HCFP loci, being PGT placed at 3.4 Mb from HCFP1 and EGR2 at 
1.25 Mb from HCFP2, as displayed by the ENSEMBL genome server. 
 
Other studies from the same authors considered PLXNA1 and PLXND1 from the HCFP1 
locus as possible candidates, since they code respectively for plexin-A1 and -D1 
proteins which have known functions in axon guidance and cell migration13. 
Particularly, Plxna1 is expressed in neural structures close to the FBM nucleus, while 
Plxnd1 is expressed in vascular endothelium so it could have a role in brain 
angiogenesis and influence therefore neural development14. However, the mutation 
analysis of their coding regions in HCFP cases yielded negative results as well14-17. 
 
Using a different experimental approach, van der Zwaag18 aimed to identify candidate 
genes from the HCFP1 locus by analysing their respective expression patterns through 
in situ hybridization analysis in mouse embryos. From 28 analysed genes, these 
authors proposed four of them as potentially involved in this disease, since they were 
expressed either in the developing hindbrain or specifically in the FBM nucleus. 
Concretely, it was found that Podxl2 (that codes for an endoglycan protein) was 
broadly expressed in the mantle layer of the developing brain, while Flj40083/Ccdc37 
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(coding for a protein with coiled-coil domains) and Klf15 (a Krüppel-like transcriptional 
regulator) were both expressed in the hindbrain ventricular layer, among other tissues. 
Finally, Kiaa0779/TMCC1 (coding for a protein with transmembrane and coiled-coil 
domains) was found to be specifically expressed in the FBM nucleus, besides other 
structures.  
 
However, the aforementioned genes were discarded as candidates in an ulterior study 
from the same lab16. In this work, the mapping of the HCFP1 locus, first obtained from 
the study of a Dutch family, was refined through the linkage analysis of a Pakistani 
family, reducing this putative locus from 5.7 to 3.0 cM. Subsequently, these authors 
studied in both families the sequences of the aforementioned genes from or close to 
the HCFP1 locus (PLXNA1, PLXND1, GATA2, PODXL2, FLJ40083, KLF15 and TMCC1). 
They analysed the coding sequences and intron-exon boundaries of these genes, as 
well as the first 1000 bp upstream of the start codon in some of them. They identified 
several polymorphisms in these sequences, but there did not appear any mutation 
cosegregating with the disorder, nor a gene duplication or deletion in either family. 
Therefore, the seven genes were accordingly excluded as possible candidates.  
 
We aimed in this work to complete the aforementioned previous reports by screening 
the expression pattern of the different genes placed within these loci or close to them. 
To this end we have used principally the ENSEMBL, GenePaint and Allen Brain Atlas 
databases, finding relevant new information concerning some genes specifically 
expressed in the developing FBM nucleus.  
 
MATERIAL AND METHODS 
We delimited in the ENSEMBL human genome browser the critical chromosomal 
regions for HCFP according to the information provided by previous works. HCFP1 is 
located between the D3S3607 and GDB ID: 11524500 markers in chromosome 3q21-
q22ref16. HCFP2 is located between the D10S581 and D10S502 markers in chromosome 
10q21.3-q22.1ref7. These loci span 2.98 and 2.57 Mb respectively. We extended the 
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regions to be analysed 1 Mb at each end, considering the possibility that these loci 
could contain regulatory elements for distant genes (see Discussion).  
 
We retrieved the lists of known and predicted genes from these regions, as well as 
their respective mouse orthologs, by using the Biomart tool from the ENSEMBL server 
(Tables 1, 2). These lists were curated manually, according to BLAST searches for 
similarity and analysis of mouse-human synteny conservation. 
 
Thereafter, we looked for the respective mRNA expression patterns of these genes in 
the embryonic mouse brain. To this end, we datamined the GenePaint online 
database. This server offers microphotographs of complete sectional series of mouse 
embryos processed for ISH with digoxigenin-labelled riboprobes. Concerning the genes 
studied in this work, the available material always consisted of 14.5 dpc embryos cut in 
the sagital plane. The description of the technical procedure can be found at the 
GenePaint webpage (http://www.genepaint.org, “Methods of Data Production”). We 
downloaded these image series, as well as magnified details from some of them by 
using the HTML zoom viewer from this server.  
 
In the case of some genes, the information about the expression pattern in the 
developing brain could be completed thanks to previous literature or to the Allen 
Developing Mouse Brain Atlas (http://developingmouse.brain-map.org/) , whose 
image series (from 11.5, 13.5, 15.5, 18.5 dpc, P4, P14 and P28 stages) were also 
downloaded and analysed when available .  
 
The search of information in the Emage (http://www.emouseatlas.org/) and 
Eurexpress (http://www.eurexpress.org/) databases provided the same sets of 
experiments and image series than those offered by the GenePaint server.  
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RESULTS 
We found that the HCFP1 locus spanned 2.98 Mb and included 35 known or predicted 
protein-coding genes, while the HCFP2 locus extended over 2.57 Mb including only the 
3’ part of one gene. We expanded the regions to be analysed 1 Mb at each end, so 
they finally included 49 and 5 protein-coding genes, respectively (Tables 1, 2).  
 
 
Figure 1. Map of the HCFP2 locus. Schema displaying the relative position of the 
HCFP2 markers and the immediately adjacent genes; arrows indicate the position and 
5' to 3’ orientation of each gene. 
 
The Biomart tool yielded 40 mouse orthologs from the expanded HCFP1 region, that 
were distributed within 3 syntenic blocks, two of them in chromosome 6 and one in 
chromosome 9, plus 1 isolated gene in chromosome 3 (Table 1). Concerning the 
expanded HCFP2 region, there were 5 mouse orthologs that appeared grouped in the 
same locus and relative order in mouse chromosome 10 (Table 2). Therefore the 
human/mouse synteny was fully conserved for this second locus although the size was 
not too much different from the first region. Comparison with other species through 
the ENSEMBL server showed that synteny of this second locus and adjacent regions 
was conserved among amniotes (data not shown). 
 
In Tables 1, 2 we list the identified protein-coding genes of each of the two loci, with 
an indication of their eventual expression in the embryo, nervous system, hindbrain 
and/or facial branchiomotor (FBM) nucleus, according to information provided by 
previous literature (5th column) but principally following the analysis of GenePaint 
image series (6th column) and the Allen Developmental Mouse Brain Atlas when 
available. In the 7th column of these tables we indicate with an ad hoc code number 
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the different categories of genes, from 1 to 6, according to their respective expression 
patterns (see legend of Table 1). We next describe in more detail these results. 
 
Group 1 comprised genes with low or absent staining, or a generalized background-like 
pattern that did not allow differentiating between ubiquitous expression or unspecific 
signal. Some of these genes were previously grouped in this category by van der Zwaag 
et al.18 while for others there were no former literature that could help to better 
characterise their respective expression patterns.  
 
Other genes displayed specific expression in some parts of the embryo excluding the 
nervous system (group 2), a pan-neural expression (group 3), or expression in neural 
regions outside the hindbrain, like Plxnd1 expressed in the forebrain (group 4), so that 
none of them had a specific relation with the FBM nucleus. 
 
The following category of genes (group 5) was formed by the genes expressed in the 
hindbrain with a specific regionalised pattern, but absent from FBM nucleus or 
expressed only in few cells of this nucleus. This group was represented by Plxna1, 
Mcm2 and Trh genes, all of them from the HCFP1 locus. 
 
Plxna1 is a member of the Plexin molecular family, formed by proteins that interact 
with semaphorins and are involved in axon guidance, synaptic development and cell 
migration13. Plxna1 expression appears in several populations in the developing 
hindbrain. In 10.5 dpc embryos, it is expressed in longitudinal columns near the 
midline in rhombomeres r1-r4, but excluding FBM neurons according to the 
comparison with Islet1 labelling19. From 16.5 dpc to P4 stages it is characteristic of 
auditory related structures, including inferior colliculi, cochlear nuclei, superior olivary 
complex and nuclei of the lateral lemniscus20. Similar results can be observed in the 
images provided by van der Zwaag14 and the GenePaint and Allen Brain servers (Figs. 
1A, B), where it can be observed that Plxna1 expression in the FBM nucleus is either 
null or indistinguishable from background signal (Figs 1a, b, and data not shown).  
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Human gene 
/ marker 
Human gene5_ 
start (Chr.:bp) 
Mouse gene5_ 
start (Chr.:bp) References GenePaint dataset Expression 
Sequence 
analysis 
D3S3607 3:127272967 
MCM2 3:127391778 6:88852245 
van der Zwaag et 
al., 2005b Ajioka 
et al., 2006 
ES111 4  
GPR175 3:127542051 6:88825038 van der Zwaag et al., 2005b EB755 1  
PODXL2 3:127634075 6:88791860 van der Zwaag et al., 2005b no data 3 
Michielse 
et al., 
2006 
ABTB1 3:127770484 6:88674406 van der Zwaag et al., 2005b EH1831 4  
MGLL 3:127872297 6:88577436  ES408 MH2900 6  
KLHDC6 
(Flj46299) 3:127872757 6:88468899 
van der Zwaag et 
al., 2005b no data 1  
SEC61A1 3:128186091 6:88396507  ES706 2  
EEFSEC (SELB) 3:128212028 6:88415403  EB781 2 
van der 
Zwaag et 
al., 2005b 
RUVBL1 3:128294929 6:88172262  EB893 1  
DNAJB8 3:128399918 6:88148328 van der Zwaag et al., 2005b EG904 1  
GATA2 3:128444965  
Nardelli et al., 
1999, Craven et 
al., 2004 
MH571 5 
van der 
Zwaag et 
al., 2002b  
Michielse 
et al., 
2006 
C3orf27 3:128598439 6:88034514     
RPN1 3:128712958 6:87995264  EH1588 1  
RAB7A 3:128720472 3:35964901  ES1148 1 
van der 
Zwaag et 
al., 2005b 
ACAD9 3:128779610 6:87640841 van der Zwaag et al., 2005b EN446 1  
KIAA1257 3:128841644 6:87680863 van der Zwaag et al., 2005b EG2516 2  
CCDC48 3:128880136 6:87728130  EG2714 1  
GP9 3:128902810 6:87762158  EH483 1  
RAB43 3:128968449 6:87788671  EB741 1  
ISY1 3:128997671 6:87801100  EH2237 1  
CNBP (ZNF9) 3:129035117 6:87837808 van der Zwaag et al., 2005b ES1275 1  
COPG 3:129147494 6:87863929  EG1798 2  
C3orf37 3:129158878 6:87931631  EH1540 1  
H1FX 3:129158968   EH1973 1  
C3orf25 3:129247483 6:115803389     
MBD4 3:129262057 6:115803488 van der Zwaag et al., 2005b EB671 1  
IFT122 
(WDR10) 3:129325661 6:115881945  EH3408 1  
RHO 3:129612419 6:115894956  EH4514 1  
H1FOO 3:129693148 6:115945023 Marzluff et al., 2002 no data 2  
PLXND1 3:129762156 6:116084348 
van der Zwaag et 
al., 2002a 
Chauvet et al., 
2007 
ES2794 4 
van der 
Zwaag et 
al., 2004 
Michielse 
et al., 
2006 
TMCC1 
(KIAA0779) 3:129800860 6:92194644 
van der Zwaag et 
al., 2005b EG1290 5 
Michielse 
et al., 
2006 
TRH 3:130064359 6:88852245 
Iwase et al., 
1991                    
van der Zwaag et 
al., 2005b 
ES1074 MH3188 5  
AC083906.1 3:127391778 6:88825038 
van der Zwaag et 
al., 2005b Ajioka 
et al., 2006 
ES111 4  
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ALG1L2 3:127542051 6:88791860 van der Zwaag et al., 2005b EB755 1  
COL29A1 3:127634075 6:88674406 van der Zwaag et al., 2005b no data 3 
Michielse 
et al., 
2006 
MCM2 3:127770484 6:88577436 van der Zwaag et al., 2005b EH1831 4  
GPR175 3:127872297 6:88468899  ES408 MH2900 6  
PODXL2 3:127872757 6:88396507 van der Zwaag et al., 2005b no data 1  
ABTB1 3:128186091 6:88415403  ES706 2  
ALG1L2 3:129800860 no ortholog     
COL29A1 3:130064359 9:105856078     
GDB:11524500 3:130249919 
Table 1. HCFP1 genes. List of human protein-coding genes from the HCFP1 locus (1st 
column), ordered according to the relative position of their 5’ ends (2nd column), 
indicating the chromosomic position of the respective mouse orthologs (3rd column), 
the references and databases providing information about their embryonic neural 
expression (4th -6th columns), and finally the studies reporting sequence analysis in 
HCFP cases (7th column). The respective positions of the markers delimiting the HCFP1 
locus are also indicated at the beginning and the end of the list. The expression pattern 
is summarised in the 6th column as follows: 
(1) Genes with undetectable, ubiquitous or generalised background-like expression in 
the embryo. 
(2) Genes with regionalised expression in the embryo, but undetectable or background 
like expression in the nervous system  
(3) Genes ubiquitously expressed in the nervous system. 
(4) Genes with regionalised expression in the brain, but absent from the FBM nucleus. 
(5) Genes with regionalised expression in the brain, including weak, partial or transient 
expression in the FBM nucleus. 
(6) Genes with regionalised expression in the brain, including strong expression in the 
FBM nucleus. 
 
Human gene 
/ marker 
Human gene5_ 
start (Chr.:bp) 
Mouse gene5_ 
start (Chr.:bp) 
References 
GenePaint 
dataset 
Expression 
Sequence 
analysis 
NRBF2 10:64893050 10:66748053  EH816 EH3705 1  
JMJD1C 10:65225722 10:66648728  EN1292 4  
REEP3 10:65281123 10:66559655  EB1097 6  
D10S581      10:65849305 
D10S502      10:68418857 
LRRTM3 10:68685764 10:63553025 
Majercak et al., 
2006 Haines and 
Rigby, 2007 
EH2220 6 Michielse et al., 2006 
CTNNA3 10:69455927 10:62892846  EN1616 1 Michielse et al., 2006 
Table 2. HCFP2 genes. List of human genes from the expanded HCFP2 locus, following 
the scheme of Table 1. The HCFP2 locus sensu stricto, delimited by the two markers, 
appears as a chromosomic region without the 5’ end for any protein-coding gene. It 
contains nevertheless the 3’ end of the CTNNA3 gene, which encompasses LRRTM3 as 
an intra-intronic gene (see Fig. 1). Genes without expression in the FBM nucleus 
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Van der Zwaag et al.14 proposed that this molecule could have some influence in FBM 
development since it is expressed in cell populations relatively close to this nucleus or 
its migratory route. However, it was discarded through sequence analysis in HCFP 
cases14,16. On the other hand, Schwarz et al.19 demonstrated, through analysis of 
knock-out mice, that Plxna3 and –a4 (but neither Plxna1 nor Plxna2) are involved in 
FBM axon guidance, so that this molecule can be discarded as related to the 
development of this nucleus. 
 
The second gene, Mcm2, codes for a protein involved in the regulation of DNA 
replication whose alteration leads to genome instability and cancer susceptibility21. 
GenePaint images showed that it is expressed in the ventricular zone (vz) of all the 
central nervous system (with greater intensity in the vz of forebrain and dorsal 
midbrain, and fainter levels in the hindbrain vz) and in the cerebellar external granular 
layer (egl) and rhombic lip (rl) -Fig. 1c-. These results are similar to those provided by 
previous literature8, 22 and the GenePaint image series (Fig. 1c). We observed that it 
was additionally expressed by vascular endothelial cells scattered throughout the brain 
parenchyma (inset in Fig. 1c). Therefore, the expression of this gene in the hindbrain 
appeared in proliferating cell populations and was excluded from the FBM nucleus, at 
least at the analysed stage. 
 
Finally, Trh (thyrotropin releasing hormone) is a well-known marker of some 
hypothalamic nuclei, but it is also expressed in several structures of the adult 
brainstem23. By examining the Allen Brain and GenePaint images, we found that in the 
hindbrain from 14.5 dpc to P56 stages there is mRNA expression in subregions of the 
raphe nuclei (Rn) and paraolivary (Po) regions, as described previously by 
immunohistochemistry in the adult rabbit brain25. Additionally, we found transitory 
expression at perinatal stages in parts of the vagal (10), hypoglossal (12) and 
ambiguous (Amb) motor nuclei and in the dorsal horn of the spinal cord (Fig. 1d and 
data not shown). The late onset and/or topographic location of the aforementioned 
positive regions points to no relation with the developing FBM nucleus. However, in 
13.5, 18.5 dpc and P4 brains there were some isolated positive cells within this nucleus 
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whose significance cannot be ascertained (Figs. 1e, f, and data not shown). Since the 
labelling appeared only in some few cells, we did not consider this gene as a marker of 
the FBM nucleus in the present ad hoc classification. 
 
 
Figure 2. Expression of Gata2, Tmcc1 and Trh. a, c, e show parasagittal sections of 
14.5 dpc mouse embryos processed respectively for ISH detection of each of these 
genes. The rostral end is to the left. The major antero-posterior subdivisions of the 
brain are outlined: secondary prosencephalon (sP), diencephalon (prosomeres p1 to 
p3), midbrain (M), isthmo-cerebellum (isthmus plus r1; I-r1), pons (rhombomeres r2 to 
r6) and medulla oblongata (rhombomeres r7 to r11)23,24 spc: spinal cord. b, d, f show 
detailed views of the adjacent panels, centered in the FBM nucleus. (A, B) Gata2 
expression in the hindbrain appears in the central gray (CG), superior olive (SO), lateral 
lemniscus (LL) and lateral paragigantocellular nucleus (LPGi), while the FBM nucleus, 
placed in r6, shows background-like signal. (C, D) Tmcc1 is faintly expressed in the 
cortical plate (cp), olfactory bulb (ob), superior olive (SO) and facial (FBM) and 
ambiguous (Amb) motor nuclei. e, f. Trh expression appears principally in the 
hypothalamus (Hyp) and additionally in the paraolivary region (Po) and in few cells 
within the FBM nucleus (arrows in F). These and following figures correspond to 
images downloaded from the GenePaint server. 
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Genes expressed in the FBM nucleus 
We have classed in group 6 the genes that appeared as specific markers of the whole 
FBM nucleus. This group included two previously known genes (Gata2 and Tmcc1, 
both of them from the HCFP1 locus) while others are reported here by the first time to 
be expressed in this nucleus (Mgll from the HCFP1 locus, and Reep3 and Lrrtm3 from 
the HCFP2 locus). We next describe in detail the expression pattern and other 
characteristics of these genes. 
 
Gata2 belongs to the Gata family of zinc-finger transcription factors, involved in 
several developmental processes like hematopoietic, cardiovascular and urogenital 
development26. It has the capacity of inhibiting the proliferation of neural 
progenitors27 and participates in the development of midbrain gabaergic cells28 and 
serotonergic raphe nuclei in the hindbrain29. Gata2 is expressed with a segmentary 
pattern in the early hindbrain (8.5-9.5 dpc), appearing in ventral rhombomere 4 which 
is the place where are born the neurons of the FBM nucleus, so that all the progenitors 
of this nucleus express this gene10,30. We have completed the description of its 
expression pattern in the hindbrain thanks to the image series provided by GenePaint 
and Allen Brain servers.  
 
At 11.5 dpc it could be observed Gata2 expression in a cell stream in r5-r6 probably 
corresponding to the migrating FBM nucleus, as well as in caudal raphe nuclei (Rn) -Figs. 2a-d-. 
At 13.5 dpc expression has disappeared from FBM, remaining in isolated cells within this 
nucleus (Figs. 2F-G). From this stage onwards, Gata2 is expressed in auditive related nuclei 
(nuclei of the lateral lemniscus –LL-, superior olivary complex –so- and nucleus of the trapezoid 
body), central gray of the pons (CG) and lateral paragigantocellular nucleus (LPGi) besides the 
aforementioned raphe nuclei (Figs. 2E, F). Expression in these structures disappears after P4 
stage (data not shown). Therefore Gata2 is transitorily expressed in the FBM nucleus, as well 
as in structures adjacent to this nucleus (superior olivary complex and lateral 
paragigantocellular nucleus, placed respectively anterior and posterior to FBM nucleus; Figs. 
2b, c).    
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Figure 3. Mgll expression. a, c, e g, i represent parasagittal sections ordered from 
lateral to medial levels, and B, D, F, H, J are higher magnification detail views centered 
in the hindbrain. A-H correspond to one of the image series offered by the GenePaint 
server (set ID MH2900) and I-J to the second one (set ID ES408) –see Table 1-. a, b. 
Section showing expression of Mgll in the cortical plate (cp), the trigeminal motor 
nucleus (5), the lateral reticular nucleus (LRt) and the caudal portion of the spinal 
trigeminal nucleus (Sp5C). There is also expression in the ventricular zone (vz) of 
rhombomeres r4-5. In r4, 7n indicates the facial nerve fibers (in white). c, d. Section 
showing expression in the FBM nucleus. e, f. Section medial to the previous one, 
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showing the FBM nucleus expressing Mgll. Other moderately positive zones are parts 
of the ganglionic eminences (ge), parts of the diencephalon (p1-3), nuclei of the lateral 
lemniscus (LL), the superior olive (SO), the ambiguous motorn nucleus (Amb) and the 
22 medial vestibular nucleus (MVe). Note expression in the ventricular zone (vz) 
corresponding to r4, r5 and r6. g, h. Section close to the midline. The positive regionin 
the ventricular zone covers from r4 to r7-r8. i, j. Section from another embryo 
processed for ISH detection of Mgll, showing specific expression in the FBM nucleus 
and in the ventricular zone of r4-r6. 
 
Tmcc1 (transmembrane and coiled-coil domain family 1) initially known in human as KIAA0779, 
codes for a protein with unknown functions. It belongs to a family with four paralogs in 
vertebrates and present also in D. melanogaster and C. elegans, according to the ENSEMBL 
genome server. Van der Zwaag14 described expression of this gene in the FBM nucleus, as well 
as in ventral spinal cord, ganglia, olfactory bulb, neocortex and olfactory epithelium from 12.5 
to 16.5 dpc stages. The GenePaint image series of a 14.5 dpc embryo displayed a similar 
expression pattern, although expression signal could be observed additionally in the different 
motor nuclei of the brainstem (data not shown). However, the expression signal in all the 
mentioned structures was very faint, as observed in the images from the GenePaint server as 
well as in those provided by van der Zwaag14. 
 
The third gene from the HCFP1 locus, Mgll (monoglyceride lipase) codes for an enzyme 
present in adipocytes that hydrolizes monoglycerides into fatty acids and glycerol, 
participating therefore in the body lipid metabolism. Additionally, it is localized in the 
brain and in the enteric nervous system where it functions to regulate the levels of 
endocannabinoids31. However it has not been identified to date which brain structures 
express this gene.  
 
GenePaint provided image series from two ISH experiments in 14.5 dpc embryos with 
different riboprobes of this gene. Outside the hindbrain, neural expression of Mgll 
appeared in the cranial and spinal ganglia, the cortical plate (cp) and, with low 
intensity, in the ganglionic eminences (ge), superior colliculus (sc) and parts of the 
prethalamus (prosomere 3; p3) and pretectum (prosomere 1; p1) -Figs. 3a, c, g, e-. 
Hindbrain positive structures were the FBM and trigeminal motor nuclei (5), lateral 
reticular nucleus (LRt), caudal portion of the spinal trigeminal nucleus (Sp5C) and 
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medial vestibular nucleus (MVe) (Figs. 3a-f). Interestingly, another structure with 
strong and clearcut expression was a portion of the hindbrain ventricular zone, that 
corresponded principally to rhombomeres r4-r6, that is, adjacent to the migratory 
route of the FBM nucleus (Figs. 3d, f, h). 
 
The first gene from the HCFP2 locus, Reep3 (receptor expression-enhancing protein 3) 
is a transmembrane protein that together with Reep1 interacts with taste receptors32 
The vertebrate Reep genes are homologs of yeast Yop1p, a probable regulator of 
cellular vesicle trafficking between the endoplasmatic reticulum and the Golgi 
network33. 
 
Reep3 expression in the forebrain and midbrain suggested a role in cell proliferation 
and/or differentiation, since the expression either in ventricular or subventricular zone 
was specific for each subregion. In the forebrain there were exprssion in the 
ventricular and subventricular zones of cortex (cx) and ganglionice eminences (ge) (Fig. 
4a). In the midbrain, the dorsal plate (superior and inferior colliculi; sc, ic) showed 
expression in the subventricular zone (svz), but in the basal midbrain the positive cells 
corresponded to the ventricular zone (vz) (Fig. 4c). In the hindbrain, Reep3 expression 
appeared with strong intensity in the ventricular zone and in the trigeminal (5), FBM 
and ambiguous (Amb) motor nuclei (Figs. 4b, d) and in the cochlear nuclei (coc) (Fig. 
4b). Low expression signal appeared in the abducens (6) and vagal and hypoglossal (10, 
12) motor nuclei (Fig. 4e). In this material it was not possible to differentiate between 
the two last motor nuclei, appearing as a conjoint structure. Additionally, there was 
Reep3 expression in vascular endothelial cells through all the brain parenchyma (inset 
in Fig. 4f). 
 
The other gene adjacent to the HCFP2 locus was Lrrtm3. It belongs to the Lrrtm family 
of transmembrane proteins with leucine rich repeats which are involved probably in 
the regulation of cell adhesion and/or signalling, similarly to other molecular families 
with this structural characteristic. Haines and Rigby34 have analysed Lrrtm1-4 
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expression in 8.5 to 11 dpc mouse embryos, finding different expression patterns for 
each of these four genes. Lrrtm3 in particular appears expressed in recently formed 
somites, hindgut, eye, telencephalon and discrete longitudinal columns within spinal 
cord and hindbrain34. 
 
Figure  4. Expression of Reep3 and Lrrtm3. a-f. Parasagittal sections and corresponding 
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detailed views showing Reep3 expression. a, b. Section at a lateral level showing 
expression in the ventricular and subventricular zones (vz, svz) of the cortex and 
ganglionic eminences, ventricular zone of the hindbrain, trigeminal motor nucleus (5), 
and cochlear nuclei (coc). c, d. Section medial to the former, showing expression in the 
ventricular zone (vz) of midbrain and hindbrain (excepting the dorsal midbrain, where 
expression appears instead in the subventricular zone, svz). The FBM and ambiguous 
nuclei (Amb) are positive. e, f. Section close to the midline showing light staining in the 
abducens motor nucleus (6), in the vagal and hypoglossal motor nuclei (10, 12) and in 
some blood vessels (bv). g-j. Parasagittal sections and corresponding detailed views, 
showing Lrrtm3 expression. There is broad expression in all the brainstem, excepting 
for the ventricular zone (vz) and rhombic lip (rhl) that appear negative, and 
regionalised expression in the forebrain. There is strong expression in the FBM and 
oculomotor (3), trochlear (4) and abducens (6) motor nuclei. The label g7 indicates the 
facial genu (in white), surrounding the abducens nucleus in r5. 
 
We examined the neural expression pattern at 14.5 dpc by using the image series 
provided by the GenePaint server (Fig. 5). We found that this gene displayed a broad 
expression pattern covering parts of the forebrain and almost all the midbrain and 
hindbrain. In every region it was excluded from the ventricular zone, appearing only in 
the mantle layer and being therefore characteristic of post-mitotic cells. Positive zones 
outside the hindbrain were the cortical plate (cp), ganglionic eminences (ge), septum 
(se), nuclei of the diagonal band (db), parts of the hypothalamus (hyp), parts of the 
pretectum (prosomere 1, p1) and the regions adjacent to interprosomeric boundaries 
(Figs. 5a, c, e). Hindbrain structures that displayed a strong expression signal were the 
nucleus of the solitary tract (data not shown), the FBM nucleus and the oculomotor 
(3), trochlear (4) and abducens (6) motor nuclei (Figs. 5a-f). While Reep3 and Mgll are 
common to trigeminal and facial branchiomotor nuclei, Lrrtm3 has a reduced 
expression in the former (Fig. 5b; see Table 3).  
 
DISCUSSION 
HCFP is a congenital developmental neurological different with two known genetic 
subtypes (HCFP1 and HCFP2) that involve specifically the facial branchiomotor (FBM) 
nucleus and its nerve1-4. In the present work we aimed to identify genes from the 
critical loci that were specifically expressed in the aferomentioned nucleus during 
embryonic development.  
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Locus Gene Motor nuclei     
  FBM 3 , 4 5 6 Amb 10, 12 
HCFP1 Gata2 + / - - - - - - 
 Tmcc1 + ? + ? + + 
 Trh + - - - + + 
 Mgll + + + - + + + - - - 
HCFP2 Reep3 + + + + + + + + + + 
 Lrrtm3 + + + + + + + + + + + + + + + 
Table 3. Expression of candidate genes in the motor nuclei. List of candidate genes 
indicating their respective expression in the different motor nuclei of the hindbrain, 
according to a semiquantitative analysis. Gata2 is expressed in FBM progenitor cells, 
but is absent at the FBM nucleus in 14.5 dpc embryos. 
 
The FBM nucleus undergoes a complex and unique developmental course 
The FBM nucleus is formed by branchiomotor neurons that innervate facial muscles 
derived from the second pharyngeal arch35. Their axons form the facial nerve, together 
with sensitive fibers as well as axons from the visceromotor neurons of the superior 
salivatory nucleus. The later is developmentally and cytoarchitecturally independent of 
the FBM nucleus. The facial visceromotor neurons form and remain within r5, but FBM 
neurons are born in r4, undergoing subsequently a complex caudal, tangential 
migration from r4 to r6ref11 . In the mouse the migration of FBM neurons starts at 10-
10.5 dpc, when the cell bodies migrate caudalwards close to the ventricular zone and 
medially to the abducens motor nucleus located in r5. They reach r6, where they 
migrate laterally and tangentially to form the FBM nucleus, that appears with its 
definitive form and position at the 14-14.5 dpc stage. During this process, the axonal 
exit point of these neurons remain within r4, so that these axons form a characteristic 
bundle around the abducens nucleus called genu facialis (see Fig. 5f)36. 
 
Several studies have adressed the mechanisms responsible of the FBM migration. 
Studer35 demonstrated experimentally that this behaviour depends on signals located 
in r5-r6. Other authors have found genes necessary for this migratory process, like 
Ebf1 which is specifically expressed in these neurons36 or Gata2, Gata3 and Hoxb1 
expressed in r430, or genes like Plxna3, -a4 that are necessary for axonal guidance of 
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these neurons19,review by Song et al37. However, to date it has been found no 
correlation of mutations of any of these genes with the HCFP disorder.  
 
Search of candidate genes for HCFP 
Linkage studies have identified two chromosomic regions that would contain specific 
mutations causing HCFP7,16. However, sequencing analysis of several of the genes 
contained within or relatively close to these loci has yielded negative results, as 
commented in the Introduction14-18 It should be taken into account that these studies 
have focused in coding sequences and intron-exon boundaries, and eventually short 
upstream sequences, so these authors do not discard the possibility that mutations in 
regulatory elements placed outside the analysed (and discarded) genes could cause 
this disease. 
 
In the present work we aimed to profit from the available online databases of genic 
expression to search which genes from the aforementioned loci are expressed in the 
developing FBM nucleus, so they would be candidates for this disease. We have 
extended our analysis into regions of 1Mb immediately adjacent to both chromosomic 
regions, considering the possibility that the eventual mutations within these loci could 
involve non-coding sequences regulating far away located genes. Long-range genic 
regulation has already been described, particularly in studies identifying causative 
mutations for some diseases38. This strategy has revealed itself apropriate in the case 
of the HCFP2 locus, which does not contain protein-coding genes, neither known nor 
predicted, so it probably contains long-range regulatory elements for genes placed in 
distant or neighbouring regions. This possibility is supported by the syntenyc 
conservation of this region in the genome of amniotes, according to the information 
available at the ENSEMBL server (data not shown). 
 
Proposal of candidate genes from the HCFP1 locus 
We have found three genes contained within this locus that are expressed in the 
developing FBM nucleus. One of them, Tmcc1 , previously reported by van der 
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Zwaag18, displays low expression signal in this nucleus that is difficult to differentiate 
from the background, moreover taking into account that motor nuclei in general are 
prone to display unspecific staining due to the large size and compactness of their 
neurons. Therefore ulterior studies would be needed to better characterize its 
expression and eventual functions. 
 
Gata2 codes for a transcription factor that appears expressed in the ventral portion of 
early r4 including therefore the progenitor cells for the FBM nucleus10,28. We have 
found that additionally this gene is expressed in the FBM migrating cells en route to r6 
at 11.5 dpc (Fig. 2d). Loss-of-function studies have shown that this gene participates in 
a r4 regulatory cascade, with Hoxb1 inducing Gata2 which in turn induces Gata3, being 
these genes necessary for the projection of contralateral vestibuloacoustic efferent 
neurons in r4 and the migration of FBM neurons28. Additionally Gata2 is involved in 
the specification of serotenergic cells in the hindbrain and gabaergic cells in the 
midbrain, as well as in hematopoietic, cardiovascular and urogenital development26. In 
humans, sequence analysis have discarded this gene as causative of HCFP8,16 but it 
would remain to be studied if mutations in the HCFP1 locus could involve its regulatory 
sequences and interfere therefore with its normal expression in r4 or in the FBM 
nucleus. 
 
The other gene from the HCFP1 locus expressed in the developing FBM nucleus is Mgll, 
which codes for a lipase enzyme. Its role in the metabolism of endocannabionoids, as 
described in the adult nervous system31 could have a counterpart in the embryonic 
brain and concretely in the FBM neurons, where it is neatly expressed. Additionally, it 
is expressed in the ventricular zone of r4-r6 (Fig. 3a-f), largely coinciding with the 
migratory route of these neurons, so it could also have a role in this process. The 
sequence analysis of this gene in HCFP cases has not been performed to date. 
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Proposal of candidate genes from the HCFP2 locus 
This locus lacks protein-coding genes within it, excepting for the 3´ region of the 
CTNNA3 gene. It belongs to the alpha-catenin family of cell–cell adhesion molecules, 
and it is expressed in the adult in cardiomyocytes, skeletal muscle, testis and brain. Its 
expression includes transversal stripes of the cerebellar cortex and portions of 
midbrain and telencephalon, as observed with a reporter transgenic line40. However, 
the detailed anatomical description of its pattern in the adult or embryonic brain has 
not been provided, while the GenePaint image series display a generalised 
background-like staining, so it cannot be discerned its eventual expression in the FBM 
nucleus.  
 
The other two genes adjacent to this locus, Reep3 and Lrrtm3, showed expression in 
the FBM nucleus (Figs. 4 and 5) . As commented in Results, Reep3 codes for a 
transmembrane protein functionally related to chemoreceptors32. It has been 
described, in a single case of autism, a translocation of a chromosomic fragment 
located in the 5´ region of REEP3. This mutation causes the deregulation of the 
expression of this gene in a fibroblast cell line from that patient, but the causative 
relation with the autistic phenotype has not been established33. The HCFP2 locus is 
placed in the 3´ region of REEP3, so it could eventually contain additional regulatory 
elements for this gene that could be affected in  HCFP cases. 
 
Interestingly, other known functions of Reep proteins are related to neuromotor 
control. Reep4 loss-of-function causes paralysis in Xenopus, although it has not been 
discerned the neural or muscular origin of this phenotype41. In humans, REEP1 
mutation causes one of the variants of hereditary spastic paraplegia42. Therefore it 
would be feasible to consider a possible role of Reep3 in the function or development 
of the FBM nuclues.  
 
While Reep3 displays a clearcut expression in the FBM nucleus, the second gene 
Lrrtm3 is expressed in almost all the hindbrain. Lrrtm3 belongs to a molecular family 
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involved in neural development and concretely in synaptic organisation, according to 
the functional analysis of other Lrrtm proteins34,43. Further studies would be necessary 
to assess if it is involved specifically in FBM development, provided its broad neural 
expression pattern (Fig. 5).  
 
The candidate genes are not exclusive of the FBM nucleus 
In more or less degree, all the candidate genes we have described share its expression 
with other structures than the FBM nucleus. If we consider in particular the cranial 
nerve nuclei, apart from Gata2 there is no other gene exclusive of the FBM nucleus 
(Table 3). This raises a problem for these candidate genes, since HCFP involves only the 
FBM nucleus, differentiating this disease from the Mobius syndrome and the rest of 
Congenital Cranial Dysinnervation Disorders. An explanation would be that, from all 
the positive structures expressing a given gene, the FBM nucleus would be the most 
sensitive to changes in its protein function or spatio-temporal expression, given the 
peculiarity and complexity of the development of this nucleus. At this respect it should 
be reminded that HCFP is an autosomal dominant disease, meaning that it is enough 
the mutation in the coding or regulatory sequence of one gene copy to trigger the 
maldevelopment of the FBM nucleus.  
 
Incidentally, the expression of the candidate genes in other brain regions like the 
telencephalon or midbrain could explain the fact that some of them have been related 
to other neurological diseases. This would be the case of the aforementioned relation 
of REEP3 with autism in one single case31 or the association of GATA2 and LRRTM3 
polymorphisms with Parkinson and Alzheimer diseases respectively44, 45. 
 
We have identified several genes from the HCFP loci that display relatively specific 
expression in the developing FBM nucleus, so they are candidates to be causative of 
this disease. One caveat of our approach is that we have not covered all the embryonic 
stages, so we could have missed genes expressed in the early FBM neurons or their 
progenitors, as it is the case of Gata2. Nevertheless, we think that our results are 
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consistent enough to propose the selected genes as candidates. Some of them have 
been previosly discarded by analysis of their coding sequence (Gata2, Tmcc1 and 
Lrrtm3) but such study remains to be done for the others (Mgll and Reep3). However, 
it could be plausible that the HCFP mutation involves instead cis-regulatory elements 
for these genes. This would be particularly the case of Reep3 and Lrrtm3 flanking the 
HCFP2 locus, which contains no protein-coding genes and is probably integrated by 
long-range regulatory sequences for the neighbouring genes.  
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ABSTRACT 
Hereditary Congenital Facial Paresis (HCFP) is an autosomal dominant disorder caused 
by uni- or bi-lateral maldevelopment of the VIIth cranial nerve (facial) and its nucleus, 
the facial branchiomotor nucleus (FBM). We here identified a heterozygous frameshift 
mutation in MEPE in a Turkish HCFP family, in which several affected individuals also 
present hearing loss associated with otosclerosis. Subsequently, we investigated 
families with facial paralysis and/or deafness and we identified one family with 
otosclerosis and one isolated patient with sensorineural hearing loss in this gene. 
MEPE encodes a matrix extracellular phosphoglycoprotein and is involved in bone 
mass production. All the patients reported in this study share an alteration of the 
temporal bone structure. We hypothesize that the increased temporal bone mass 
production results in an alteration of the inner ear bones and obstruction of the facial 
nerve canal that may lead to the different phenotypes. We identified for the first time 
a causative gene for HCFP and otosclerosis and novel causative gene for sensorineural 
hearing loss.  
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INTRODUCTION 
HCFP belongs to the group of Congenital Cranial Dysinnervation Disorders (CCDD) 
characterized by abnormal motility of the eyes, eyelid and facial muscles1,2. Hereditary 
Congenital Facial Paresis (HCFP) is a rare autosomal dominant disease caused by uni- 
or bilateral maldevelopment of the VIIth cranial nerve (facial) and its nucleus, the facial 
branchiomotor nucleus (FBM)3. Patients have an inappropriate innervation of the facial 
muscles that leads to facial weakness or paralysis and abnormal facial expression. Two 
loci have been identified by linkage analysis, HCFP1 on chromosome 3q21.2-q22.1ref4,5 
(MIM601471) and HCFP2 on chromosome 10q21.3-q22.1ref6 (MIM604185). The HCFP1 
locus was identified in a large Dutch family4 and refined in a Pakistani family5. Both 
families present a similar phenotype with an asymmetric, unilateral, weakness of facial 
muscles and unequal involvement of the muscles of the three branches of the facial 
nerve. The second locus (HCFP2) was identified in another Dutch family6, with 
unilateral or asymmetric bilateral congenital facial paralysis. In addition, some patients 
from this family present hearing loss, ranging from congenital deafness to progressive 
hearing loss with age. Several candidate genes from both loci have been analyzed, 
according to their function and their expression in mouse hindbrain during 
development5-9. PGT, GATA2, PLXNA1, PLXND1, GATA2, PODXL2, FLJ40083, KLF15 and 
TMCC1 genes mapping to the HCFP1 locus5,7-10 and EGR2, CTNNA3 and LRRTM3 
genes6,10 from the HCFP2 locus have been analyzed in patients. Very recently, de novo 
mutations in PLXND1, which maps to the HCFP1 locus, have been identified in patients 
with a Möbius syndrome phenotype, characterized by maldevelopment of the VIth and 
VIIth cranial nerve and other developmental defects. Moreover, de novo mutations in 
REV3L were identified in two patients with a MBS phenotype and in one patient with 
an HCFP phenotype. Remarkably, no mutations in PLXND1 nor in any other gene have 
been identified yet in HCFP families.  
 
We have investigated a Turkish family by whole-exome sequencing in two affected 
members. All eight affected subjects of the family present bilateral facial paralysis and 
at least five of them have conductive hearing loss in addition (Fig. 1a, Supplementary 
Table 1). The clinical, audiological and images analysis of four of the deafness patients 
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indicate the presence of osteopetrosis and otosclerosis. Filtering and validation of the 
variants identified by exome-sequencing revealed only a single variant that co-
segregates with the HCFP phenotype, a heterozygous frameshift mutation in MEPE. 
Subsequently, we identified two additional heterozygous loss-of-function MEPE 
mutations in unrelated deafness families. For at least two of the three families, the 
HCFP/deafness phenotype is associated with otosclerosis. 
 
MATERIAL AND METHODS 
Patients 
We studied a four generation Turkish family of 29 members (Fig. 1a). In this family 
there are eight affected individuals previously diagnosed with HCFP, characterized by 
bilateral weakness of facial muscles. Besides the facial palsy, there are five patients 
who also present conductive hearing loss (III:7, III:5, III:16, IV:1 and IV:2) (Fig. 1, 2, 
Supplementary Table 1). Pure tone audiometric (PTA) evaluation of four of the patients 
(III-7, III-15, IV-1 and IV-2) with hearing loss revealed uni- or bilateral mixed hearing 
loss, whereas non-affected members (IV-3 and IV-9) had normal hearing thresholds. 
Temporal high resolution computed tomography (HRCT) performed in four deafness 
patients showed sclerosis and diploic thickening of the calvarial bones, reduced 
pneumatization of the mastoid cells and ossicular chain deformation. All these features 
are consistent with otosclerosis. In three of this patients (III:7, III:5, and IV:2) the facial 
canals were bilaterally narrowed. Informed consent was obtained from all the subjects 
involved in this study and all procedures were in accordance with the ethics of the 
World Medical Association Declaration of Helsinki.  
 
Genotyping 
Genotyping analysis was carried out with four polymorphic markers from the 3q21.2-
q22.1 region (D3S1589, RHO, D3S1587 and D3S1290) and six polymorphic markers 
from the 10q21.3-q22.1 region (D10S196, D10S539, D10S1767, D10S589, D10S581 and 
D10S1670), in ten members of this family, six of whom were affected and four were 
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unaffected. The order of the markers is according to the Human Genome Working 
Draft (May 2004; http://genome.ucsc.edu).  
 
Whole-exome sequencing 
Exome sequencing was performed in two affected individuals (II:3 and IV:2), using the 
SureSelect Human All Exon 50Mb Kit (Agilent, Santa Clara, CA) followed by multiplexed 
analysis on a SOLiD 4 System sequencing slide (Life Technologies, Carlsbad, CA). Color 
space reads were mapped to the hg19 reference genome with the SOLiD BioScope 
version 1.3 software, which utilizes an iterative mapping approach. 72% of bases 
mapped inside the targets, resulting in an average target coverage 66.93x fold and 85% 
of the exons were covered at least 10 times. (Supplementary Table 2) Single-nucleotide 
variants were subsequently called by the Di-Bayes algorithm with high call stringency.  
 
Called variants were combined and annotated with a custom analysis pipeline. We 
then applied a filtering scheme excluding variants observed in dbSNP (v138) and in our 
in-house database (5031 exomes). Comparison of the unique variants from each 
patient identified 140 overlapping variants (Supplementary Table 3). Of these, 53 
variants were located in the exonic sequence or located in canonical splice sites, 
defined as the dinucleotides up- and downstream of exonic sequence.  
 
Diagnostic exome sequencing was performed in an isolated patient with sensorineural 
hearing loss. The total number of variants identified is summarized in Supplementary 
Table 3. We excluded all synonymous variants, as well as variants present in 
dbSNPv138 or in our in-house-sequenced exome database with a minor frequency 
allele (MAF) >0.5%, and variants in noncoding regions with the exception of canonical 
splice site sequences. Manual inspection of mapped reads excluded additional, likely 
false positive, variants. We further analyzed all truncating variants, missense variants 
with a PhyloP score >3 or those affecting genes with a possible involvement in 
sensorineural hearing loss as suggested by the GO term or mouse mutant phenotype. 
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Candidate variants were validated by Sanger sequencing, and parental DNAs were 
tested for de novo occurrence of the respective variant (Supplementary Table S3). 
 
Sanger Sequencing analysis 
We performed systematic validation and segregation analysis through Sanger 
sequencing, of all 53 shared variants in all members of the family. Furthermore, we 
performed mutation analysed of the coding regions of MEPE in nine unrelated HCFP 
patients from our cohort and nine families with otosclerosis.  
 
Oligonucleotide primers were designed for amplification of all selected variantsand for 
amplification of all exons of MEPE (Genbank ID NM_NM_001184694) by using Primer3 
software (http://frodo.wi.mit.edu/). Primers sequences are shown in Supplementary 
table 4. PCR was performed on 50 ng genomic DNA using Taq DNA polymerase 
(Invitrogen, Carlsbad, CA). Nucleofast 96 PCR plate (Clontech Lab, Mountain View, CA) 
was used to purify the PCR amplicons, according to the manufacturer’s protocol. 
Sequence analysis was performed with the ABI PRISM Big Dye Terminator Cycle 
Sequencing V3.1 ready Reaction Kit and the ABI PRISM 3730 DNA Analyzer (Applera 
Corp, Foster City, CA). PCR products were sequenced by Sanger sequencing and 
analysed using Vector NTI® software (Life Technologies).   
 
RESULTS 
Identification of a HCFP family with involvement of a novel HCFP locus 
We studied a four generation Turkish family of 29 members (Fig. 1a, Fig. 2). In this 
family there are eight affected individuals previously diagnosed of HCFP, with a 
phenotype of bilateral weakness of facial muscles. Besides the facial palsy, there are 
five patients who also show osteopetrosis and otosclerosis (III:7, III:5, III:16, IV:1 and 
IV:2) (Supplementary Table 1). A temporal Computed tomography (CT) scan performed 
in four of the patient with hearing loss (III:7, III:15, IV-1, IV-2) showed diploic thickening 
of the calvarial bones, reduced pneumatization of the mastoid cells, narrowing of the 
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internal auditory and facial canals (Fig. 2). Audiological evaluation of these four 
patients by pure tone audiometry confirmed bilateral mixed hearing loss, with Cahart 
notches at 2000 Hz and absence of the acoustic reflexes. Their clinical signs and 
audiological exams were compatible with otosclerosis. Targeted linkage analysis using 
polymorphic markers from the HCFP1 and HCFP2 loci excluded the involvement of a 
genetic defect at these chromosomal regions. 
 
Whole exome sequencing reveals frameshift mutations in MEPE 
Following the exclusion of the HCFP1 and HCFP2 loci, we decided to perform whole-
exome sequencing in two affected patients of the Turkish HCFP family (II:3 and IV:2; 
Fig. 1a). We analyzed all variants present in both affected individuals (Supplementary 
Tables 2-3). From the 140 variants that remained, we excluded all synonymous 
variants, variants present in dbSNPv138 or our in-house-sequenced exome database 
(5030 exomes), and variants in noncoding regions with the exception of canonical 
splice site sequences. Confirmation and segregation analysis of the 53 remaining 
variants was carried out by Sanger sequencing, which revealed only one variant 
cosegregating with the disease: MEPE (M1: c.1273del; p.Gln425Lysfs*38) (Fig. 1a, 
Table 1) located at chromosome 4q22.1. 
 
The heterozygous deletion creates a frameshift starting at codon Gln425. The new 
reading frame ends in a STOP codon after 37 illegitimate amino acids. The mutation is 
not present in 1000 Genomes, Exome Variant Server (EVS) or in our in-house 
databases (5030 samples).  
 
MEPE is a matrix extracellular phosphoglycoprotein comprising 525 amino acids. MEPE 
belongs to the family of small integrin-binding ligand proteins, N-linked glycoproteins 
(SIBLINGs)11. This family is characterized by an acidic serine apartate-rich MEPE-
associated (ASARM) motif, which has a key role in bone mineralization12,13. MEPE is 
expressed in osteocytes, osteoblasts, odontoblasts, renal proximal tubules and salivary 
glands14-19, and its expression increases during osteoblast matrix mineralization20-21. In 
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mammalian cells it can act as a cofactor of CHK1, which plays an important role 
protecting cells from DNA-damage-induced killing19,22. As mentioned above, there are 
five patients in this family (III:7, III:5, III:16, IV:1 and IV:2) that present both facial palsy 
and otosclerosis.  
 
Mutation analysis 
On the premise that MEPE is a candidate gene for HCFP and otosclerosis, we 
sequenced this gene in nine HCFP families and nine families with otosclerosis. Sanger 
sequencing revealed one frameshift mutation (M2: c.209_212del; pLys70Ilefs*26) 
(Fig.1b, 1d, Table 1) in one family with otosclerosis (Fig. 1b). This deletion of four base 
pairs creates a frame shift starting at codon Lys70. The new reading frame ends in a 
stop codon 25 positions downstream. The mutation was identified in two affected 
members of the family (II:1 and (III:13) and seven unaffected members suggesting a 
reduced penetrance of the otosclerosis phenotype. It was reported in EVS database 
with a minor allele frequency (MAF) of 0.1%. The mutation was not found in 140 Dutch 
controls analyzed. 
 
Exome 
sequencing 
case 
Genomic 
position1 Mutation Amino acid 
Mutation 
type 
MAF% 
EVS 
Pheno-
type 
Family 1 g.88767293 c.1273del p.Gln425Lysfs*38 Frameshift  HCFP+ OTOSC 
Family 2 g.88766229_88766232del c.209_212del Lys70Ilefs*26 Frameshift 
EA: 0.11 
AA: 0.09 OTOSC 
Family 3 g.88766637del c.617del p.Ser206Ilefs*3 Frameshift EA: 0.07 AA: 0.05 DFNA 
Table 1. Frameshift mutations in MEPE patients. 
1 Genomic position is with respect to chromosome 4 in hg19.  
Mutations are described numbered from the first nucleotide of the initiation codon in 
the nucleotide sequence NM_001184694 (MEPE). MAF:  minor frequency allele in EVS 
database. EA: European-American population+ AA:  African-American population. 
OTOSC: Otosclerosis. DFNA: autosomal dominant sensorineural hearing loss. 
 
Independently, diagnostic exome sequencing performed in an isolated patient with 
sensorineural hearing loss (Fig. 1c) identified a third heterozygous frameshift mutation 
(M3: c.617del; p.Ser206Ilefs*3) (Fig.1d, Table 1, Supplementary Table 1-3) in MEPE.  
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Figure 1. Clinical features of HCFP patients and pedigree of families in which a MEPE 
mutation was identified. a. Pedigree of HCFP family (Family 1) in which the mutation 
M1 (c.1273del; p.Gln425Lysfs*38) fully segregate. Clinical features of the patients 
carrying the mutations in MEPE. Patients III-7, III:15, IV:1 and IV:2 show bilateral facial 
paralysis, they are not able to smile. b. Pedigree of the family with otosclerosis (Family 
2) in which the mutation M2 (c.209_212del; pLys70Ilefs*26) was identified. c. Pedigree 
of the Family 3 with sensorineural hearing loss in which the mutation M3 was 
identified (c.617del; p.Ser206Ilefs*3). d. Sanger sequencing of the mutations carriers. 
Arrows point the mutations. e. Genomic structure of the MEPE protein structure and 
the position of the frameshift mutations. The ASARM protein domain is depicted. e. 
Schematic structure of human MEPE gene. HCFP associated mutation is indicated in red, 
otosclerosis mutation in grey and DFNA mutation in pink. Ligh blue color indicated the non- 
coding region, and dark blue the codin regions. f. Schematic structure of three of human MEPE 
protein isoforms. The mutations are indicated in the same colors as in (e). 
 
This deletion creates a frame shift starting at codon Ser206. The new reading frame 
ends in a stop codon 2 positions downstream. The mutation was present in EVS 
database with a minor allele frequency (MAF) of 0.06% and 0.029% in EXAC database. 
This patient has progressive hearing loss since 22 years old; tinnitus and the audiogram 
present a ski slope shape (Supplementary Table 1). 
 
Figure 2. CT-scan images of patient III:7, from Family 1. CT-scan of the head, axial 
slides from superior to inferior positions. Right side is on the left. a. Normal 
appearance of superior semicircular canal (red arrow). b. Narrowed internal auditory 
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meatus (red arrow) and narrowed facial nerve canal (yellow arrow). c. Normal 
appearance of the cochlea (red arrow) and lateral semicircular canal (yellow arrow). d. 
Abnormal middle ear, with absence of ossicles and significant loss of aeration of the 
antrum (yellow arrow). Absence of aeration surrounding the oval window (red arrow). 
e. Increased thickness and density of the skull bones (red arrow) and mastoid bone, 
with significant loss of aeration (yellow arrow). f. Absence of aeration surrounding the 
round window (red arrow). 
 
DISCUSSION 
The present study identified three frameshift mutations in MEPE, the first one in a 
HCFP Turkish family, the second in one family with otosclerosis and the third one in an 
isolated patient with sensorineural hearing loss. MEPE plays an inhibitory role in bone 
mineralization, inhibits bone resorption, suppresses renal calcification and regulates 
serum phosphate13,14. Transgenic overexpression of Mepe (Mepe transgene under the 
control of the Col1a1 promoter) in mice gives rise to a mineralization defect and a 
lower bone remodeling level14. Both homozygous (Mepe-/-) and heterozygous (Mepe+/-) 
knockout mice exhibit an increased of bone mass production due to increased 
numbers of osteoblasts and their increased activity23. In mice the overproduction of 
bone mass affects mainly the craniofacial bones, whereas the gross body skeletal 
structure remains intact. In addition, they do not show hyperphosphatemia. Further 
studies have revealed that MEPE exerts its inhibitory effect on mineralization after the 
proteolytic release of a 2.2 kDa ASARM peptide by β-cathepsin12,14. The cleaved 
ASARM peptide inhibits mineralization by binding to hydroxyapatite12. The three 
frameshift mutations we have identified are located in front of the ASARM motif which 
is located at C-terminal end of the MEPE protein.  
 
Otosclerosis it is disease caused by an alteration of the bone remodelling of the otic 
region capsule that leads to fixation of the stapes and results in conductive hearing 
loss24. The age of onset is usually in the third decade and despite of intensive research 
the etiology of otosclerosis remains elusive. Some theories suggest that it is a complex 
disease caused by a combination of several elements as environmental and endocrine 
factors, immune and connective tissue disorders, viral infections and genetic factors25. 
A genetic defect as the underlying cause is supported by the presence of large families 
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with autosomal dominant inheritance with reduced penetrance (40%)24. Linkage 
analysis studies have identified eight loci associated with otosclerosis (Table 2)26-34. 
Furthermore, several genetics association studies in otosclerosis cohorts have found 
statistical significant associations between some polymorphisms at the COL1A1, ACE, 
AGT, OTSC2, RELN, TGFB1 gene loci and at 11q13.1ref35-40. However, the lack of 
replication of these association studies, do not allow the identification of causative 
genes. 
 
Importantly, the trajectory of the facial nerve to its final destinations (i.e striated 
musculature of face, neck and stapedius muscle of the middle ear, parasympathetic 
fibres to the lacrimal, submandibular and sublingual glands, seromucinous glands of 
the nasal cavity and taste receptors from the anterior two-thirds of the tongue, the 
palate and the tonsilar fossae) runs inside the tympanic and mastoid bones41. 
Therefore, congenital defects of the facial canal may result in abnormalities of the 
facial nerve course with clinical significance such as facial palsy42. In fact, narrowed 
internal auditory canal can produce atresia of the nerves that run through it, the facial 
(VIIth) and the vestibulochoclear nerve (VIIIth)43. In this study we observed that the 
facial canals of three of the HCFP patients from Family 1 (III-7, III-15 and IV-2) were 
bilaterally narrowed. Moreover, the development of the facial nerve is linked to the 
development of the inner and middle ear43.  
 
One of the most common affected areas in otosclerosis is the region anterior to the 
oval window. There is a fixation of the stapedial footplate that leads to reduced 
mobility of the ossicular chain, and as a consequence conductive hearing loss. On the 
other hand, it has been estimated that 76% of the patients with congenital absence of 
the oval window have a malformation of the facial nerve44. Finally, 10% of the patients 
with otosclerosis have both sensorineural and conductive hearing loss and even a few 
cases of pure sensorineural hearing loss have been reported46. In this case 
sensorineural hearing loss is attributed to otosclerosis of the cochlear bones45. 
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Origin Locus (OMIM number) Position 
Candidate 
Gene Reference 
India OTOSC1 (166800) 
15q26.1-
qter CSPCP 31 
Belgium OTSC2 (605727) 7q34-q36 
TIF1A, 
PLOD3, 
TRB 
32 
Cyprus OTSC3 (608244) 
6p22.3-
p21.3 
HLA, 
COL1A1, 
COL11A2, 
CDKN1A 
33 
Israel OTSC4 (611571) 
16q22.1-
q23.1 
CDH1, 
CDH3, 
COG4 
34 
The Netherlands OTSC5 (608787) 3q22-q24  
PCOLCE2, 
CHST2, 
ATP1B3 
35 
Greece, The 
Netherlands 
OTSC7 
(611572) 
6q13-
q16.1 
COL12A1, 
COL9A1, 
TGFB 
36,37 
Tunisia 
OTSC8 
(612096) 
 
9p13.1-
q21.11 
TJP2, 
TRMP3, 
KLF9 
38 
The Netherlands  1q41-q44 TGFB2, AGT 39 
Table 2. Loci associated with otosclerosis.  
 
Sclerosing bone disorders are caused by an increased bone formation or an imbalance 
between bone formation and bone resorption. In some of these disorders the co-
occurence of facial palsy has been reported. Sclerostosis type 1 (MIM269500), 
sclerostosis type 2 (MIM 614305) van Buchem disease type 2 (MIM607636), autosomal 
dominant endosteal hyperostosis (MIM144750), autosomal dominant craniodiaphyseal 
dysplasia (MIM122860), hyperostosis cranialis interna (MIM144755) and Charge 
syndrome (MIM214800), are some examples of diseases with bone and facial palsy 
phenotypes. Sclerostosis type 1 is caused by loss of functions mutations in SOST47-50, in 
van Buchem type 1 a 52-kb deletion 35 kb downstream of the SOST51,52 was identified. 
Sclerostosis type 2 is caused by mutations in LRP4ref53 and heterozygous mutations in 
LRP5 have been associated with van Buchem type 2ref54, and endosteal hyperostosis54. 
In view of the increased cranial bone density observed in individuals from family 1 it 
seems that MEPE can be added to this group of sclerosing bone disorders. 
Interestingly, previous genome-wide association studies identified associations 
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between several WNT-pathway genes and SIBLING family genes, including LRP5, LRP4, 
SOST and MEPE, with bone mineral density (BMD)55-57. Thus it seems that common 
variants involved affecting these genes are associated with BMD58-60, whereas 
mutations give rise to rare cranial bone disorders. The Wnt/β-catenin pathway is 
necessary for the correct function of osteocytes, wich are located at bone matrix. 
Osteocytes are differentiated from osteoblasts and they control and regulate 
mineralization processes61. Previous studies suggest that there is a functional 
relationship between Wnt signalling and MEPE in osteocyte-mediated bone 
homeostasis. Similar to LRP5, SOST and LRP4, MEPE is expressed in osteocytes. 
Mutations in SOST cause high bone mass in humans46 and in mice64 as a result of 
activation of Wnt signaling. Conversely, in vitro administration of sclerostin (SOST) to 
pre-osteocytes inhibits matrix mineralization by increasing the level of MEPE-ASARM 
deposited into the matrix62,63.  
 
In our study we have identified three frameshift mutations in patients with three 
different phenotypes. However, they all share an alteration of the temporal bones 
morphology that could be cause by an increased of bone mass production, as occurs 
with other bones remodeling disorders. We hypothesize that the increased of bone 
mass could be restricted to the middle ear bones. In addition, the diverse severity 
levels of bone alteration would results in different phenotypes. Otosclerosis can be 
present in the population without clinical symptoms, also called histological 
otosclerosis, and the prevalence in the Caucasian population is 3,4%ref64 whereas the 
clinical otosclerosis prevalence varies between ethnicities, being 0,3-0,4% in 
Caucasians65. Therefore the presence of two of the mutations in EVS and in our in 
house database and in some healthy members of the second family could be explained 
by the subclinical presentation of otosclerosis. Furthermore, the influence of 
environmental factors could also play a role in the clinical presentation of the disease. 
 
In conclusion, frameshift mutations in MEPE cause the alteration of temporal bone 
structure leading to different clinical phenotypes. In this particular HCFP family the 
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facial paralysis would be secondary to a disruption of the facial nerve course and not to 
an alteration of the facial nerve nucleus as it has been reported in other families3. 
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SUPPLEMENTARY INFORMATION 
 
Supplementary tables 
Supplementary Table 1. Clinical data of patients 
 
Family Patient Facial palsy 
Type of 
hearing loss Severity 
Carhart 
notch 
frequency 
(Hz) 
Audiometric 
configuration 
Symetry of 
hearing 
impairment 
Age 
of 
onset 
Thickenin 
calvarial 
bones 
Ossicular 
deformation 
Reduced 
pneumatization 
Acustic 
reflexes 
Internal 
acoustic 
canal 
narrowed 
Slerosis 
Facial 
canal 
narrowed 
Additional 
features 
1 III:7 +/+ Mixed Moderate 2000 R-B, L-As Bilateral 45 + + + - +x + +  
1 III:15 +/+ Mixed Mild  As Bilateral 35 + + + + + + +  
1 IV:1 +/+ Mixed 
R-
severe,L-
moderate 
2000 R-B, L-As Asymetrical 21 + + + -  +  
Timpanic 
cavity 
reduced 
1 IV:2 +/+ Mixed 
R-normal , 
L-
moderateL 
2000 R-As, L-B Asymetrical 19 + + + R+, L- + + + Air bone gap 
2 II:10 -/- Mixed Mild 2000 x Asymetrical x x x x R+, L- x x X x 
2 III:13 -/- Mixed Moderate,  - x Asymetrical x x x x - x + X x 
2 III:14 -/- Conductive Mild - x Bilateral x x x x on-off effect x x X x 
2 III:15 -/- Conductive Mild - x Bilateral x x x x + x x X Vertigo 
3 II:1 -/- Sensorineural   Skilope  22 x x x x x x X Tinitus 
R: right; L: left; As: A-shallow; +/+: complete bilateral facial palsy; x: unknown; -: absent. 
 
144 
 
Supplementary Table 2. Sequencing statistics of exome sequencing analysis 
 
 Family 1 
Patient II:3 
Family 1 
Patient IV:2 
Family3 
Patient II:3 
Total reads 97,175,871 94,002000 97,175,871 
Total mapped reads  64,154,672 61,851,652 88,941,864 
Total mapped reads near  targeted regions: 17,2% 17.4% 17.23% 
Total mapped reads in regions 72% 71.6% 72.0% 
Total mapped reads outside regions: 10,8% 10.9% 10.78% 
% targets with at least 10x coverage  85.51 85.98x 
Mean target coverage (fold)  61,851,652 88,941,864 
Total mapped reads near  targeted regions:  17.4% 17.23% 
Mean target coverage (fold) 66.93x 69.80x 
 
Supplementary Table 3. Filtering steps of exome sequencing data analysis 
 
QC  Quality Control cut-off are ≥5 unique variant reads >5 and ≥15% variation reads. 
 
 
  
 Patient 1 II:3 
Patient 2 
IV:2 
Shared 
variants 
Patient 3 
Total of variants QC* 37,625 38,663 140 122,527 
Exonic and canonical sílice site variants 17,033 20,537 75 21,605 
After exclusion of synonymous, known variants 
(SNPvs135) and variants present in in-house database 346 349 53 189 
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Supplementary Table 5. Primers sequences for MEPE Sanger sequencing validation 
 
 Sequence 
Exon Foward Primer Reverse primer 
2 gtccacactcgggtataagc gctgatttgaaatgctgcgg 
3 ttctgtagtggagacggcac agccaccttcccctttactc 
4a CTCCATGAAACCTGATTTGACC AGAGCTGCGCCATATTCTTC 
4b CACAATGGCCTGAGGATGTC ACCGCTGCCTTCAAAATCAC 
4c CAAAGAGATTCCCAAGCCCAG GCTGCATCACTACTGCCTTC 
4d GGCAGCAACGATATCATGGG TTCACCTGGTCAGCTGTCAG 
Primers used for polymorphic markers 
D3S158
9 
tgtaaaacgacggccagtAACTTGAAATGCTGGC
TACG 
caggaaacagctatgaccGCTGCTGTTTAATGGGC
ATA 
RHO tgtaaaacgacggccagtGAGAGGGAGGAAGGACTGC 
caggaaacagctatgaccTTATTTGCTTAGCGCTCT
GG 
D3S158
7 
tgtaaaacgacggccagtTACAGTTCTATAAGGG
CAGCC 
caggaaacagctatgaccAGGGAGACAGAGTGAT
GGATT 
D3S129
0 
tgtaaaacgacggccagtGATGATTCTTTGCAGT
AATGACC 
caggaaacagctatgaccCGTCAATAAGGCCAAAT
AGG 
D10S19
6 
tgtaaaacgacggccagtAAGGTGGAGACCCTTC
AAGA 
caggaaacagctatgaccCCTCCTCTCCATTGCTGT
T 
D10S53
9 
tgtaaaacgacggccagtTCCCTATCAAAGTTCCA
ATGTC 
caggaaacagctatgaccCAGGTGATCCTCCCACC
T 
D10S17
67 
tgtaaaacgacggccagtCCTTAAGCTCATTCTAT
TGATGG 
caggaaacagctatgaccGAAATGTTGGCAGAAG
ATGC 
D10S58
9 
tgtaaaacgacggccagtTAGCTGCACTTCCATG
TTCC 
caggaaacagctatgaccGGCTGGTCTCGAACTTC
TG 
D10S58
1 
tgtaaaacgacggccagtCAGGGCTCAGCTGTCA
AA 
caggaaacagctatgaccCTTCTCCACTCAACCCTC
AG 
D10S16
70 
tgtaaaacgacggccagtATCCTCTCCAGGACAC
CTTC 
caggaaacagctatgaccACATAACTACCAGCACA
CACCTAA 
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ABSTRACT 
Möbius syndrome (MBS) is a neurological disorder that is characterized by paralysis of 
the facial nerves and variable other congenital anomalies. The aetiology of this 
syndrome has been enigmatic since the initial descriptions by von Graefe in 1880 and 
by Mo¨bius in 1888, and it has been debated for decades whether MBS has a genetic 
or a non-genetic aetiology. Here, we report de novo mutations affecting two genes, 
PLXND1 and REV3L in MBS patients. PLXND1 and REV3L represent totally unrelated 
pathways involved in hindbrain development: neural migration and DNA translesion 
synthesis, essential for the replication of endogenously damaged DNA, respectively. 
Interestingly, analysis of Plxnd1 and Rev3l mutant mice shows that disruption of these 
separate pathways converge at the facial branchiomotor nucleus, affecting either 
motoneuron migration or proliferation. The finding that PLXND1 and REV3L mutations 
are responsible for a proportion of MBS patients suggests that de novo mutations in 
other genes might account for other MBS patients.  
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INTRODUCTION 
Möbius syndrome (MBS) (MIM 157900) is a rare congenital cranial dysinnervation 
disorder characterized by non-progressive facial palsy and impairment of ocular 
abduction, due to paralysis or weakness of the facial (n7) and abducens (n6) nerves, 
and frequently other cranial nerves1–6. Both intrauterine environmental factors and 
genetic causes have been proposed for the aetiology and pathogenesis of MBS. A 
disruption of blood vessel migration during development, which can be secondary to 
misoprostol7 or cocaine8 exposure during pregnancy, has been hypothesized to lead to 
hindbrain hypoxia, resulting in cranial nerve dysfunction9. A limited number of familial 
cases with an atypical manifestation of MBS have been reported10–13. In addition, a 
founder mutation in HOXB1 has been associated with an autosomal recessive form of 
an MBS-like syndrome, with limited phenotypic overlap with typical MBS14. However, 
the vast majority of patients has a sporadic occurrence with a very low recurrence risk 
for siblings. This is consistent with either the involvement of environmental factors or 
with dominant de novo mutations as the underlying mechanism15. The broad spectrum 
of neuropathological and neuroradiological findings suggests that MBS is due to a 
developmental defect of the entire rhombencephalon16,17, rather than an isolated 
cranial nerve disruption. This is in contrast to hereditary congenital facial palsy (HCFP), 
which is characterized by the isolated dysfunction of the facial nerve. Two HCFP loci 
have been identified: HCFP1 (MIM 601471) at chromosome 3q21-q22(ref. 18) and HCFP2 
(MIM 604185) at chromosome 10q21.3- q22.1(ref. 19) . Extensive studies have been 
conducted to explain the HCFP phenotype and to pave the way for genetic studies in 
MBS, but analysis of genes in the HCFP1 and HCFP2 loci, including the prime candidate 
gene PLXND1 at chromosome 3q21-q22(ref. 20), has so far not identified any causative 
mutations in HCFP and in MBS patients21. 
 
In this study we undertake exome sequencing of two case–parent trios and six isolated 
patients with classical MBS to investigate the possibility of an underlying genetic cause. 
We identify de novo mutations in five different genes. For two of these genes, PLXND1 
and REV3L, additional de novo mutations in other MBS patients are identified. The 
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causality of de novo PLXND1 and REV3L mutations for the neuropathological features 
of MBS is further supported by analysis of the respective knockout mice. Strikingly, for 
both heterozygous mutants we observe hypoplasia of the facial branchiomotor 
nucleus, which is consistent with the facial nerve weakness in MBS patients. Taken 
together, the present data establish de novo mutations as a cause for MBS, providing a 
rationale for exome sequencing in patient–parent trios to identify de novo mutations 
in other genes underlying MBS. 
 
 
Figure 1. Clinical features of Möbius syndrome patients and de novo mutations in 
PLXND1 and REV3L. a. Clinical features of the patients carrying the mutations in 
PLXND1 (P1, P9, P10). Patient P1 shows an impairment of ocular abduction in a relaxed 
facial position and she is not able to smile and she cannot close her eyes completely. 
Patient P10 in a relaxed facial position presents left upper facial paralysis. Patient P11 
showing bilateral facial paralysis, inability to close his mouth, and lagophthalmos. b. 
Genomic structure of the PLXND1 gene and the PLXND1 protein structure and the 
position of de novo mutations. The different protein domains are depicted. GAP, 
GTPase activating protein; IPT/TIG, Immunoglobulin-like fold, Plexins, Transcription 
factors/Transcription factor ImmunoGlobin; D1-PBM, PDZ-binding motif; MET, 
Mesenchymal–Epithelial Transition. c. Clinical features of the patients carrying the 
mutations in REV3L (P5, P11, P12). Patient P5 in a relaxed position, showing the 
characteristic inability of MBS patients to smile in the second photograph. Both eyes 
show incomplete closure. There is agenesis of left pectoralis muscle (Poland variant) 
and absence of digits from the left hand. Patient P11 has both eyes fixed in straight 
position and a complete deficiency of both abduction and adduction. There is a 
complete inability to follow objects laterally. Furthermore, a bilateral facial nerve palsy 
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is present producing a lagophthalmos on eye closure in both eyes, and oral rim 
asymmetry with an inability to smile. Patient P12 in a relaxed facial position. The ability 
to smile of P12 has been improved following plastic surgery at age of 13. Inappropriate 
closure of both eyes is still present. d. Schematic structure of human REV3L gene (left) 
and REV3L protein (right). MBS-associated mutations detected in three patients (P5, 
P11, P12) are indicated. The colored bands represent the known domains of the 
protein. Rev7 binding domain: site of binding of the heterodimeric Rev3l partner Rev7. 
ZF: zinc finger.  
 
MATERIAL AND METHODS 
Patients: 
We identified eight isolated Möbius patients in this study. They were the only affected 
individuals in their families. These patients (Patient 1-8) were selected from a cohort of 
patients with the pathognomonic signs of MBS6,22: facial and abducens palsy17 Clinical 
details of these patients and other patients carrying de novo mutations (P9, P10, P11, 
P12) are given in the Supplementary Table 5 and in Figure 1a. Informed consent was 
obtained from all the subjects involved in this study, and all procedures were in 
accordance with the ethics of the World Medical Association Declaration of Helsinki. 
Ethical approval for the reported studies was obtained from the Medical Ethical 
Committee Arnhem-Nijmegen, from the University of Parma, the University of 
Istanbul, and University Hospital LA FE, Valencia. 
  
Whole-Exome Sequencing 
Exome sequencing was performed on DNA from peripheral blood, using the SureSelect 
Human All Exon v2 50 Mb Kit (Agilent, Santa Clara, CA) followed by multiplexed 
analysis on a SOLiD 4 System sequencing slide (Life Technologies, Carlsbad, CA) as 
described previously23. Color space reads were mapped to the hg19 reference genome 
with the SOLiD BioScope version 1.3 software, which utilizes an iterative mapping 
approach. Sequence analyses from all the patients are summarized in Supplementary 
Table 4. Statistical Single-nucleotide variants were subsequently called by the Di-Bayes 
algorithm with high call stringency. Called variants were combined and annotated with 
a custom analysis pipeline. The total number of variants identified in each patient, are 
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summarized in Supplementary Table 1. Of these variants, some were located in the 
exonic sequences or located in canonical splice sites, defined as the dinucleotides up 
and downstream of exonic sequence (Supplementary Table 1).  
 
Under the hypothesis of de novo mutations as the underlying cause of MBS syndrome, 
we excluded all variants inherited from either parent in the two trios (Supplementary 
Table 1). From the remaining variants in these two patients, we excluded all 
synonymous variants, as well as variants present in (single-nucleotide polymorphism 
database) dbSNP (v138) or in our in-house-sequenced exome database (5,031 
exomes), and variants in noncoding regions with the exception of canonical splice-site 
sequences. Manual inspection of mapped reads excluded additional, likely false 
positive, variants. After Sanger sequencing, only two variants were validated de novo 
mutations in one of the trios. 
 
The approach for the six isolated cases was slightly different. For these, we applied a 
filtering scheme excluding variants observed in dbSNP (v138) and in our in-house 
database (5031 exomes (Supplementary Table 1). We further analyzed all truncating 
variants, missense variants with a PhyloP score >3 or those affecting genes with a 
possible involvement in MBS as suggested by the GO term or mouse mutant 
phenotype. Candidate variants were validated by Sanger sequencing, and parental 
DNAs were tested for de novo occurrence of the respective variant (Supplementary 
Tables 2, 3). 
 
Mutation analysis 
Primer sequences were designed by using Primer3 software (http://frodo.wi.mit.edu/) 
encompassing the candidate variants. To exclude additional changes in either REV3L, 
PLXND1 or CCDC160 we designed primers for the amplification of all exons and intron-
exon boundaries of REV3L (Genbank ID NM_002912), PLXND1 (Genbank ID 
NM_015103), SPO11 (Genebank ID NM_012444) and CCDC160 (Genbank ID 
NM_001101357). Sequences of primers are shown in Supplementary Table 6. PCR was 
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performed on 50 ng of genomic DNA with Taq DNA polymerase (Invitrogen, Carlsbad, 
CA). A nucleofast 96 PCR plate (Clontech Lab, Mountain View, CA) was used to purify 
the PCR amplicons, according to the manufacturer’s protocol. Sequence analysis was 
performed with the ABI PRISM Big Dye Terminator Cycle Sequencing V3.1 ready 
Reaction Kit and the ABI PRISM 3730 DNA Analyzer (Applera Corp, Foster City, CA). PCR 
products were sequenced by Sanger sequencing and analysed by using Vector NTI® 
software (Life Technologies). 
 
Cell culture 
EBV-LCL from Patient P5 and five controls were cultured to a density of 0.5x106 
cells/ml. After incubation for 4 hrs at 37°C, cells were harvested by centrifugation at 
200xg for 5 min at room temperature, washed once with phosphate-buffered saline 
(PBS), pelleted by centrifugation at 200xg for 5 min at room temperature, and snap 
frozen in liquid nitrogen. Mouse embryonic fibroblasts (MEFs) were obtained from 
E13.5-days old embryos of intercrossed Rev3+/-, p53+/- mice. The embryos were finely 
minced, trypsinized and the resulting MEFs were cultured in D-MEM supplemented 
with 10% fetal calf serum and antibiotics until spontaneous immortalization24. 
 
First strand synthesis 
EBV-LCL cells were harvested by centrifugation at 6000g at room temperature. RNA 
isolation was performed using the NucleoSpin RNA kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s protocols. RNA was reverse transcribed using the 
iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA, USA) according to the 
manufacturer’s protocol. cDNA was purified with NucleoSpin extract II (Qiagen, Hilden, 
Germany) according to the manufacturer’s protocol. 
 
Quantitative PCR (QPCR) analysis 
SYBR Green-based real-time quantitative PCR (QPCR) expression analysis was 
performed on an Applied Biosystem Fast 7500 System machine. Primer sequences 
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around exon 10 were designed by using Primer3 software (http://frodo.wi.mit.edu/) 
(Supplementary Table 6). Primers encompassed at least one boundary between two 
exons. GUSB was used as reference gene25. QPCR quantifications were performed in 
duplicate on the equivalent of 5µg of total RNA from the first strand synthesis and 
included a water control. Experimental threshold cycles (Ct) values were within the 
range of cDNA dilutions used to validate the primers. The melt curves of all PCR 
products showed a single PCR product. All water controls were negative. Differences in 
expression of the REV3L alleles were calculated by the comparative Ct or 2ΔΔCt 
method26. The p-value was derived from the standard score (Z-value) as compared to 
the normal distribution of the five controls. We used an α level of 0.05, because only 
one gene was assessed.  
 
Reverse Transcriptase PCR (RT-PCR) 
cDNA from Patient 1 EBV-LCLs cells and one control were used to amplify REV3L. The 
first pair of primers was designed surrounding the canonical splice site mutation 
(c.1096+1G>A) in exon 10, and a control pair of primers was designed within exon 14 
(see Supplementary Table 6).  
 
Mouse breeding 
Plxnd1- mutant mice 
Plxnd1 heterozygous mice were maintained on a C57BL/6 background and mated to 
generate Plxnd1 knockout and heterozygous embryos (male and female) for analysis. 
Plxnd1 null and wild type (wt) mouse embryos (E16.5) were harvested from timed 
matings. Noon was designated E0.5. Embryos were genotyped as described27. All 
Plxnd1 mouse work was performed according to the University of Pennsylvania animal 
care guidelines. 
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Rev3l- mutant mice 
C57BL/6 wt, Rev3l-heterozygous and Rev3l-deficient mice and embryos were described 
before28. C57Bl/6 Rev3l-heterozygous mice were mated to generate male and female 
embryos for analysis. Rev3l-heterozygous and wt mouse embryos (E16.5) were 
harvested from timed matings. Noon was designated E0.5. Embryos were genotyped 
as described28. Mice were treated using FELASA (Federation of Laboratory Animal 
Science Associations) standards and mouse experiments were performed under permit 
DEC 11108 from the animal experiment committee of the Leiden University Medical 
Center. 
 
Mouse tissue preparation 
Plxnd1-mutant mice 
Seven Plxnd1-wt, seven Plxnd1-heterozygous and seven Plxnd1-homozygous embryos 
at E16.5 (stage corroborated according to Theiler29) were sacrificed and brains were 
dissected in PBS at room temperature and fixed in 4% paraformaldehyde at 4°C 
overnight. The next day, brains were washed in PBS, dehydrated in ethanol and stored 
at -20oC. Brains were processed for paraffin and agarose embedding and sectioning 
into 16 µm and 90 µm slices with a microtome and vibratome, respectively.  
 
Rev3l-mutant mice 
We analyzed two different stages in order to compare phenotypic aberrations. Five wt 
and five Rev3l-heterozygous embryos at E16.5 (stage corroborated according to 
Theiler29), five wt and five Rev3l-heterozygous P0 newborn pups were sacrificed and 
fixed by immersion in phosphate-buffered 4 % paraformaldehyde (0.1 M PB; pH7.4) at 
4°C for 24 h. Fixed brains and heads were embedded in paraffin and they were 
sectioned into 16 µm slices with a microtome.  
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Tissue staining 
Seven Plxnd1-wt, seven Plxnd1-heterozygous and Plxnd1-homozygous embryos at 
E16.5 and five Rev3l-wt and five Rev3l-heterozygous embryos at E16.5 (stage 
corroborated according to Theiler29), five Rev3l-wt and five Rev3l-heterozygous P0 
newborn were embedded in paraffin sectioned and were stained with Nissl stain 
according to routine protocols30.  
 
Immunohistochemistry 
Two Plxnd1-wt, two Plxnd1-heterozygous and two Plxnd1-homozygous embryos were 
embedded in agarose and processed for immune histochemistry with the Islet1 
antibody (clone 39.4D5) obtained from the Developmental Studies Hybridoma Bank 
(University of Iowa, Iowa City). Sections were washed in PBS and then treated with 
0.1% hydrogen peroxide in PBS for 1 h in the dark to inactivate endogenous peroxidase 
activity. After several rinses in PBT (PBS with 0.2% Triton X-100), sections were blocked 
with 0.5% goat serum, 0.2% bovine serum albumin (BSA) and 0.2% Triton X-100 
(Sigma, St. Louis, MO, USA) in PBS for 4 h, and then, incubated overnight at 4 ºC with 
monoclonal antibody anti Islet-1 (1:50 in blocking solution. Subsequently, sections 
were incubated with biotinylated goat anti-mouse secondary antibody (1:300, BA-
9200, 2 h incubation; Vector Laboratories, Burlingame, CA, USA), and then with 
streptavidin/horseradish peroxidase (HRP) complex (1:200, PK-4000, 2 h incubation; 
Vectastain-ABC kit; Vector Laboratories, Burlingame, CA, USA). All antibodies were 
diluted in the same blocking solution as the primary antibody. The histochemical 
detection of the peroxidase activity was carried out using 0.03% diaminobenzidine 
(DAB) and 0.005% H2O2. After immunoreaction, the sections were mounted, 
dehydrated and then coverslipped with Eukitt (Fluka, Buchs, Switzerland). 
 
Quantification of motoneurons 
We counted the total number of motoneurons presents in the facial motor nucleus in 
paraffin sagittal sections processed with Nissl staining. We used five Plxnd1-wt, five 
Plxnd1-heterozygous and five Plxnd1-homozygous mice at E16.5 and five Rev3l-wt and 
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five Rev3l- heterozygous P0 newborns and we counted separately the number of 
motoneurons from the right and left hindbrain sides (around 12 sections each side) 
(20-25 slices total per animal). For the counting we used the open source ImageJ Cell 
Counter software31. Differences in the number of motoneurons between the 
heterozygous, homozygous and the wt mice were calculated by a comparative t-test, 
using Graphpad Software (http://graphpad.com/quickcalcs/ttest1.cfm). 
 
Brain structures volume rendering 
We performed volume rendering of image stacks on serial light microscopic sections of 
16 µm by using the open source ImageJ TrakEM2ref32. For the volume rendering of the 
subarachnoid space around 100 sagittal slices of each of the five Rev3l-wt and five 
Rev3l-heterozygous mice at E16.5 were used. This embryonic stage was selected 
because the calcification of the cranial bones is not completed yet allowing the 
sectioning. For hindbrain volumes comparison, around 80 slices of each of the five 
Rev3l wt and five Rev3l heterozygous brains at P0 were employed. After alignment of 
all images from each brain respectively, we highlighted the areas of interest in each 
section to measure their volumes. The boundaries of the hindbrain were delineated 
according to the Allen Developing Mouse Brain Atlas from rhombomere r1 until r11, 
including the cerebellum.  
 
Survival assay 
Rev3l survival assays were conducted with Rev3l+/+, Rev3l+/- and Rev3l-/- mouse 
embryonic fibroblasts (MEFs). In each well of a 6-well plate, 0.5 x 106 exponentially 
growing cells were seeded in MEF medium (DMEM supplemented with 10% fetal calf 
serum, glutamax and antibiotics) and cultured overnight. Then, the cells were exposed 
to 0–300 nM Benzo[a]pyrene diolexpoxide (BPDE; Biochemical Institute for 
Environmental Carcinogens, Grosshansdorf, Germany) that was dissolved in anhydrous 
tetrahydrofuran (THF, Sigma Aldrich) for 60 min in serum-free medium at 370C. The 
cells were trypsinized and seeded in MEF medium at clonal densities in 9 cm dishes. 
After culturing for 12-14 days at 370C, cell clones were fixed, stained with methylene 
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blue and the number of cell clones was counted (n=3). The number of clones after 
mock treatment was set at 100%. The data were obtained with two and three 
independent Rev3+/+ and Rev3+/- MEF lines, respectively, and one Rev3-/- MEF line.  
 
Replication progression assay 
Progression of replicons using the Alkaline DNA Unwinding assay was determined with 
minor modifications as described previously24. Thus, 5 x 104 exponentially growing cells 
were seeded per well in a 24-well plate and cultured overnight in MEF medium at 
370C. The cells were mock treated with the solvent THF or exposed to 500 nM BPDE in 
serum-free medium for 15 min at 370C. The medium was removed, cells were washed 
once with 150 mM NaCl and pulse labeled with [3H]thymidine (2 μCi/ml; 76 Ci/mmol) 
in MEF medium for 15 min at 370C. MEF medium with radioactive thymidine was 
removed and the cells were cultured in MEF medium supplemented with 10 μM cold 
thymidine. At different times after pulse labeling, the local unwinding of DNA ends of 
elongating replication forks, the separation of single stranded DNA (ssDNA) and double 
stranded DNA (dsDNA) using hydroxylapatite columns and the determination of 
radioactivity in the fractions containing ssDNA and dsDNA was performed as 
described55 (n=3). The percent of maturation of replicons was calculated by the 
following equation: (radioactivity in dsDNA/total radioactivity) x 100%. The data were 
obtained with single Rev3+/+ and Rev3-/- MEF lines and two Rev3+/- MEF lines.  
 
Western blotting 
In each well of a 6-well plate, 2.5 x 105 exponentially growing cells were seeded in MEF 
medium and cultured overnight. Then, the cells were mock treated with the solvent 
THF or exposed to 500 nmol BPDE for 15 min in serum-free medium at 370C. After 
rinsing the cells with PBS, cells were cultured in MEF medium. At different times after 
treatment, up to 12 hrs, cells were lysed using Laemmli buffer. The proteins were 
separated by SDS polyacrylamide gel electrophoresis and blotted onto nitrocellulose 
membranes (Hybond-C extra; Amersham Biosciences). The membranes were 
incubated overnight at 40C with antibodies specific for γH2AX (S129) (mouse 
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monoclonal; Millipore; cat. no. 05-0636; dilution 1:1000), phosphorylated Chk1 (at 
serine 345; rabbit polyclonal; Cell Signaling; cat. no. 2348; dilution 1:1000), 
phosphorylated Rpa32 (at serines 4/8; rabbit polyclonal; Bethyl; cat. no. A300-245A; 
dilution 1:1000), total Rpa (rat polyclonal; Cell Signaling; cat. no. 2208; dilution 1:1000) 
and β-actin (mouse monoclonal; Oncogene; cat. no. CP01; dilution 1:20000). After 
incubation with appropriate secondary antibodies conjugated to peroxidase (Bio-Rad), 
proteins were visualized using enhanced chemoluminescence detection. Uncropped 
scans with indicated size markers are shown in supplementary Figure 5. 
 
Statistical analysis 
The probability of finding two mutations in a cohort of 103 in each gene was calculated 
by Poisson test. We took into account the presence of two alleles and estimated gene 
mutation rates based on recent exome sequencing data33. Moreover, a conservative 
Bonferroni correction was done for multiple testing. Statistical significance of 
differences in motoneuron counts between the wt mice and the mutant mice were 
determined by the unpaired t-test. The significance of differences of the hindbrain 
volume and subarachnoid space between the Rev3l-heterozygous and the wt mice was 
calculated by the comparative t-test. Significance in sensitivities of MEF lines to BPDE 
and in replication fork progression after exposure to BPDE was determined using the 
unpaired t-test, σ=0.90. A P-value smaller than 0.05 was considered to be statistically 
significant (*), and smaller than 0.01 highly significant (**). 
 
RESULTS 
Identification of de novo mutations by exome sequencing. We excluded all variants 
inherited from either parent in the two trios under the hypothesis of de novo 
mutations as the underlying cause of MBS (Supplementary Table 1). Two de novo 
variants were detected in patient 1 (P1) (Fig. 1a; reported previously17), one in the 
SPO11 (NM_012444) gene (c.712T>C; p.Cys238Arg) and the other in the PLXND1 gene 
(c.5685C>A; p.Asn1895Lys) (Fig. 1a,b; Supplementary Fig. 1; Supplementary Tables 2 and 
3). SPO11 is involved in meiotic recombination, and targeted disruption of this gene in 
 165 
 
mice results in fertility problems34, but no features related to MBS. The occurrence of a 
de novo mutation in PLXND1 was more consistent with a role for this gene in MBS, 
given that PLXND1 was previously considered a strong candidate for HCFP1 and 
MBS20,21. Trio-exome sequencing in patient 2 did not reveal any de novo variant. A 
different analytical approach was taken for the six patients with isolated MBS and this 
was to Sanger sequence all candidate variants identified in the exome studies 
(Supplementary Tables 1 and 4). Sanger sequencing confirmed de novo variants, 
identified by exome sequencing, in IFT172, CCDC160 and REV3L, in three unrelated 
patients. The de novo missense mutation in the IFT172 gene (NM_015662) identified 
in patient 3 (Fig. 1; Supplementary Tables 2 and 3) is unlikely to be causative for the 
MBS phenotype, because biallelic mutations are associated with the unrelated Jeune 
and Mainzer- Saldino Syndromes in humans35. The de novo variant in the X-
chromosomal CCDC160 gene of patient 4 (P4) (a male) is a c.501delA frameshift 
mutation in exon 2 (NM_001101357) (Supplementary Fig. 1; Supplementary Tables 2 
and 3). Patient 5 (P5; Fig. 1c) carries a de novo variant in REV3L, c.1096+1G>A, 
affecting the canonical donor splice site in exon 10 (NM_002912) (Fig. 1d; 
Supplementary Fig. 1, Supplementary Tables 2 and 3). Aberrant splicing products were 
identified by quantitative reverse transcriptase–PCR analysis of REV3L messenger RNA 
obtained from EBV-LCLs of patient P5. Sequencing of these products revealed aberrant 
REV3L transcripts lacking either exon 9 or exons 9 and 10, in addition to decreased 
levels of normal REV3L transcript (Supplementary Fig. 2). 
 
Additional de novo mutations in the PLXND1 and REV3L genes in MBS patients 
Next, we screened CCDC160, PLXND1 and REV3L by Sanger sequencing in a cohort of 
103 MBS patients, including some HCFP patients who were not previously tested for 
PLXND1 (ref. 21). The screening identified four additional de novo mutations in unrelated 
patients, two affecting PLXND1 and two affecting REV3L (Fig. 1; Supplementary Fig. 1; 
Supplementary Tables 2 and 3). The PLXND1 mutations were identified in patients P9 
(c.4454_4455GC>CA; p.Arg1485Pro) and P10 (c.3018C>T; p.Leu1006Leu). The mutation 
in P9 affects a conserved arginine residue in the GTPase-activating protein domain of 
the protein. The missense mutation in P9 affects a histidine residue in the IPT/TIG 
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domain (immunoglobulin-like fold, plexins, transcription factors/transcription factor 
immunoglobin) that is characteristic for plexin proteins36. The two additional de novo 
mutations in REV3L were identified in patients P11 and P12. A de novo missense 
mutation c.1160A>G was identified in patient P11, predicting an amino-acid 
substitution p.Glu387Gly. In addition, patient P12 carried a nonsense mutation 
(c.2662A>T; p.Lys888*), which is predicted to result in a loss-of-function allele. 
phenotype, because biallelic mutations are associated with the unrelated Jeune and 
Mainzer-Saldino Syndromes in humans35. The de novo variant in the X-chromosomal 
CCDC160 gene of Patient 4 (P4) (a male) is a c.501delA frameshift mutation in exon 2 
(NM_001101357) (Supplementary Fig. 1, Supplementary Table 2, 3). Patient 5 (P5; Fig. 
1c) carries a de novo variant in REV3L, c.1096+1G>A, affecting the canonical donor 
splice site in exon 10 (NM_002912) (Fig. 1d, Supplementary Fig. 1, Supplementary 
Table 2, 3). Aberrant splicing products were identified by quantitative RT-PCR analysis 
of REV3L mRNA obtained from EBV-LCLs of patient P5. Sequencing of these products 
revealed aberrant REV3L transcripts lacking either exon 9 or exons 9 and 10, in 
addition to decreased levels of normal REV3L transcript (Supplementary Fig. 2).  
 
The absence of PLXND1, REV3L and CCDC160 truncating variants in ESP and a low 
Residual Variant Intolerance Score (RVIS) for these genes of -1.30 (4.88th percentile), -
2.1 (1.55th percentile) and 0.014 (54.98th percentile) respectively, are consistent with 
PLXND1, REV3L and CCDC160 being intolerant to loss-of-function mutations37. The 
amino acids that are affected by the missense variants in REV3L and PLXND1 are highly 
conserved throughout evolution (p.Glu387Gly (P11), p.Asn1895Lys (P1), p.Arg1485Val 
(P9), and p.His1007Tyr (P10)) (Supplementary Fig. 3).The probability of identifying 
multiple de novo mutations in the same gene in a cohort of 103 individuals is 
0.0001217 for REV3L (P-value = 2.4 x 10-4) and 9.34e-05 for PLXND1 (P-value= 1.8 x 10-
4). The presence of a mutation in the other allele in these patients was excluded by 
sequencing the coding exons of PLXND1 and REV3L. Screening of CCDC160 gene in our 
cohort of male MBS patients did not reveal additional de novo mutations.  
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Figure 2. Plxnd1 mouse brain characterization. a. Paraffin sagittal sections of 
embryonic mouse brains processed with Nissl staining at E16.5. These two pictures are 
medial sections of a view of the corpus callosum (CC), the anterior commisure (ac) and 
the fasciculus retroflexus (rf). These three structures appear hypoplastic in Plxnd1-/- 
mice. Scale bars 500 µm. b. Graphic representation of the number of motoneurons in 
facial motor nucleus in wt, heterozygous and homozygous Plxnd1 knockout (mean ± 
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SD). Unpaired t-test was used to calculate the P-value= 0.0049 (N=5).  c. Schematic 
representation of the facial nerve migratory process along the hindbrain. The 
motoneuron migratory pathway is delimited with a red arrow. The rhombomeres (r3-
r11) boundaries are marked with a line. Spinal cord (SpC), Cb (Cerebellum). The upper 
part in panel d shows the immunohistochemical staining of facial FBM motoneurons 
with anti-Islet-1 antibody (dark brown). The rhombomere units (r3-7) are marked with 
a dashed line. Black arrows point the motoneurons migration across the rhombomeres 
in the heterozygous and the homozygous Plxnd1 knockout mouse. The area of the 
facial motor nucleus is marked by the square. Scale bar is 300 µm. A detailed view of 
the facial motor nucleus and motoneurons migration is shown in the lower part of d. 
Motoneurons appear outside the facial nucleus along the migratory path of the facial 
nerve in both the heterozygous and the homozygous genotypes. Scale bar 100 µm. All 
reported P values tested were calculated with the unpaired t test using Graphpad 
Software.  A P value smaller than 0.05 was considered to be statistically significant (*). 
P values smaller than 0.01 (**) or 0.001 (***) were considered highly significant. 
 
PLXND1 deficiency affects neural fibers structures 
PLXND1 encodes a protein of 521 amino acids and is a member of the plexin family of 
proteins. Plexins bind to semaphorins (Semas), a large family of extracellular, secreted 
and membrane proteins38,39. PLXND1 is expressed in the vascular system20 and in 
specific structures of the central nervous system, such as the cranial and spinal ganglia, 
the cortical plate, the external granular layer of the cerebellum, the striatum and in 
dendritic cells40–42. Sema3E/PlexinD1 signalling is involved in the development of two 
descending forebrain tracts, the corticofugal and the striatonigral tracts43. To 
determine the effect of deficiency of PLXND1 in central nervous system development, 
we compared morphologic structures of the embryonic brain of wild-type (wt), 
heterozygous and homozygous PlexinD1 knockout mice at E16.5(ref. 27). Histological 
comparison of the three genotypes revealed consistent hypoplasia of the corpus 
callosum, anterior commissure and fasciculus retroflexus in Plxnd1-/- mice (Fig. 2a). 
These three brain structures are bundles of neural fibres that connect brain areas. 
Both the corpus callosum and the anterior commissure allow interhemispheric 
communication, whereas the fasciculus retroflexus links the forebrain with the 
midbrain. 
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Plxnd1-mutant mice show a defect of neuronal migration 
The facial nerve phenotype in Plxnd1 heterozygous and homozygous mice was 
investigated. Analogous to observations in brain autopsies of an MBS patient3, we 
observed a significant decrease in the number of motoneurons in the facial 
branchiomotor nucleus in homozygous mice as compared with wt mice (Unpaired t-
test, P value 0.0049; Fig. 2b). The development of the cranial nerve undergoes a 
complex migration within the rodent hindbrain44 (Fig. 2c). Between E10.5 and E14.5, 
neurons in rhombomere 4 (r4) start migrating tangentially along the ventral midline, 
reaching r5 and r6. Then they migrate dorsally until the alar/basal plate boundary and 
begin to migrate radially to their final destination in the pial surface of r6(refs 44–46). To 
trace the nature of the decreased neuronal density of the FBM, we carried out an 
immunohistochemical analysis using the motoneuron-specific molecular marker Islet-1 
in brains from E16.5 embryos (Fig. 2d). In line with this migration pattern, all FBM 
motoneurons reached r6 at E16.5 in wt mice (Fig. 2d). In sharp contrast, in all of the 
Plxnd1+/- and Plxnd1-/- mutant mice, a subpopulation of a subpopulation of 
motoneurons was still located in r4 and r5 at E16.5. Collectively, these results support 
a causative role of a defect in motoneuron migration caused by a heterozygous Plxnd1 
mutation akin to the de novo PLXND1 mutations in MBS patients P1, P9 and P10. 
 
Rev3l heterozygous mice show hypoplasia of neural structures 
The human REV3L protein acts as the catalytic subunit of DNA polymerase ζ, a key 
protein in replication of endogenously or exogenously damaged DNA28,47. Consistent 
with the phenotypes of the Rev3l heterozygous mice, in situ hybridization data show 
that Rev3l is highly expressed in the developing embryonic brain around mid-gestation 
(Supplementary Fig. 4). Biallelic inactivation of Rev3l in mice leads to mid-term 
embryonic lethality. Rev3l-deficient mouse embryos display pleiotropic morphological 
abnormalities, but are invariably growth-retarded and display massive apoptosis, 
notably of the brain28. Analysis of the subarachnoid space at E16.5 in Rev3l+/- mice 
revealed a highly significant increase in subarachnoid volume (Unpaired t-test, P value: 
0.0047; Fig. 3a). In addition, Rev3l heterozygous mice at P0 showed significantly 
reduced hindbrain volumes as compared with wt (Unpaired t-test, P value: 0.015; Fig. 
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3b). We then analysed the facial motor nucleus at P0 (Fig. 3c,d). In contrast to the 
Plxnd1 mutant mice, there was no evidence for a motoneuron migration defect in the 
Rev3l heterozygous embryos. Nevertheless, there was a strong decrease in the number 
of motoneurons in Rev3l heterozygous embryos (Unpaired t-test, P value: 0.0001; Fig. 
3d). These data provide strong support for hypoplasia of the motor nucleus 
consequent to a heterozygous Rev3l mutation, similar as the REV3L mutation in MBS 
patients P5, P11 and P12. 
 
Figure 3. Morphological analysis of the brains of Rev3l embryonic and newborn mice. 
a. Example of a sagittal section of the embryonic mouse head at E16.5 stage used for 
subarachnoid volume rendering, processed with Nissl staining. The subarachnoid space 
is shown in green. Scale bar 1 mm. Right: subarachnoid volume rendering measures of 
both genotypes. In all Rev3l-heterozygous embryos the subarachnoid space is 
significantly increased as compared to wt embryos calculated with unpaired t-test (P-
value = 0.0047 N=5). b. Example of one of the hindbrain sagittal sections at P0 used for 
hindbrain volume rendering. We measured the volume of five wt and five 
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heterozygous mice. The hindbrain boundaries are indicated by dashed lines. Scale bar 
500 µm. Right: heterozygous Rev3l mice show a significant decrease of hindbrain 
volume (P-value = 0.015) (N=5). c. Lateral hindbrain sections at P0 stage of a view of 
the facial motor nucleus, inside the square. Scale bar 300 µm. d. Higher magnification 
of the facial motor nucleus showing paucity of Rev3l-heterozygous motoneurons. Scale 
bar is 100 μm. Right: quantification of motoneurons in the facial motor nucleus, in 
each side of the hindbrain, in five wt and five heterozygous P0 mice (mean ± SD). The 
difference is statistically highly significant (P-value< 0.0001, N=10). We do not show 
both genotypes because there are not visible differences between them. 5N 
(trigeminal nucleus), 7N (facial nucleus), Cb (cerebellum), HB (hindbrain), Is (isthmus), 
r1-11 (rhombomeres r1 to r11, Sb (subarachnoid space), Sk (skull), SpC (spinal cord). A 
P value smaller than 0.05 was considered to be statistically significant (*). P values 
smaller than 0.01 (**) or 0.001 (***) were considered highly significant. 
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Figure 4. Survival, replication of bulky DNA lesions, and DNA damage signaling in 
Rev3l-mutated MEF lines. a. Survival of wt (+/+), Rev3l-heterozygous (+/-) and Rev3l-
deficient (-/-) MEF lines after mock exposure, or after exposure to Benzo(a)pyrene 
diepoxyde (BPDE). Rev3l-heterozygous MEFs are slightly sensitive to BPDE indicating 
haploinsufficiency. Experiments were performed in triplicate. Error bars, S.E.M. b. 
Replication fork progression representation after exposure to BPDE, or mock exposure. 
Rev3l-heterozygous MEFs display normal fork progression at undamaged DNA (mock 
treated, left panel), but a marginal defect in replication of bulky lesion-containing DNA 
(BPDE, right panel). Error bars, S.E.M. c. displays immunoblots to detect the 
phosphorylation of DNA damage-signalling markers upon treatment with BPDE. γ-
H2AX: phosphorylated histone H2AX. RpaS4/8-P: 32 kDa subunit of ssDNA binding 
protein Rpa, phosphorylated at Ser 4 and/or Ser 8. Total levels of Rpa are somewhat 
variable consequent to slight differences in proliferation rate between the lines. 
Chk1S354-P Checkpoint kinase-1, phosphorylated at Ser 354. β-actin: loading control. 
Rev3l-heterozygous MEFs display DNA damage signalling that is almost as strong as 
Rev3l-deficient MEFs. The full blots are shown in Supplementary Figure 5. 
 
Rev3l-mutant MEFs displayed increase of DNA damage 
The essential role of Rev3l in replication of damaged DNA has been extensively studied 
in vitro and in Rev3l-deficient cells and mice28,47-49. We wondered whether the 
neuronal defects in MBS patients and Rev3l-heterozygous mice reflect partial 
replication defects at DNA carrying endogenous DNA lesions. To this aim we analyzed 
responses of immortalized Rev3l-mutant mouse embryonic fibroblast (MEFs) to 
Benzo[α]pyrene diolexpoxide (BPDE), an agent that induces DNA damage that mimics 
bulky endogenous nucleotide lesions. Rev3l-heterozygous MEFs displayed a slight, but 
significant, decrease in cell survival (Fig. 4a). To substantiate the effect of 
haploinsufficiency, we measured replication of BPDE-damaged DNA in these cells and 
found that Rev3l-heterozygous cells displayed a slight but significant defect, suggesting 
the presence of replication stress (Fig. 4b, right panel). Since replication stress induces 
DNA damage signaling cascades that initiate cellular senescence or apoptosis we 
measured phosphorylation of the signaling proteins Rpa, Chk1 and H2AX (Fig. 4c)50. 
Remarkably, the Rev3l-heterozygous cells displayed a level of DNA damage signaling 
that was almost as high as in Rev3l-deficient cells. These data suggest that, in Rev3l-
heterozygous mice, marginally under-replicated endogenous DNA lesions induce 
strong DNA responses, contributing to the observed neuronal phenotypes.  
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DISCUSSION 
We have identified de novo mutations in PLXND1 and REV3L in six unrelated sporadic 
MBS patients. The neuropathological alterations and other clinical findings in MBS 
patients correlate to those in the Plxnd1 and Rev3l mutant models. Thus, hypoplasia of 
the facial motor nucleus that was observed in both mouse models has also been 
documented in MBS patients3,16. In addition, several developmental anomalies that 
were previously reported in Plxnd1 knockout mice are mirrored in patients carrying a 
PLXND1 mutation, as well as other MBS patients. For example, craniofacial bone  
abnormalities observed in Plxnd1 knockout mice51,52 were also seen in patients P1 and 
P9, and which are commonly seen in other MBS patients17 (Supplementary Table 5). In 
addition, the vertebral defects in Plxnd1 mutant mice are reminiscent of the scoliosis 
in patient P1, and the haemorrhages seen in Plxnd1 mutant mouse resemble the facial 
haemangiomas seen in patient P1 (Supplementary Table 5). A possible causative de 
novo mutation was also identified in CCDC160. No PLXND1-coding mutations were 
identified in HCFP1 families, although their genetic defect maps to the PLXND1 locus20, 
suggesting the presence of regulatory mutations affecting the spatiotemporal 
expression of PLXND1 during embryonic brain development. 
 
The clinical features of patients with heterozygous PLXND1 and REV3L mutations are 
highly variable with no obvious genotype–phenotype correlations. While the variable 
phenotype of patients P1, P5 and P9–P11 are consistent with the clinical criteria for 
MBS6,22, patient P12, who was identified as having a heterozygous nonsense mutation 
in REV3L, only had bilateral facial paralysis and no weakness of the abducens nerves, 
suggestive of the restricted HCFP phenotype (Fig. 1; Supplementary Table 5). Thus, our 
data show that MBS and HCFP can be allelic conditions. In contrast to P12, the 
phenotype of patient P5, who was identified as having a heterozygous loss-of-function 
splice-site mutation in REV3L, presented with a wide range of features in addition to 
the cranial nerve palsies  
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including absence of digits on the left hand, Poland anomaly, hearing loss and cardiac 
defect. This variability is highly reminiscent of the variable phenotype of completely 
Rev3l-deficient embryos. Rev3l deficiency may result in a stochastic ablation of cell 
lineages during embryonic development28. On the basis of these and our current data, 
it is conceivable that the spectrum of MBS symptoms reflects the stochastic loss of 
neuronal precursors, caused by replicative stress at endogenous DNA lesions and 
consequent DNA damage responses, during embryonic development. Likewise, the 
variable clinical presentation that is seen for PLXND1 mutations might be due to similar 
stochastic disruptions of motoneuron migration to the FBM nucleus. 
 
Exome sequencing has detected causative de novo mutations in two (or three 
including the CCDC160 mutation) in the initial cohort of eight MBS patients. This result 
is of general interest, as several studies have suggested previously that vascular 
disruptions during the first trimester of pregnancy rather than genetic mechanisms are 
the leading cause of MBS5–7,53. While vascular disruptions caused by various teratogens 
can explain the MBS phenotype in some patients, our current data indicate that exome 
sequencing in parent–patient trios is a powerful approach for identifying causative 
mutations in MBS. It is to be expected that whole-genome sequencing will deliver an 
even higher yield when focusing on de novo mutations in coding and noncoding 
regions54. That only three de novo mutations were identified in PLXND1 and three in 
REV3L in our cohort suggests a low frequency of mutations in these genes as a cause of 
MBS, implying genetic heterogeneity and intrauterine insults as causative events in 
other MBS patients. We expect that the implementation of whole-exome sequencing 
and whole-genome sequencing of parent–patient trios in a diagnostic setting will 
further dissect the aetiology of MBS. 
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SUPPLEMENTARY INFORMATION 
Supplementary figures
Supplementary Figure 1. a. Sanger sequencing validation of the novo mutations in 
Möbius patients. The first row shows the PLXND1 mutations in P1 (c.5685C>A),  P9 
(c.4454_4455GC>CA) and P10 (c.3018C>T). Patient 3 carries the c.1655T>C mutation in 
IFT172. Patient 4 carries a de novo c.501delA mutation in CCDC160. The last row shows 
the REV3L mutations in Patients P5 (c.1096+1G>A), P11 (c.1160A>G) and P12 
(c.2662A>T). b. Left. Reads from exome sequencing showing the  presence of the 
PLXND1 mutation in P1 and its absence in the parents. The mutation was present in 11 
reads out of 31. Right. Reads from exome sequencing showing the presence of the 
REV3L mutation in patient P5. 
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Supplementary Figure 2. REV3L Q-PCR and RT-PCR.  
Effect of the c.1096+1G>A mutation on REV3L expression. a. Shown are mRNA 
expression levels in EBV-LCLs cells in patient P5 compared to the average expression 
level of REV3L in five controls. b. RT-PCR products of mRNA from patient P5 and one 
healthy control c with primers surrounding the canonical splice mutation 
(c.1096+1G>A) and control primers. Four bands of different sizes appear on the gel. 
The Sanger sequence of the first band corresponds to the correct size from the normal 
REV3L allele (657 bp). The sequence of the third band (508 bp) reveals skipping of exon 
10 and the fourth band (423 bp) skipping of both exons, 9 and 10. Right two lanes: 
control RT-PCR (321 bp). The second band consists of heteroduplexes from the other 
products. c. Sanger sequencing of RT-PCR products. The top three chromatograms are 
the cDNA sequences derived from the normal allele. The bottom two chromatograms 
are cDNA sequences of the 508 bp mutant product lacking exon 10 and of the 423 bp 
product lacking exons 9 and 10.  
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Homo sapiens I L N E E A I S N L M E N S Q T F Q P L T Q I 
Pan troglodytes L I N E E A I L N L M E N S Q T F Q P L T Q L 
Macaca mulatta L I N E E A I L N L M E N S Q T F Q P L T Q L 
Ratus norvegicus L I N E E A I L N L I E N S Q T F Q P L T Q L 
Mus musculus L I N E E A I L N L I E N S Q T F Q P L T Q L 
Canis lupus familiaris L I N E E A I L N I V E N S Q S F H R L S Q L 
Bos taurus V V D E E A I L S M L E N S Q S F L Q L S Q V 
Gallus gallus T L S D Q T I L - - - - - - - - - - - - - - T 
Xenopus laevis I L N E E A I S N L M E N S Q T F Q P L T Q I 
Tetraodon nigroviridis L I N E E A I L N L M E N S Q T F Q P L T Q L 
 
Homo sapiens I M A A L E A N P T A R T Q L Q H K F E Q V 
Pan troglodytes I M A A L E A N P T A R T Q L Q H K F E Q V 
Macaca mulatta I M A A L E A N P T A R T Q L Q H K F E Q V 
Ratus norvegicus I M A A L E A N P T A R T Q L Q Y K F E Q V 
Mus musculus I M A A L E A N P T A R T Q L Q H K F E Q V 
Canis lupus familiaris I M T A L E A N P T A R T Q L Q H K F E Q V 
Bos taurus I M S A L E A N P T A R T Q L Q H K F E Q V 
Ornithorhynchus anatinus I V A A L E A N S T T R T Q L Q H K F E Q V 
Gallus gallus I V A A L D S N P T T K T Q L Q H K F E Q V 
Xenopus laevis I V T A L E T N P T T K G Q L Q H K F D Q V 
Tetraodon nigroviridis L D A T I S D D V W L Q A R F R R G P E D A 
 
Homo sapiens S A A K N P K L M L R R T E S V V E K M L T 
Pan troglodytes S A A K N P K L M L R R T E S V V E K M L T 
Macaca mulatta S A A K N P K L M L R R T E S V V E K M L T 
Ratus norvegicus S A A K N P K L M L R R T E S V V E K M L T 
Mus musculus S A A K N P K L M L R R T E S V V E K M L T 
Canis lupus familiaris S A A K N P K L M L R R T E S V V E K M L T 
Bos taurus S A A K N P K L M L R R T E S V V E K M L T 
Gallus gallus S A S K N P K L M L R R T E S V V E K M L T 
Xenopus laevis S A S K N P K L M L R R T E S V V E K M L T 
Tetraodon nigroviridis S A S K N P K L M L R R T E S V V E K M L T 
 
Homo sapiens T R I T I H G N D L H V G S E L Q V L V N D 
Pan troglodytes T R I T I H G N D L H V G S E L Q V L V L D 
Macaca mulatta T R I T I H G N D L H V G S E L Q V L V L D 
Ratus norvegicus T R I T I H G S D L N V G S M L Q V L V L D 
Mus musculus T R I T I H G S D L N V G S M L Q V L V L D 
Canis lupus familiaris T R I T I H G S D L H V G S E L Q V L V L D 
Bos taurus T R I T I H G S E L H V G S E L Q V L V L N 
Gallus gallus T R V T I R G S W L D V G S E L R V L V L S 
Xenopus laevis T R V T I S G T N L N V G R D V R V L F L K 
Tetraodon nigroviridis T T I T I T G E H L D I G S Q V R V M N T H 
 
Supplementary Figure 3: Cross-species alignment of REV3L and PLXND1 protein 
sequence surrounding the missense mutations. Cross-species alignment of REV3L and 
PLXND1 protein sequence surrounding the missense mutations. Cross species 
alignment of two regions of REV3L and PLXND1 showing the high amino-acid 
conservation of the missense variants of the p.(Glu387Gly) (P11, REV3L), 
p.(Asn1895Lys) (P1, PLXND1), p.(Arg1485Pro) (P9, PLXND1), and p.(Leu1006Leu) (P10, 
PLXND1) substitutions (in red) respectively. Residues with a grey background are 
conserved across the species. 
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Supplementary Figure 4: Rev3l expression pattern in 14.5 d.p.c. embryonic mouse.  
a-f. Sagittal sections of 14.5 dpc mouse embryos processed respectively for ISH 
detection of Rev3l expression. The rostral is to the left. a. Sagittal section of the entire 
mouse embryo to show specific Rev3l expression in brain (Br) and choanae (Ch). Other 
body structures are indicated such as the heart (He), liver (Li), lung (Lu), kidney (Ki), 
skull (Sk), sternum (St), tongue (To) and vertebral bodies (Vc) to show the absence of 
Rev3l expression. b-d. Sagittal sections of embryonic mouse brain. The major antero-
posterior subdivisions of the brain are outlined: diencephalon (prosomeres p1–p3), 
midbrain (M), isthmus (Is), cerebellum (rhombomeres r1–r11) and spinal cord (SC). 
Rev3l is expressed in ventral pallium (VP), lateral pallium (LP), hypothalamus (Hyp), p1-
p3, midbrain, and it is broadly expressed in isthmus, rhombomeres and spinal cord. d-
e. Magnification of Rev3l expression centered at hindbrain positions. f. Magnification 
of Rev3l expression centered at choanal position. In the sections processed for 
nonradioactive in situ hybridization, the positive cells appear with blue precipitate. g. 
3D reconstruction of Rev3l expression (in purple) in mouse at E14.5. These figures 
correspond to images downloaded from the GenePaint server 
(http://www.genepaint.org). This server offers microphotographs of complete section 
series of mouse embryos processed for ISH with digoxigenin-labelled riboprobes. Other 
embryonic stages were not available in expression genes databases. Hb (hindbrain), nc 
(neocortex), Th (thalamus). 
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Supplementary Figure 5: Full blots of the panels shown in Figure 4 of the main text. 
The top panel shows a copy of Figure 4c in the main text. Each portion of the blot that 
was used for composing this figure has been lettered (a to m). These letters are also 
used to highlight the position on the original immunoblots from which they were 
derived (lower panel). 
 
  
 
 
Supplementary tables 
Supplementary Table 1. Filtering steps of exome sequencing data analysis. 
QC  Quality Control cut-off are ≥5 unique variant reads >5 and  ≥15% variation reads.* Patients carrier of de novo mutations. 
 
  
 
Patient 1* 
(P1) 
Patient 2 
(P2) 
Patient 3* 
(P3) 
Patient 4* 
(P4) 
Patient 5* 
(P5) 
Patient 6 
(P6) 
Patient 7 
(P7) 
Patient 8 
(P8) 
Total variants  after QC 41468 39805 42288 41826 41522 40071 40604 41144 
Exonic and canonical splice site variants 16736 16119 17068 16772 16244 15784 16011 16998 
After exclusion of synonymous, known variants 
(dbSNP135) and variants present in in-house 
database 
110 107 453 153 143 178 158 214 
Possible stop and frameshift mutations  5 6 32 13 11 13 12 16 
de novo candidates (or maternal X-linked) 2 - 1 1 1 - - - 
 
 
Supplementary Table 2. Relation of patient and mutations. 
Patient Case Gene Mutation Technique 
Patient 1 P1 PLXND1;  SPO11 c.5685C>A; c.598T>C NGS 
Patient 2 P2 -  NGS 
Patient 3 P3 IFT172 c.1655A>G NGS 
Patient 4 P4 CCDC160 c.501delA NGS 
Patient 5 P5 REV3L c.1096+1G>A NGS 
Patient 6 P6 -  NGS 
Patient 7 P7 -  NGS 
Patient 8 P8 -  NGS 
Patient 9 P9 PLXND1 c.4454_4455GC>CA Sanger sequencing 
Patient 10 P10 PLXND1 c.3018C>T Sanger sequencing 
Patient 11 P11 REV3L c.1160A>G Sanger sequencing 
Patient 12 P12 REV3L c.2662A>T Sanger sequencing 
   NGS: Next Generation Sequencing . 
  
  
 
Supplementary Table 3. De novo mutations in MBS patients 
case Gene Chromo- some 
Genomic 
position1 Mutation Amino acid 
Mutation 
type 
PhyloP 
score SIFT 
Polyphen 
Prediction 
 
CADD 
score 
Patient 1 PLXND1 3  g.129,275,248 
 
c.5685C>A p.Asn1895Lys 
 
Missense 0.771 Deleterious 
Probably 
Damaging 
Pathogenic 
22.6 
Patient 1 SPO11 20 g.55,910,931 c.712T>C p.Cys238Arg Missense 5.5 Tolerated Probably Damaging 
Pathogenic 
16.7 
Patient 3 IFT172 2 g. 27,693,832 c.1655A>G p.Ile552Thr Missense 4.706 Tolerated Probably Damaging 
Pathogenic 
22.6 
Patient 4  CCDC160 X g.133,379,331 c.501del A p.Glu167Aspfs*21 Frameshift 1.198 NA NA 
Non-
Pathogenic 
14.5 
Patient 5  REV3L 6 g.111,708,967 c.1096+1G>A See text splice site 4.08 NA NA 
Pathogenic 
23.8 
Patient 9 PLXND1 3 g.129,284,263 c.4454_4455GC>CA p.Arg1485Pro Missense 3.84 Deleterious Probably Damaging 
Pathogenic 
23.8 
Patient 10  PLXND1 3 g.129,291,510 c.3018C>T p.Leu1006Leu Silent -0.12 Tolerated Neutral - 
Patient 11 REV3L 6 g.111,702,584 c.1160A>G p.Glu387Gly Missense 4.3 Not tolerated 
Probably 
damaging 
Pathogenic 
27.9 
Patient 12  REV3L 6 g.111,696,896 c.2662T>A p.Lys888* Nonsense 2.47 NA 
 
NA 
Pathogenic 
35 
1 Genomic position is with respect to chromosome 2, 3, 6 and X in hg19.  
Mutations are described numbered from the first nucleotide of the initiation codon in the nucleotide sequence NM_015103 (PLXND1), 
NM_001101357 (CCDC160), NM_015662 (IFT172) and NM_002912 (REV3L). SIFT (sorting intolerant from tolerant; http://sift.jcvi.org/). 
Polyphen is an amino acid substitution prediction method (http://genetics.bwh.harvard.edu/pph2/). Not tolerated, variants predicted to 
have a phenotypic effect. The CADD score (Combined Annotation Dependent Depletion) uses multiple annotations to predict 
pathogenecity57. 
  
 
 
Supplementary Table 4. Sequencing statistics of exome sequencing analysis 
Patient 1 and 2 correspond to the patients in which we performed trio-exome sequencing. We performed exome sequencing in the 
isolated Patients 3-8. *Patients were we confirmed de novo mutations. Patient 1 is the carrier of the mutation in PLXND1, Patient 3 is the 
carrier of the mutation in IFT172, Patient 4 is the carrier of the mutation in CCDC160 and patient 5 the carrier of the mutation in REV3L. 
 
 
 
Patient 1* (P1) 
 
Patient 2 
 
Patient 3* 
 
Patient 4* 
 
Patient 5*  
 
Patient 6 
 
Patient 7 
 
Patient 8 
 
Total reads 93,393,301 114,283,533 67,808,654 99,254,389 90,359,530 72,961,544 85,343,182 82,358,391 
Total mapped bases 4,53Gb 5,49 Gb 3,24Gb 4,79Gb 4,33Gb 3,49Gb 4,08Gb 3,97Gb 
Total mapped bases in 
targeted exons 3,706,404,046 3,672,657,533 2,515,750,529 3,884,801,966 3,319,497,862 2,625,060,286 3,131,034,093 3,183,131,055 
Total mapped bases 
near targeted regions 6,8% 6,3% 8,6% 7,5% 9,2% 9% 9% 7,8% 
Total mapped bases in 
regions 81,8% 66,8% 77,5% 81% 76,7% 75,1% 76,6% 80,2% 
Total mapped bases 
outside regions: 11,3% 26,9% 14% 11,5% 14,2% 15,9% 14,4% 12% 
% targets with at least 
10x coverage 86,9 85,3% 79,9% 86,8% 82,2% 80% 81,2% 85,5% 
Mean target coverage 
(fold) 72,1 72,4 48,5 73,6 64,1 50,6 60,6 59,9 
Median target 
coverage (fold) 56,9 56,9 37,8 55,4 50,2 39,8 47,1 44,9 
 185 
 
Supplementary Table 5. Clinical data of Möbius syndrome patients. 
 P1 P5 P9 P10 P11 P12 
Gender F M F M F F 
Cranial nerve defects       
Right upper/lower facial 
palsy 
++/- ++ -/- ++/++ ++ + 
Left upper/lower facial palsy ++/++ ++ ++/- ++/++ + + 
Abduction palsy RE/LE ++/++ ++ ++/++ ++/++ ++  
Horizontal gaze palsy +  + + ++  
Tongue malformations + +     
Lagophthalmos     + + 
Fibrosis of extra-ocular 
muscles 
  +    
Oral dysfunction       
Feeding problems +  + +   
Swallowing difficulties + +   +  
Palatal weakness + +     
Dysarthria + +  +   
Language delay + +     
Craniofacial malformation       
Microcephaly   +    
Epincanthic folds + +     
Flat nasal bridge + + +    
Micrognatia +   +   
External ear defects +      
Dental defects +  + + +  
Bifid uvula +      
Skeletal malformation       
Clinodactyly +      
Ectrodactyly  +     
Low set thumbs +      
Rib deformities  +     
Hip defect +      
Pes valgus +      
Scoliosis +      
Anisomelia  + +     
Poland anomaly  + +    
Motor retardation + +  +  + 
Clumsy motor performance + +     
Dysdiadochokinesis +  +    
Hypotonia  +     
Sensory disturbances       
Hearing loss  +     
Elevated pain threshold +      
Autism +      
Vascular defects       
Cardiac defect  +     
Facial Hemangiomas  +      
The following abbreviations are used: F, Female; RE, right eye; LE, left eye; ++, 
paralysed; + paretic or affected. 
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Supplementary Table 6. Primers sequences used in this study.  
Sanger sequencing  
Exon Foward Primer Reverse primer 
PLXND1-Exon1a ggcggaaaagagaaaacag gctgatagaggcggttgac 
PLXND1-Exon1b ggtcgaaggtgaagagcttg ggtcgaaggtgaagagcttg 
PLXND1-Exon1c tccatctaccagggcttctg ggtcgaaggtgaagagcttg 
PLXND1-Exon 2 tcatctccttggaacagctc agtggcaaaaacagacttgc 
PLXND1-Exon 3 tcctgaagggtccaagacag gcagaggaacagcgtgtgta 
PLXND1-Exon 4&5 agtgttgaccctcagtttcc atttgtcttcaggtccttgg 
PLXND1-Exon 6&7 gggtcacatgtagggcatag tgtgctggtgaatgaacaac 
PLXND1-Exon 8 ctcttgttagcaggcagctc gcaaaggcattgaaacattc 
PLXND1-Exon 9 caggactgaaccaggcag gaaagaaaagcaaagcccac 
PLXND1-Exon 10&11 aaaggcctgacagttcgac ggcaaccactggaatgag 
PLXND1-Exon 12 gaaggggctaagaacctcag ggtggctttagtgatcatgg 
PLXND1-Exon 13 tcctctaagcagtgggtctg tgattttcctcagagcaagg 
PLXND1-Exon 14&15 gaactgtgggaaactgatgg cttggctcaaggatgtcac 
PLXND1-Exon 16&17 actgggcagaagatgagttg aggaagaggggacagagatg 
PLXND1-Exon 18 atctctgtcccctcttcctc ctgtcctgctccttctgtg 
PLXND1-Exon 19 agcctctcaccctcgttatc cagtgaattcaggtgctgg 
PLXND1-Exon 20 ctgggtgcctaacctgttc ctgggtgcctaacctgttc 
PLXND1-Exon 21&22 cagatggacaacctggagtc tctcgaggttcttctcgatg 
PLXND1-Exon 23 catgacagggatcaatgc catgacagggatcaatgc 
PLXND1-Exon 24 taatgagctccccatccc caggaagggctggaatatg 
PLXND1-Exon 25 ggttgctgtggacgtagaag ctgcataacaggtcctacgg 
PLXND1-Exon 26&27 cctgacacggggtctctg ggcagcaactcactgacctt 
PLXND1-Exon 28&29 tacatggagagagcgagagg caggaaatcagcttgaggag 
PLXND1-Exon 30&31 caccctcatcctgtccaag acgctctggaagaagttgtc 
PLXND1-Exon 32 atgtggcttcctcattcagc agctgggaaatggcagag 
PLXND1-Exon 33 tctctcctccacaactgtcc ggtgtctccctgtctgaatg 
PLXND1-Exon 34 gtcacttatgtggcaggagg tccctgcccttactccag 
PLXND1-Exon 35 cgctgaactgttctgtggg agtgacatccgtccattagg 
PLXND1-Exon 36 actcgtggtagacgttcagg ttcccagtctgagtcacagg 
REV3L-Exon1 gagaaagccccttctcgg gacaaacctgtagtgcctcc 
REV3L-Exon 2 actggttactttgaactatggg ggttgggatcagaggtttg 
REV3L-Exon 3 taagactgaatttggccagc cagtttgttcttgaacttagagatg 
REV3L-Exon 4 ttccggtaaaattgagatgg tgctgagctgtgactttgtc 
REV3L-Exon 5 aggtcagatcgagaccatcc ggggagatgttttcttaatttg 
REV3L-Exon 6 caggttttctgggtacaagc ggggagatgttttcttaatttg 
REV3L-Exon 7 gggataatttgtccactttattacac aggagggagggagagacttc 
REV3L-Exon 8 & 9 tgtgtgattctatggtaaaactacag aattatgattcagttgtactgcac 
REV3L-Exon 10 atggtaatgcttccaaatttac ttagcatactttgcttaaaggc 
REV3L-Exon 11 cactgcactccaactccag cttattctgaaaagcagattatcc 
REV3L-Exon 12 agaatgcaggaattgtggtg ttttggtaatgaggcaaataaac 
REV3L-Exon 13a tcttggtgtgggaaaatgtc ttcaattcctgacagttggc 
REV3L-Exon 13b tgggcaaaaattctttcaac ttttctcgtttcatttctgg 
REV3L-Exon 13c gtcactttggagatggaacg gcattagacaagagtcatagcc 
REV3L-Exon 13d aatgctgaaaccgaagattg Ttatatcatgaatttgttgggc 
REV3L-Exon 13e ggctctgctgtagatcatcc Caggttacccagtagttacataattg 
REV3L-Exon 13f tgcattgcaaagacagtcag Tgagaaagatggcttccataac 
REV3L-Exon 13g gtaacgtccccaagaaaacc Agctttgctgtgaagctgac 
REV3L-Exon 13h tgtttcttagcctcccacag Tgtctgccagtaatctgtgg 
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REV3L-Exon 14a acctgcacaatatagagggg Gacaaacctgtagtgcctcc 
REV3L-Exon 14b gacaaacctgtagtgcctcc Agtttgactacatcccgtgg 
REV3L-Exon 15 ggttgggatcagaggtttg Acagcagaaagacagttgc 
REV3L-Exon 16 cagtttgttcttgaacttagagatg Ttgtctcaaagatatgcaaataatg 
REV3L-Exon 17 tgctgagctgtgactttgtc Gaattcaatatactcctcccttg 
REV3L-Exon 18 ggggagatgttttcttaatttg Tctcctacccctacctcagc 
REV3L-Exon 19 ggggagatgttttcttaatttg Ttcgctttcttcctacctttac 
REV3L-Exon 20 aggagggagggagagacttc Ttcgctttcttcctacctttac 
REV3L-Exon 21 aattatgattcagttgtactgcac Gttttgccatgttgctcag 
REV3L-Exon 22 ttagcatactttgcttaaaggc Caactggcctgaacaatacac 
REV3L-Exon 23 cttattctgaaaagcagattatcc Gccggaaagttggcatag 
REV3L-Exon 24 ttttggtaatgaggcaaataaac Atagggaaggtgtccagagc 
REV3L-Exon 25 ttcaattcctgacagttggc Caaggtgactggtttgttc 
REV3L-Exon 26 ttttctcgtttcatttctgg Aggattcaactctgggctg 
REV3L-Exon 27 gcattagacaagagtcatagcc Cgtaaggactggaaaggactc 
REV3L-Exon 28 ttatatcatgaatttgttgggc Agacatgagccagtgaccc 
REV3L-Exon 29 caggttacccagtagttacataattg Acctagatgcatgtttaaggg 
REV3L-Exon 30 tgagaaagatggcttccataac Tcagtgaggcttcatgtgc 
REV3L-Exon 31 agctttgctgtgaagctgac Tgaaagcaggagtgcctatc 
REV3L-Exon 32 tgtctgccagtaatctgtgg Atggccattcttgttgtagc 
CCDC160-Exon2a tagattcttcacccgtgagc Gcaggtagagttatcttctgtgc 
CCDC160-Exon2b catttcaaagaatgaaacagacac Ttgtggatgacttctttggc 
CCDC160-Exon2c ttttcaagaaacagagacgg Aaagagaaagcagaagcttgg 
Q-PCR   
GUSB   agagtggtgctgaggattgg Ccctcatgctctagcgtgtc 
PPIB cggaaagactgttccaaaaac Gattacacgatggaatttgctg 
REV3L tcgtctggacattgaagctc Gactcaggttggctcatttg 
REV3L RT-PCR   
REV3L-Exon 4-10 gctgtcaagttccgaaaagc Ttgggtcaaaggctgaaaag 
REV3L-Exon 13 acagaaaagccaagcctcag Tgcgtttggctctaagtgtg 
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DISCUSSION 
The major aim of this thesis was to provide more insight in the molecular organization 
of the developing hindbrain specifically - the medulla oblongata- and the study of the 
genetic defects underlying Möbius syndrome (MBS) and Hereditary Congenital Facial 
Paresis (HCFP).  
 
This study was divided in two phases. During the first phase, I have analyzed the 
expression pattern of Hox transcription factors in order to recognize the morphological 
segmental subunits (cryptorhombomeres) of the medulla oblongata in mouse 
embryos. During the second phase of this project, I have identified causative genes for 
MBS and HCFP using a combination of morphological and genetic approaches. In a first 
morphological approach I have proposed candidate genes for HCFP according to their 
genomic localization at HCFP candidate loci and their specific expression in embryonic 
mouse hindbrain. Subsequently, a genetic strategy using next generation sequencing 
techniques (NGS) was applied to MBS and HCFP patients in order to identify the 
genetic cause of both syndromes. Finally, a morphological study of the mutant mouse 
brains was used to prove the participation of the causality of gene mutations in the 
pathogenesis of MBS syndrome. 
 
Cryptorhombomeres units according to the Hox gene collinear expression pattern in 
embryonic mouse medulla oblongata.  
The medulla oblongata is the caudal portion of the hindbrain, which contrary to the 
rostral part of the hindbrain that is subdivided into five rhombomeres (r2-r6), appears 
as large territory without observable outer transverse constrictions1. Classically, the 
medulla oblongata has been described as a unique r7 segment or r7 plus a large r8 
subunit, because it lacks the typical interrhombomeric boundaries1,2. A possible hidden 
segmentation of the medulla oblongata was suggested for the first time by 
Cambronero and Puelles by performing quail-to-chick grafts3. According to their 
results, the medulla oblongata was subdivided into five segments or neuromeres, r7-
r11, which were called pseudo- or crypto- rhombomeres, according to their lack of 
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visibility as compared to the rhombomeres r1 to r6 of the anterior hindbrain. A 
posterior Hox genes expression analysis (paralogous groups three to seven) in 
embryonic chick medulla oblongata with paralogous Hox groups four to seven, 
demonstrated that the proposed hidden cryptorhombomeres boundaries3 coincide 
with the anterior limit of expression of Hox genes4. In this work I have extrapolated the 
previously described hidden segmentation to the mammalian hindbrain with respect 
to Hox genes expression domains and morphological landmarks. Similar studies in 
other species could confirm the same pattern in different vertebrate phyla, as it has 
been already suggested by comparative anatomical studies5-8. I conclude that Hox 
genes have a role in cryptorhombomeres (r7-r11) segmentation processes as occurs 
within the overtly segmented region (r2-r6). These territories lack the 
interrhombomeric boundaries9-11 typical cellular and molecular characteristics that 
restrict the cells intermingling between segments, suggesting a more homogeneous 
organization of nuclei and columns in this region. Nevertheless, my results show a 
molecular regionalization into discrete segmental units within the sensory and motor 
longitudinal columns and nuclei of the medulla oblongata, implying a role of the Hox 
code in the organization, migration and differentiation of the neuronal populations 
along the anteroposterior axis. Studies of loss of function Hox mutants of paralogous 
groups 1-4 corroborate the role of Hox genes play in segmental identity and cell 
segregation across the interrhombomeric boundaries of the overtly segmented 
hindbrain12. Future studies including Hox genes from groups 5-8 could provide more 
insight in the function of these genes in the medulla oblongata where the typical 
boundaries are lacking. 
 
Morphological identification of causative genes for HCFP and Möbius syndrome 
The etiology and pathogenesis of HCFP and MBS disorders has been extensively 
investigated and debated. However, all efforts to elucidate them have failed so far. The 
two conditions were initially considered to reflect the same disorder13 according to the 
features they share, but currently they are recognized as two different entities based 
on neuropathological and genetic data14.  
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HCFP is an autosomal dominant disorder clinically characterized by isolated facial palsy 
caused by the disruption of the facial nerve (VIIth) and/or its nucleus, the facial 
branchiomotor nucleus (FBM). With the aim of identifying candidate genes for HCFP I 
used a morphological strategy to analyze the expression pattern of the genes located 
within the two loci associated with this disease14-16.The HCFP1 locus (MIM 601471)14-15 
includes 34 known or predicted protein-coding genes, while the HCFP2 (MIM 
604185)16 locus just contains the 3’ part of CTNNA3 gene. For further analyses of 
positional candidate genes, I extended the analysis of this region by including 1 Mb 
surrounding this interval at both ends. I categorized the genes from both loci into six 
groups according to their specific expression in the facial motor nucleus. One of these 
groups contained genes with a transient or weak expression in the FBM, such as 
Tmmc1 and Gata2. In addition, I described that Mgll from the HCFP1 locus, and Reep3 
and Lrrtm3 from the expanded HCFP2 locus are specifically expressed in the FBM. 
Previously, Sanger sequencing of LRRTM3 coding regions failed to identify mutations in 
HCFP patients17. In line with these findings I have sequenced both candidate genes, 
MGLL and REEP3, in our cohort of HCFP patients (data not shown). Unfortunately, this 
study did not reveal any pathogenic mutations. It is important to emphasize that I have 
only studied the available images in the online database, which precludes studying the 
spatiotemporal expression of genes during all the embryonic stages. As a consequence, 
some candidate genes could have been missed and it would require additional 
experiments to have a complete overview.  
 
Despite these limitations, in my opinion the expression databases contain a wealth of 
information that is highly valuable for users that have adequate knowledge of 
development and anatomy. Focusing on the specific structures affected in the 
respective diseases could be a useful tool for the identification of candidate genes for 
HCFP and other developmental diseases. In addition, gene expression studies can also 
provide some clues about the function of the different genes in the specific tissues or 
gene interactions. However, given the results of my study I conclude that such gene 
expression analyses are best done for a few genes that emerge as (positional) 
candidates following genetic studies, because it limits the high number of genes and 
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stages in laborious interpretation experiments. Thus, expression analysis could be used 
as a valid proof of the role of candidate genes in the pathogenesis of the disease. 
 
Next Generation Sequencing in HCFP 
The introduction of next generation techniques (NGS) in our research provided a 
robust tool for identification of causative mutations for HCFP and MBS, giving for the 
first time insights into the etiology and pathogenesis of both disorders. I have applied 
whole exome sequencing to one HCFP family which was not linked to any of the 
already known loci. Only a single variant of unknown significance was found to 
segregate with the phenotype: a heterozygous frameshift mutation in the MEPE gene. 
MEPE encodes a matrix extracellular phosphoglycoprotein that is expressed in 
osteocytes, osteoblasts, odontoblasts, cartilage, in renal proximal tubules and salivary 
glands18-24. It plays an inhibitory role in bone mineralization25,26. Heterozygous and 
homozygous Mepe-mutant mice show increased bone mass production, mainly 
affecting the facial bones, whereas the general skeletal structure is not affected in 
those mice24. Interestingly, in the respective HCFP family there are at least five 
patients with conductive hearing loss in addition to the facial paralysis. The hearing 
impairment is caused by osteopetrosis and otosclerosis of the temporal bones and 
remarkably the high resolution computed tomography scan revealed thickening of the 
calvarial bones. Therefore, I hypothesize that the mutation in MEPE gene could lead to 
both phenotypes. With the premise that MEPE was a candidate gene for otosclerosis I 
analyzed this gene in families with otosclerosis and I identified a second frameshift 
mutation segregating in one family. Furthermore, independent diagnostic exome 
sequencing in one isolated patient with sensorineural hearing loss revealed a third 
frameshift mutation in MEPE. In summary, I have identified three frameshift mutations 
in MEPE in three families with a different phenotype, although all the patients involved 
in this study shared an alteration of the temporal bone structure.  
 
Otosclerosis is a bone remodeling disorder that affects the otic region capsule, and 
leads to fixation of the staping, resulting in hearing loss27. It is a very heterogeneous 
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disease with different age of onset and clinical manifestations. Some theories 
postulate that it is a complex disease caused by a combination of environmental and 
genetic factors. Epidemiological studies and the presence of familial cases support that 
it is and autosomal dominant disorder28,29,30. However, 40-50% of clinical otosclerosis 
cases are sporadic28,29 and there is a high variability of expression within the same 
family suggesting the contribution of environmental factors29. However despite the 
extensive research and the identifications of a variety of factors and loci associated 
with the disease, the etiology is poorly understood. 
 
Interestingly, the oval window, where the facial nerve runs through, is one of the 
regions that is most frequently involved in otosclerosis31. Therefore, the facial nerve 
course can be disrupted as a consequence of the deformation of the temporal bones32 
and thereby facial paralysis. Our results suggest that disruption of MEPE protein could 
result in different phenotypes according to the severity of facial bones deformation 
and the structures affected, indicated by the presence of hearing loss in at least five 
family members. In turn, this alteration variability would explain the presence of 
bilateral and unilateral facial palsy cases, the presence of both hearing loss and facial 
palsy or just hearing loss, in the same family. Thus, in this study the facial paralysis 
might be secondary to the alteration of surrounding body structures of the facial 
nerve, instead of a primary alteration of the facial motor nucleus as it has been 
previously established for HCFP patients33. Although, the HCFP-like features caused by 
a loss-of-function mutation in MEPE appear to lie in a peripheral nervous system 
disruption. The fact that Sanger sequencing did not reveal additional mutation in MEPE 
in our cohort of imply a low frequency of MEPE as the causative gene for HCFP, 
indicating that other HCFP families are likely to have another etiology, which may 
involve the central nervous system, as suggested by the alterations of the FBM nucleus 
as observed in autopsy of a patient from the HCFP1 family33. 
 
The presence of patients carrying the mutations without hearing impairment could be 
explained by the difference of prevalence between the clinical and histological in the 
population. Histological otosclerosis is present in 3,4%ref34of the population, whereas 
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the prevelance of clinical otosclerosis in Caucasican population is 0,3-0,4%ref35. Further 
clinical examinations in the unaffected members carrying the frameshift mutation 
would be required to discard the presence of histologic otosclerosis. Another plausible 
explanation for the variability of clinical expression is the influence of environmental 
factors in otosclerosis, as it is considered as a complex disease25. Finally, otosclerosis 
can be presented as pure sensorineural hearing loss, when it just affect the cochlear 
bones36.  
 
In conclusion, I identified three mutations predicted to disrupt MEPE protein 
increasing the bone mass production, as occurs with other bone remodeling disorders. 
The increased of the bone mass in specific areas of the temporal bones would lead to 
different phenotypes. 
 
Next Generation Sequencing in MBS 
The lack of a clear hereditary pattern in MBS makes the challenge to identify its 
etiology even higher. Since the description of the disorder by Graefe in 1880ref37 and by 
Möbius in 1888ref38, two opposing hypotheses have been coined for the underlying 
pathology: an ischemic process of the hindbrain region39 and a genetic cause40. Except 
for some rare familial cases40-43, the typical MBS phenotype is restricted to isolated 
cases with no secondary affected members in the families. With the assumption that 
the typical MBS cases are caused by de novo mutations, I identified de novo mutations 
in five genes, IFT172, SPO11, CCDC160, PLXND1 and REV3L in eight unrelated patients. 
The missense variant found in IFT172 was discarded as a pathogenic variant in MBS, 
because biallelic mutations are associated with the unrelated Jeune and Mainzer-
Saldino Syndromes and and non-syndromic retinitis pigmentosa44,45. whereas 
heterozygous carriers do not present a phenotype. The missense variant in SPO11 was 
discarded, because its expression is restricted to spermatogenesis and the Spo11 
mutant mouse has no neurodevelopmental features reminiscent of MBS. In addition, 
the SPO11 variant was found in an MBS patient also carrying a de novo PLXND1 
mutation, which was more likely to be causative for the phenotype (see below). A de 
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novo frameshift mutation in the X-chromosomal gene CCDC160 (c.501delA) was found 
in a male MBS patient. This gene is highly intolerant to loss-of functions mutations46 
(Residual and the Variant Intolerance Score (RVIS) 0.014; 54.98th percentile) and there 
are no truncating variants reported in 6503 samples in the ESP database, nor in our in 
house database (5031 samples). Furthermore, Ccdc160 plays a possible role of in 
vascular and nervous system development47, which makes it an attractive MBS 
candidate gene. However, so far no mutations have been identified in other male MBS 
patients. 
 
NGS identified two additional de novo mutations in MBS patients: one in PLXND1 and 
another in REV3L. Screening of both genes in our cohort of 103 MBS patients revealed 
four additional de novo mutations in four unrelated patients, two mutations in PLXND1 
and two in REV3L gene. Subsequently, I analyzed the mutant mice of both genes, 
which revealed phenotypic abnormalities that are matching those of MBS patients. 
PLXND1 belongs to the Semaphorin family which is a group of secreted and 
transmembrane signaling proteins48 and it plays a crucial role in vascular patterning, 
skeletal and central nervous system development49-51. The REV3L protein acts as the 
catalytic subunit of DNA polymerase zeta, a key protein in replication of endogenously 
or exogenously damaged DNA52,53.  
 
The most important finding to proof the causal role of PLXND1 and REV3L in MBS is the 
hypoplasia of the facial motor nucleus in both mutant mice. Apparently, the reduction 
of the number of motoneurons in this nucleus is caused by two different mechanisms. 
Deficiency of Plxnd1 results in a migration failure of the FBM motoneurons during 
development, as previously observed in zebrafish for Plxna3 and Plxna4ref54. In 
contrast, Rev3l haploinsuficiency appears to affect proliferation of neural progenitors, 
resulting in a stochastic ablation of the neurons during development. Other important 
similarities between mutant mice and MBS patient phenotype are the consistent 
hypoplasia of three bundles of nervous fibers, the corpus callosum, the anterior 
commissure and the fasciculus retroflexus in Plxnd1-/- mice. In fact, the latter was 
previously addressed as a cause of denervation of the cranial nerves nuclei in MBS55. 
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Some other characteristics of the mutant phenotypes previously reported in literature, 
such as the vascular defects observed in mouse and zebrafish Plxnd1- mutant50,56,57 and 
vertebral defects50 in Plxnd1- mutant mice, are similar to those described in one of our 
MBS patients. In addition, the disruption of blood vessel system in Plxnd1-mutant 
could explain the vascular hypothesis for MBS etiology and the clinical features of 
some of MBS. Finally, the pleiotropic phenotype of both mouse models52 is 
reminiscent of the heterogeneity of clinical finding of MBS patients. 
 
Our study did not find any genotype-phenotype correlation. Hence, one patient 
carrying a nonsense mutation predicted to disrupt REV3L protein has a HCFP like 
phenotype, whereas the patient with the canonical splice site mutation in REV3L 
presents a severe phenotype with Poland variant and absence of some digits. 
Moreover, although the three patients, with de novo variants in PLXND1, carry 
missense mutations they have a different phenotype. For instance, one of the patients 
is severely affected and she presents a wide variety of additional features, including, 
craniofacial dysmorphism, scoliosis, sensory problems, pes valgus, anisomelia, motor 
retardation, autism and facial hemangiomas, while the other two patients present a 
mild phenotype concurring to the Bethesda Criteria for MBS58,59. 
 
One plausible explanation for the absence of a genotype- phenotype correlation is the 
involvement of stochastic events or other factors, such as environmental factors and 
genetic modifiers, contributing to the phenotype. Common or rare Copy Number 
Variants (CNVs) and Single Nucleotide Polymorphisms (SNPs) affecting genes or their 
regulatory elements can potentially act as genetic modifiers that can cause clinical 
variability. A high proportion of the non- coding regions of our genome is filled with 
regulatory elements60 and mutations in these regions have the potential to modify the 
transcriptional regulation and gene expression, leading in some cases to diseases or 
phenotypic variability61,62. In fact, genetic interactions have been proven to play a role 
in the etiology and severity of some complex neurological diseases63,64 However, 
nowadays the identification of these genetic modifiers and genetic interactions is still 
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challenging and it requires the use of new techniques65. Future research in this field 
could provide new candidate genes and new pathways for either HCFP or MBS. 
 
A third explanation for the clinical variability of mutations, besides the nature of the 
mutation (allelism) and genetic modifiers, might be found in the timing of the 
occurrence of the mutation. The vast majority of reported MBS cases are sporadic with 
a very low recurrence risk for siblings. I have analyzed the presence of the REV3L 
truncating mutation in the three unaffected sons of one of the patients carrying a 
REV3L mutation. The absence of this variant in the offspring together with the lack of 
evidence for dominantly inherited instances of the typical MBS phenotype may suggest 
that MBS mutations such as the one in REV3L are embryonic lethal in most cases. Thus, 
it is possible that the de novo mutations have not occurred in the germline of one of 
the parents, but are somatic and that at least some of the mutation carriers are 
mosaic. Mosaicism could also explain the variable phenotype of mutation carriers. It 
has been suggested that some syndromic brain disorders are caused by somatic 
mutations in progenitor cells, including neural progenitors68. The analysis of DNA from 
several types of tissues would be needed to identify possible mosaicism. These studies 
could also allow the identification of mutations in the MBS genes reported in this 
thesis and that may have gone unnoticed because of their low abundance in blood 
cells.  
 
The results reported in my thesis show that REV3L mutations are associated with both 
MBS and HCFP phenotypes (chapter 4). Consequently, these results suggest that HCFP 
and MBS are not completely separate entities13. The differential phenotype cannot be 
explained the nature of the REV3L mutation and modifying factors seem to be a more 
likely explanation. A similar observation can be made for PLXND1. It is important to 
remark that PLXND1 was the best candidate gene for HCFP66 and MBS67, since the 
identification of the HCFP1 locus14-15. However, Sanger sequencing of PLXND1 in a 
cohort of HCFP patients and targeted next generation sequencing in two HCFP families 
previously linked to HCFP1ref14-15 did not reveal any variant in coding regions (data not 
shown). My current results indicate that PLXND1 is still a good candidate gene for 
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HCFP. Very likely, the mutations in HCFP1 families are located within regulatory 
elements that have not been analyzed previously. Rather, it seems that HCFP and MBS 
can be allelic conditions with different genetic and pathological characteristics that are 
to be explained by the nature of the underlying genetic defect and/or the effect of 
modulatory factors. RNA analysis of lymphoblastoid cells of HCFP1 patients did not 
reveal any qualitative or quantitative differences in PLXND1 transcripts as compared to 
controls67. However, these analyses cannot detect specific disruptions of expression 
that might occur during a tight interval in rhombomeric development.  
 
The results of this study corroborate that exome sequencing is a successful tool to 
identify de novo mutations in Mendelian disorders as it has been previously 
demonstrated in several studies69. Since I have proven the genetic etiology of MBS in 
six cases out of 103 patients, these results suggest that the genetic causes of MBS are 
very heterogeneous and a large number of genes, pathways and probably 
environmental factors and genetic modifiers have not been identified it yet.  
 
Future perspectives 
To expand the knowledge on the genetic defects underlying HCFP and MBS it would be 
very interesting to perform whole genome sequencing analysis (WGS) in new HCFP 
families and MBS patients. WGS enables the detection of variants in non-coding 
regions that are missed by other techniques. In this study we have identified less than 
one de novo variant per individual and recently studies establish a novo mutation rate 
of 1.2×10−8 per generation on average, in coding regions70,71. One of the biggest 
challenges is the assessment of the pathogenecity of the many non coding variants 
identified by WGS using functional analyses. Epigenomics techniques can give new 
clues about the active enhancers than control the expression genes and whose 
variations can modify disease susceptibility or clinical variability60,78. One of the main 
problems of the epigenetic studies is that these chromatin modifications are highly 
species- and cell-specific79-80. A potential strategy to circumvent this problem is the use 
of human induced pluripotent stem cells (hiPSC) to differentiate into the cell type 
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needed for the identification of the enhancers involved in the respective disorder by 
ChIP-seq technology81. Once the enhancers with the genetic variants have been 
identified by these techniques the second challenge is to recognize their targeted 
genes, with technologies like those based on chromatin conformation capture82. 
 
Finally, there is not treatment for HCFP or MBS, patient can just received a palliative 
treatment throughout their lifes for some of the symptoms they present. However, the 
elucidation of the genetic cause of of HCFP or MBS it is very important for a better 
understanding of the pathogenic mechanisms of both disease and for family 
counseling. 
 
206 
 
REFERENCES 
 
1. Lumsden A. The cellular basis of segmentation in the developing hindbrain. 
Trends Neurosci, 1990. 13:329–335. 
2. Vaage S. The segmentation of the primitive neural tube in chick embryos 
(Gallus domesticus). A morphological, histochemical and autoradiographical 
investigation. Ergeb Anat Entwicklungsgesch, 1969. 41:3–87. 
3. Marín F, Aroca P, Puelles L. Hox gene colinear expression in the avian medulla 
oblongata is correlated with pseudorhombomeric domains. Dev Biol, 2008. 323: 230–
247. 
4. Cambronero F, Puelles L. Rostrocaudal nuclear relationships in the avian 
medulla oblongata: a fate map with quail chick chimeras. J Comp Neurol, 2000. 
427:522-545. 
5. Neal HV. Neuromeres and metameres. J Morphol 1918. 31:293–315. 
6. Nieuwenhuys R (1998) Morphogenesis and general structure. In: Nieuwenhuys 
R, ten Donkelaar HJ, Nicholson C (eds) The Central Nervous System of Vertebrates. 
Springer, Berlin, New York 199. pp 159–228. 
7. Murakami Y, Pasqualetti M, Takio Y, Hirano S, Rijli FM, Kuratani S. Segmental 
development of reticulospinal and branchiomotor neurons in lamprey: insights into the 
evolution of the vertebrate hindbrain. Development, 2004. 131:983–995. 
8. Rodríguez-Moldes I, Carrera I, Pose-Méndez S, et al. Regionalization of the 
shark hindbrain: a survey of an ancestral organization. Front Neuroanat, 2011. 5:16. 
doi: 10.3389/fnana. 00016. 
9. Fraser S, Keynes R, Lumsden A. Segmentation in the chick embryo hindbrain is 
defined by cell lineage restrictions. Nature, 1990. 344:431–435. 
10. Martínez S, Geijo E, Sánchez-Vives MV, Puelles L, Gallego R. Reduced junctional 
permeability at interrhombomeric boundaries. Development, 1992.116:1069–1076 
11. Jimenez-Guri E, Udina F, Colas J-F, et al. Clonal analysis in mice underlines the 
importance of rhombomeric boundaries in cell movement restriction during hindbrain 
segmentation. PloS One 2010. 5:e10112. doi:10.1371/journal.pone.0010112. 
12. Legum C, Godel V, Nemet P. Heterogeneity and pleiotropism in the Moebius 
syndrome. Clin Genet, 1981. 20: 254-259. 
13. Verzijl HT, van der Zwaag B, Cruysberg JR, Padberg GW. Möbius syndrome 
redefined: a syndrome of rhombencephalic maldevelopment. Neurology, 2003. 61: 
327-333. 
14. Kremer H, Kuyt LP, van den Helm B, et al. Localization of a gene for Möbius 
syndrome to chromosome 3q by linkage analysis in a Dutch family. Hum Mol Genet, 
1996. 5:1367-1371. 
15. Michielse CB, Bhat M, Brady A, et al. Refinement of the locus for hereditary 
congenital facial palsy on chromosome 3q21 in two unrelated families and screening of 
positional candidate genes. Eur J Hum Genet 2006.14:1306-1312. 
16. Verzijl HT, van den Helm B, Veldman B, et al. A second gene for autosomal 
dominant Möbius syndrome is localized to chromosome 10q, in a Dutch family. Am J 
Hum Genet, 1999. 65:752-756. 
17. Van Der Zwaag B, Verzijl HT, Beltran-Valero De Bernabe D, et al. Mutation 
analysis in the candidate Möbius syndrome genes PGT and GATA2 on chromosome 3 
and EGR2 on chromosome 10. J Med Genet, 2002. 39:E30. 
 207 
 
18. Gowen LC, Petersen DN, Mansolf AL, et al. Targeted disruption of the 
osteoblast/osteocyte factor 45 gene (OF45) results in increased bone formation and 
bone mass. J Biol Chem, 2003. 278: 1998-2007. 
19. Nampei A, Hashimoto J, Hayashida K, et al. Matrix extracellular 
phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone. J Bone 
Miner Metab, 2004. 22:176-184. 
20. Rowe PS, Matsumoto N, Jo OD, Shih RN,  et al. Correction of the mineralization 
defect in hyp mice treated with protease inhibitors CA074 and pepstatin. Bone, 2006. 
39 773-86. 
21. Ogbureke KU, Fisher LW. Expression of SIBLINGs and their partner MMPs in 
salivary glands. J Dent Res, 2004. 83:664-670. 
22. Ogbureke KU, Fisher LW. Renal expression of SIBLING proteins and their partner 
matrix metalloproteinases (MMPs). Kidney Int, 2005. 68:155-166. 
23. Boukpessi T, Gaucher C, Léger T, et al. Abnormal presence of the matrix 
extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif 
peptide in human hypophosphatemic dentin. Am J Pathol, 2010. 177:803-812. 
24. Shibata S, Sakamoto Y, Baba O, Qin C, Murakami G, Cho BH. An 
immunohistochemical study of matrix proteins in the craniofacial cartilage in midterm 
human fetuses. Eur J Histochem, 2013. 57:e39. 
25. David V, Martin A, Hedge AM, Rowe PS. Matrix extracellular 
phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization 
modulator. Endocrinology, 2009. 150: 4012–4023. 
26. Rowe PS, Kumagai Y, Gutierrez G, et al. MEPE has the properties of an 
osteoblastic phosphatonin and minhibin. Bone, 2004. 34, 303-319. 
27. Menger DJ, Tange RA. The aetiology of otosclerosis: a review of the literarure. 
Clin Otolaryngol Allied Sci, 2003. 28: 112-120. 
28. Moumoulidis I, Axon P, Baguley D, Reid E. A review on the genetics of 
otosclerosis. Clin Otolaryngol, 2007. 32:239-347. 
29. Markou K, Goudakos J. n overview of the etiology of otosclerosis. Eur Arch 
Otorhinolaryngol, 2009. 266:25-35. 
30. Uppal S, Bajaj Y, Rustom I, Coatesworth AP. Otosclerosis 1: the 
aetiopathogenesis of otosclerosis. Int J Clin Pract, 2009. 63:1526-1530. 
31. Jahrsdoerfer RA, Congenital absence of the oval window, ORL J. 
Otorhinolaryngol. Relat Spec, 1977. 84: 904—914. 
32. Măru N, Cheiţă AC, Mogoantă CA, Prejoianu B. Intratemporal course of the 
facial nerve: morphological, topographic and morphometric features. Rom J Morphol 
Embryol, 2010. 51:243-248. 
33. Verzijl HT, van der Zwaag B, Lammens M, ten Donkelaar HJ, Padberg GW. The 
neuropathology of hereditary congenital facial palsy vs Möbius syndrome. Neurology, 
2005. 64: 649-653. 
34. De clau F, van Spaendonck M, Timmermans JP, et al. Prevalence of otosclerosis 
in an unselected series of temporal bones. Otol Neurotol, 2001. 22: 596-602. 
35. Altmann F, Glasgold A, Macduff JP. The incidence of otosclerosis as related to 
race and sex. Ann Otol Rhinol Laryngol, 1967. 76: 377-392. 
36. Balle V, Linthicum FH Jr. Histologically proven cochlear otosclerosis with pure 
sensorineural hearing loss. Ann Otol Rhinol Laryngol, 1984. 93:105–111 
208 
 
37. von Graaefe A. In: von Graaefe A, Saemisch T, eds. Handbuch der gerammten 
Augenheilkunde. Vol 6. Leipzig: W Engelmann, 1880. 
38. Möbius, P.J. Ueber angeborene doppelseitige Abducens-Facialis-Lähmung. 
Münchener Medicinische Wochenschrift. Translated in English: Möbius PJ. About 
congenital, 1888. 35:91-94. 
39. Bavinck JN, Weaver DD. Subclavian artery supply disruption sequence: 
hypothesis of a vascular etiology for Poland, Klippel-Feil, and Möbius anomalies. Am J 
Med Genet, 1986. 23: 903-918. 
40. Krueger KE, Friedrich D. Familial congenital disorders of motility of the eye. Klin 
Monbl Augenheilkd, 1963. 142:101-117. 
41. Legum C, Godel V, Nemet P. Heterogeneity and pleiotropism in the Moebius 
syndrome. Clin Genet, 1981. 20: 254-259. 
42. Journel H, Roussey M, Le Marec B. MCA/MR syndrome with oligodactyly and 
Möbius anomaly in first cousins: new syndrome or familial facial-limb disruption 
sequence? Am J Med Genet, 1989. 34: 506-510 
43. Ziter FA, Wiser WC, Robinson A. Three-generation pedigree of a Möbius 
syndrome variant with chromosome translocation. Arch Neurol, 1977. 34: 437-442. 
44. Bujakowska KM, Zhang Q, Siemiatkowska AM, et al. Mutations in IFT172 cause 
isolated retinal degeneration and Bardet-Biedl syndrome. Hum Mol Genet, 2014. 
24:230-242. 
45. Halbritter J, Bizet AA, Schmidts M, et al. Defects in the IFT-B Component IFT172 
cause Jeune and Mainzer-Saldino syndromes in humans. Am J Hum Genet, 2013. 
5:915-925. 
46. Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic Intolerance to 
Functional Variation and the Interpretation of Personal Genomes. PLOS Genetics 2013. 
47. Cox BJ, Vollmer M, Tamplin O, et al. Phenotypic annotation of the mouse X 
chromosome. Genome Res, 2010. 8:1154-1164.  
48. Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev 
Mol Cell Biol 2005. 6: 789–800. 
49. Torres-Vázquez J, Gitler AD, Fraser SD, et al. Semaphorin-plexin signaling guides 
patterning of the developing vasculature. Dev Cell, 2004. 7: 117-123. 
50. Ding JB, Oh WJ, Sabatini BL, Gu C. Semaphorin 3E-Plexin-D1 signaling controls 
pathway-specific synapse formation in the striatum. Nat Neurosci, 2011. 15: 215-223. 
51. Zhang Y, Singh MK, Degenhardt KR, et al. Tie2Cre-mediated inactivation of 
plexinD1 results in congenital heart, vascular and skeletal defects. Dev Biol, 2009. 325: 
82-93. 
52. Van Sloun PP, Varlet I, Sonneveld E, et al. Involvement of mouse Rev3 in 
tolerance of endogenous and exogenous DNA damage. Mol Cell Biol, 2002. 22: 2159-
2169. 
53. Lin W, Wu X, Wang Z. A full-length cDNA of hREV3 is predicted to encode DNA 
polymerase zeta for damage-induced mutagenesis in humans. Mutat Res, 1999. 433: 
89-98. 
54. Tanaka H, Maeda R, Shoji W, et al. Novel mutations affecting axon guidance in 
zebrafish and a role for plexin signalling in the guidance of trigeminal and facial nerve 
axons. Development, 2007. 134: 3259-3269. 
 209 
 
55. Nardelli E, Vio M, Ghersini L, Rizzuto N. Möbius-like syndrome due to multiple 
cerebral abnormalities including hypoplasia of the descending tracts. A case report. J 
Neurol, 1982. 227:11-19. 
56. Zhang Y, Singh MK, Degenhardt KR et al. Tie2Cre-mediated inactivation of 
plexinD1 results in congenital heart, vascular and skeletal defects. Dev Biol, 2009. 325: 
82-93. 
57. Zygmunt T, Gay CM, Blondelle J, et al. Semaphorin-PlexinD1 signaling limits 
angiogenic potential via the VEGF decoy receptor sFlt1. Dev Cell, 2011. 21:301-314. 
58. MacKinnon S, Oystreck DT, Andrews C, Chan WM, Hunter DG, Engle EC. 
Diagnostic distinctions and genetic analysis of patients diagnosed with moebius 
syndrome. Ophthalmology, 2014. 121:1461-1468.  
59. Ventura BV, Miller MT, Danda D, Carta A, Brandt CT, Ventura LO. Profile of 
ocular and systemic characteristics in Möbius sequence patients from Brazil and Italy. 
Arq Bras Oftalmol, 2012. 75: 202-206.  
60. ENCODE Project Consortium, Dunham I, Kundaje A, et al. An integrated 
encyclopedia of DNA elements in the human genome. Nature, 2012. 489: 57- 74. 
61. Prokunina L, Castillejo-Lopez C, Oberg F, et al. A regulatory polymorphism in 
PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. 
Nat Genet, 2002. 32: 666 - 669. 
62. Lettice LA, Heaney SJH, Purdie LA, et al. A long-range Shh enhancer regulates 
expression in the developing limb and fin and is associated with preaxial polydactyly. 
Hum Mol Genet, 2003. 12: 1725- 1735. 
63. van Blitterswijk M, Mullen B, Wojtas A, et al. Genetic modifiers in carriers of 
repeat expansions in the C9ORF72 gene. Mol Neurodegener, 2014. 38: 1326-1329. 
64. Bergen SE, O'Dushlaine CT, Lee PH, et al. Schizophr Res, 2014. 154:48-53. 
65. Tyler AL, McGarr TC, Beyer BJ, Frankel WN, Carter GW. A Genetic Interaction 
Network Model of a Complex Neurological Disease. Genes Brain Behav, 2014. doi: 
10.1111/gbb.12178. 
66. van der Zwaag B, Hellemons AJ, Leenders WP, et al. PLEXIN-D1, a novel plexin 
family member, is expressed in vascular endothelium and the central nervous system 
during mouse embryogenesis. Dev Dyn, 2002. 225: 336-343. 
67. van der Zwaag B, Verzijl HT, Wichers KH, et al. Sequence analysis of the PLEXIN-
D1 gene in Möbius syndrome patients. Pediatr Neurol, 2004. 31114-118. 
68. Poduri A, Evrony GD, Cai X, Walsh CA. Somatic mutation, genomic variation, 
and neurological disease. Science, 2013. 5: 341(6141): 1237758. doi: 
10.1126/science.1237758. 
69. Allen AS, Berkovic SF, Cossette P, et al. De novo mutations in epileptic 
encephalopathies. Nature, 2013. 501: 217-21. 
70. Kong A, Frigge ML, Masson G, et al. Rate of de novo mutations and the 
importance of father's age to disease risk. Nature, 2012. 488:471-475. 
71. Gilissen, C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major 
causes of severe intellectual disability. Nature, 2014. 511, 344-347. 
72. Maurano, MT, Humbert R, Rynes E, et al. Systematic localization of common 
disease-associated variation in regulatory DNA. Science, 2012. 337: 1190 – 1195.  
73. Ward LD, Kellis M. Interpreting noncoding genetic variation in complex traits 
and human disease. Nat Biotechnol, 2012. 30: 1095- 1106.  
210 
 
74. Trynka G, Sandor C, Han B, Xu H, Stranger BE, Liu XS, Raychaudhuri S. 
Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat 
Genet, 2013. 45: 124- 130. 
75. Heintzman ND, Hon GC, Hawkins RD, et al. Histone modifications at human 
enhancers reflect global cell-type-specific gene expression. Nature, 2009. 459, 108-
112. 
76. Weedon MN, Cebola I, Patch AM, et al. Recessive mutations in a distal PTF1A 
enhancer cause isolated pancreatic agenesis. Nat. Genet, 2013. 46, 61- 64. 
77. Sanyal A, Lajoie BR, Jain G, Dekker, J. The long-range interaction landscape of 
gene promoters. Nature, 2012. 489, 109– 113. 
78. Ward LD, Kellis M. Interpreting noncoding genetic variation in complex traits 
and human disease. Nat. Biotechnol, 2012. 30: 1095- 1106. 
79. Trynka G, Sandor C, Han B, et al. Chromatin marks identify critical cell types for 
fine mapping complex trait variants. Nat Genet, 2013. 45, 124- 130. 
80. Heintzman ND, Hon GC, Hawkins RD, et al. Histone modifications at human 
enhancers reflect global cell-type-specific gene expression. Nature, 2009. 459: 108-
112. 
81. Weedon MN, Cebola I, Patch AM, et al. Recessive mutations in a distal PTF1A 
enhancer cause isolated pancreatic agenesis. Nat Genet, 2013. 46: 61- 64. 
82. Sanyal A, Lajoie BR, Jain G, Dekker, J. The long-range interaction landscape of 
gene promoters. Nature, 2012. 489: 109– 113. 
 
  
 
Summary 
 
 
 
 
 
 
  
 213 
 
SUMMARY 
The hindbrain is the caudal region of the brain, containing nuclei with a role in body 
homeostasis, sensory and motor functions. It is also the origin of most of the cranial 
nerves, and consequently, disorders characterized by cranial nerve dysgenesis are 
thought to be the results of disruption occurring during hindbrain development. The 
aim of the research reported in this thesis was to obtain more insight in the molecular 
organization of the developing hindbrain and to identify the genetic causes of two 
cranial dysinnervation disorders: Mönius syndrome (MBS) and hereditary congenital 
facial palsy (HCFP). To achieve these goals, I have used a morphological and a genetic 
approach.  
 
The morphological approach was aimed at the elucidation genes and molecular 
pathways associated with pattern development in the hindbrain. Chapter 1 provides a 
comprehensive overview on hindbrain development and segmentation processes. In 
vertebrates, the developing hindbrain is divided into transverse units called 
rhombomeres (r0-r11). This segmentation patterning is governed by different cues 
such as transcription factors and regulatory mechanisms. Gene expression pattern 
studies during hindbrain development can provide insight in the molecular 
mechanisms underlying in these developmental processes. In this thesis I aimed to 
corroborate the predicted cryptorhombomeres in mouse embryos by correlating Hox 
gene expression patterns and morphological landmarks. In Chapter 2 I describe the 
study of Hox gene expression patterns and how these are correlated with 
morphological landmarks in developing mouse medulla oblongata. The expression 
patterns corroborate the predicted cryptorhombomeres in mice. In addition, the 
expression patterns of hindbrain development genes Calb2, Th, Trh, Gal and Cart are 
integrated in the resulting map. In Chapter 3 I report the identification of candidate 
genes for HCFP following the analysis of gene expression patterns of genes located 
within HCFP1 and HCFP2 loci in the facial motor nucleus in embryonic mice.  
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The genetics approach of my thesis research started with genetic studies carried out in 
MBS patients and families with HCFP. Until the elaboration of this work the genetic 
cause remained elusive, although important efforts have been made to elucidate the 
etiology of both diseases. In recent years, Next Generation Sequencing (NGS) 
technologies have proven to be a useful tool for the elucidation of the genetic cause of 
many disorders. The aim of my genetics approach was to identify the underlying 
genetic causes of MBS and HCFP and to use this knowledge to get insight into the 
molecular and developmental mechanisms that are affected by these gene defects 
during hindbrain development. 
 
In Chapter 4 I describe the identification of frameshift mutations in MEPE in a family 
with HCFP, in one isolated patient with hearing loss and in one family with 
Otosclerosis, which has led to the identification of a novel gene for otosclerosis and 
the first causative gene for HCFP. MEPE encodes a secreted calcium-binding 
phosphoprotein, it is involved in bone mineralization and the mice knockout model 
presents an increase of bone mass production in craniofacial bones. The common 
characteristic shared between the individuals with mutations in MEPE is the alteration 
of the temporal bones, resulting in facial paralysis and deafness phenotypes. 
 
In Chapter 5 the identification of de novo mutations in PLXND1 and REV3L in MBS 
isolated cases by NGS is reported. I identified three de novo mutations in PLXND1 gene 
which is involved in vascular and axonal pathfinding and three de novo mutations in 
REV3L gene, that encodes the catalytic subunit of DNA polymerase ζ, a key protein in 
replication of endogenously or exogenously damaged DNA. We observed a defect in 
replication at BPDE-damaged DNA and an increase of DNA damage of Rev3l-
heterozygous fibroblast. The neuropathological alterations and other clinical findings 
in MBS patients are highly similar to those in the Plxnd1 and Rev3l mutant mice 
reported here.  
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Chapter 6 discusses the main findings of the thesis and reflects the future prospects. 
First, the predicted hidden segments of the avian medulla oblongata are extrapolated 
to the mammals. In addition, this chapter discusses the use of the morphological 
approach for gene candidate identification. It also highlights the power of NGS as a 
tool to identify the genetic cause underlying MBS and HCFP. The extremely 
heterogeneity of clinical features of MBS could be probably explained by the effect of 
environmental factors or variants in non-coding regions. The role of somatic mutations 
in MBS is also discussed. Finally, a possible association between HCFP and MBS is not 
discarded. 
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SAMENVATTING 
De rhombencephalon (hindbrain)  vormen het meest caudale deel van de hersenen, ze 
bevatten kernen die een belangrijke rol spelen in lichaamshomeostase, zintuiglijke en 
motorische functies. Daarnaast zijn ze ook het beginpunt van het merendeel van de 
hersenzenuwen. Om deze redenen wordt verwacht dat aandoeningen met afwijkingen 
in de hersenzenuwen een resultaat zijn van een verstoring tijdens de ontwikkeling van 
de hindbrain. Het doel van het onderzoek dat beschreven is in dit proefschrift is, om 
meer te begrijpen van de ontwikkeling van de hindbrain en om de genetische oorzaak 
van twee ‘’cranial dysinnervation’’ aandoeningen: Möbius syndroom (MBS) en erfelijke 
aangeboren gezicht verlamming (HCFP). In mijn  poging om dit doel te verwezenlijken, 
heb ik gebruik gemaakt van een morfologische en een genetische benadering. 
 
De morfologische benadering was gefocust op het verklaren van genen en moleculaire 
mechanismen die betrokken zijn bij de ontwikkeling van de hindbrain. Hoofdstuk 1 
geeft een uitgebreid overzicht van de ontwikkeling en verdelingsprocessen van de 
hindbrain. Bij gewervelde dieren is de ontwikkelende hindbrain verdeeld in delen die 
rhombomeren worden genoemd (r0-r11).  Het verdelingspatroon hiervan wordt 
geregeld door verschillende signalen zoals transcriptiefactoren en regulatoire 
mechanismen. Studies naar genexpressiepatronen tijdens de ontwikkeling van de 
hindbrain kunnen inzicht geven naar de moleculaire mechanismen die betrokken zijn 
bij dit ontwikkelingsproces. Een doel van het onderzoek in dit proefschrift was om de 
voorspelde crypto-rhombomeren in muis embryo’s te bevestigen door HOX 
genexpressie te correleren aan morfologische kenmerken. In Hoofstuk 2 beschrijf ik de 
studie van HOX genexpressiepatronen en hoe deze correleren aan de morfologische 
kenmerken van de ontwikkelende medulla oblongata in muizen. Deze patronen van 
genexpressie bevestigen de crypto-rhombomeren in muizen. Naast HOX zijn ook de 
expressiepatronen van Calb2, Th, Trh, Gal en Cart toegevoegd aan het resultaten 
overzicht. In hoofdstuk 3 wordt de identificatie van kandidaat genen voor HCFP 
beschreven. Hiervoor zijn de analyses gebruikt van genexpressiepatronen voor genen 
die binnen de loci lagen van HCFP1 en HCFP2 in de ‘’facial motor nucleus’’ van muis 
embryo’s. 
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Het genetische benadering van mijn onderzoek begon met het testen van MBS 
patiënten en families met HCFP. Hoewel er al belangrijke bijdrages waren geleverd om 
de etiologie van beide ziektes te verklaren, was tot aan de totstandkoming van dit 
onderzoek de genetische oorzaak hiervan onbekend. De laatste jaren heeft Next 
Generation Sequencing (NGS) bewezen een bruikbare technologie te zijn om de 
genetische oorzaak van vele aandoeningen te verklaren. Het doel van mijn genetisch 
onderzoek was dan ook om genetische oorzaken te vinden voor MBS en HCFP. Met het 
vinden van deze gendefecten zouden we ook de moleculaire- en ontwikkelingsfactoren 
die  betrokken zijn bij de ontwikkeling van de hindbrain beter kunnen begrijpen. 
 
In Hoofdstuk 5 beschrijf ik de identificatie van frameshift mutaties in MEPE in een 
familie met HCFP, een patiënt met gehoorverlies, en een familie met otosclerose. Dit 
leidde tot de identificatie van een nieuw gen dat betrokken is bij otosclerose, en het 
eerstgevonden oorzakelijke gen voor HCFP. MEPE codeert voor een calciumbindend 
fosfoproteïne, dat betrokken is bij de mineralisatie van botten. Het Mepe knock-out 
muis model laat dan ook een toename van botaanmaak zien in de craniofaciale 
beenderen. De overlappende eigenschappen van de individuen met mutaties in MEPE 
is een verandering van de rotsbeenderen, wat resulteert in gezichtsverlamming en 
gehoorverlies.  
 
In Hoofdstuk 6 wordt de identificatie van de novo mutaties in PLXND1 en REV3L bij 
MBS patiënten beschreven. Ik heb drie de novo mutaties gevonden in het PLXND1 gen, 
dat betrokken is bij vasculaire en axonale ontwikkelingsorientatie. Daarnaast zijn ook 
drie de novo mutaties in REV3L gevonden wat codeert voor een katalytisch onderdeel 
van de DNA polymerase ζ. Dit DNA polymerase is een belangrijk enzym voor de 
replicatie van endogeen en exogeen beschadigd DNA. We hebben een defect 
gevonden in replicatie van BPDE (‘’Benzo[a]pyrene diolexpoxide’’) beschadigd DNA en 
een toename van beschadigd DNA in REV3L-heterozygote fibroblasten. De 
neuropathologische veranderingen en klinische eigenschappen van de MBS patienten 
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komen in hoge mate overeen met de kenmerken van de PLXND1 en REV1L mutante 
muizen die hier beschreven worden. 
 
In Hoofdstuk 7 bediscussieer ik de bevindingen van dit thesis, en bekijk ik de 
vooruitzichten voor de toekomst.  Ten eerste zijn de voorspelde verstopte  segmenten 
van de medulla oblongata in vogels doorgetrokken naar zoogdieren. Daarnaast, wordt 
in dit hoofdstuk het gebruik van de morfologische benadering voor de identificatie van 
kandidaat genen bediscussieerd. Ook wordt de kracht van NGS benadrukt als techniek 
voor het identificeren van genetische oorzaken van MBS en HCFP. De extreme 
verschillen van klinische kenmerken binnen MBS kan waarschijnlijk worden verklaard 
door omgevingsfactoren of varianten in het niet coderende deel van het DNA. Als 
laatste onderwerpen bediscussieer ik nog een mogelijke rol voor somatische mutaties 
in MBS, en de mogelijke overeenkomsten tussen HCFP en MBS.  
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